'rhabdomyosarcome'
(id=394529 ; fe=rhabdomyosarcome ; type=1 ; niveau=200 ; luminosité=50 ; somme entrante=38057 creation date=2014-09-10 touchdate=2025-09-30 14:16:09.000)

≈ 1488 relations sortantes rhabdomyosarcome -- r_associated #0: 490 / 1 -> médecine n1=rhabdomyosarcome | n2=médecine | rel=r_associated | relid=0 | w=490 rhabdomyosarcome -- r_associated #0: 379 / 0.773 -> maladies n1=rhabdomyosarcome | n2=maladies | rel=r_associated | relid=0 | w=379 rhabdomyosarcome -- r_associated #0: 257 / 0.524 -> tumeur maligne n1=rhabdomyosarcome | n2=tumeur maligne | rel=r_associated | relid=0 | w=257 rhabdomyosarcome -- r_associated #0: 251 / 0.512 -> rhabdomyosarcomes n1=rhabdomyosarcome | n2=rhabdomyosarcomes | rel=r_associated | relid=0 | w=251 rhabdomyosarcome -- r_associated #0: 239 / 0.488 -> carcinologie (oncologie) n1=rhabdomyosarcome | n2=carcinologie (oncologie) | rel=r_associated | relid=0 | w=239 rhabdomyosarcome -- r_associated #0: 238 / 0.486 -> cancer n1=rhabdomyosarcome | n2=cancer | rel=r_associated | relid=0 | w=238 rhabdomyosarcome -- r_associated #0: 237 / 0.484 -> sarcomes n1=rhabdomyosarcome | n2=sarcomes | rel=r_associated | relid=0 | w=237 rhabdomyosarcome -- r_associated #0: 237 / 0.484 -> tumeurs maligne n1=rhabdomyosarcome | n2=tumeurs maligne | rel=r_associated | relid=0 | w=237 rhabdomyosarcome -- r_associated #0: 236 / 0.482 -> tumeurs n1=rhabdomyosarcome | n2=tumeurs | rel=r_associated | relid=0 | w=236 rhabdomyosarcome -- r_associated #0: 234 / 0.478 -> Médecine n1=rhabdomyosarcome | n2=Médecine | rel=r_associated | relid=0 | w=234 rhabdomyosarcome -- r_associated #0: 234 / 0.478 -> médecine spécialisée n1=rhabdomyosarcome | n2=médecine spécialisée | rel=r_associated | relid=0 | w=234 rhabdomyosarcome -- r_associated #0: 234 / 0.478 -> spécialités médicales n1=rhabdomyosarcome | n2=spécialités médicales | rel=r_associated | relid=0 | w=234 rhabdomyosarcome -- r_associated #0: 233 / 0.476 -> muscle strié n1=rhabdomyosarcome | n2=muscle strié | rel=r_associated | relid=0 | w=233 rhabdomyosarcome -- r_associated #0: 231 / 0.471 -> médecine (science) n1=rhabdomyosarcome | n2=médecine (science) | rel=r_associated | relid=0 | w=231 rhabdomyosarcome -- r_associated #0: 231 / 0.471 -> processus pathologique n1=rhabdomyosarcome | n2=processus pathologique | rel=r_associated | relid=0 | w=231 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:acinar cell carcinoma n1=rhabdomyosarcome | n2=en:acinar cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:acinar cell neoplasm n1=rhabdomyosarcome | n2=en:acinar cell neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:acral lentiginous melanoma n1=rhabdomyosarcome | n2=en:acral lentiginous melanoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:acute leukemia n1=rhabdomyosarcome | n2=en:acute leukemia | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:acute lymphoblastic leukemia n1=rhabdomyosarcome | n2=en:acute lymphoblastic leukemia | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:acute lymphoblastic leukemia (in 1 patient) n1=rhabdomyosarcome | n2=en:acute lymphoblastic leukemia (in 1 patient) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:acute megakaryoblastic leukemia n1=rhabdomyosarcome | n2=en:acute megakaryoblastic leukemia | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:acute myeloid leukemia n1=rhabdomyosarcome | n2=en:acute myeloid leukemia | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:adamantinoma n1=rhabdomyosarcome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:adenocarcinoma (some) n1=rhabdomyosarcome | n2=en:adenocarcinoma (some) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:adenocarcinoma in villous adenoma n1=rhabdomyosarcome | n2=en:adenocarcinoma in villous adenoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:adenoid cystic carcinoma n1=rhabdomyosarcome | n2=en:adenoid cystic carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:adenomyoepithelioma with carcinoma n1=rhabdomyosarcome | n2=en:adenomyoepithelioma with carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:adenosquamous carcinoma n1=rhabdomyosarcome | n2=en:adenosquamous carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:adnexal and/or skin appendage neoplasm n1=rhabdomyosarcome | n2=en:adnexal and/or skin appendage neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:adnexal carcinoma n1=rhabdomyosarcome | n2=en:adnexal carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:adrenal cortex carcinoma n1=rhabdomyosarcome | n2=en:adrenal cortex carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:adrenal gland pheochromocytoma n1=rhabdomyosarcome | n2=en:adrenal gland pheochromocytoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:adrenal glands are most common site n1=rhabdomyosarcome | n2=en:adrenal glands are most common site | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:adult pleomorphic rhabdomyosarcoma n1=rhabdomyosarcome | n2=en:adult pleomorphic rhabdomyosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:adult rhabdomyoma n1=rhabdomyosarcome | n2=en:adult rhabdomyoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:alveolar rhabdomyosarcoma n1=rhabdomyosarcome | n2=en:alveolar rhabdomyosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:alveolar soft part sarcoma n1=rhabdomyosarcome | n2=en:alveolar soft part sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:amelanotic melanoma n1=rhabdomyosarcome | n2=en:amelanotic melanoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:ameloblastic fibrosarcoma n1=rhabdomyosarcome | n2=en:ameloblastic fibrosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:ameloblastic odontosarcoma n1=rhabdomyosarcome | n2=en:ameloblastic odontosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:anal canal cloacogenic carcinoma n1=rhabdomyosarcome | n2=en:anal canal cloacogenic carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:anaplastic (malignant) meningioma n1=rhabdomyosarcome | n2=en:anaplastic (malignant) meningioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:anaplastic ganglioglioma n1=rhabdomyosarcome | n2=en:anaplastic ganglioglioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:angioleiomyoma n1=rhabdomyosarcome | n2=en:angioleiomyoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:angiomyoliposarcoma n1=rhabdomyosarcome | n2=en:angiomyoliposarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:angiomyosarcoma n1=rhabdomyosarcome | n2=en:angiomyosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:angiosarcoma n1=rhabdomyosarcome | n2=en:angiosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:angiosarcoma nci grade 3 n1=rhabdomyosarcome | n2=en:angiosarcoma nci grade 3 | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:aplastic anemia n1=rhabdomyosarcome | n2=en:aplastic anemia | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:askin tumor n1=rhabdomyosarcome | n2=en:askin tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:aspects of mortality statistics n1=rhabdomyosarcome | n2=en:aspects of mortality statistics | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:associated with other malignancies n1=rhabdomyosarcome | n2=en:associated with other malignancies | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:astrocytoma n1=rhabdomyosarcome | n2=en:astrocytoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:atypical teratoid/rhabdoid tumor n1=rhabdomyosarcome | n2=en:atypical teratoid/rhabdoid tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:avian leukosis/sarcoma n1=rhabdomyosarcome | n2=en:avian leukosis/sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:b-cell lymphomas n1=rhabdomyosarcome | n2=en:b-cell lymphomas | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:basal cell nevus n1=rhabdomyosarcome | n2=en:basal cell nevus | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:basaloid carcinoma n1=rhabdomyosarcome | n2=en:basaloid carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:basocellular neoplasms n1=rhabdomyosarcome | n2=en:basocellular neoplasms | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:beckwith-wiedemann syndrome n1=rhabdomyosarcome | n2=en:beckwith-wiedemann syndrome | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:benign digestive system neoplasm n1=rhabdomyosarcome | n2=en:benign digestive system neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:benign endocrine neoplasm n1=rhabdomyosarcome | n2=en:benign endocrine neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:benign genitourinary tract neoplasm n1=rhabdomyosarcome | n2=en:benign genitourinary tract neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:benign male reproductive system neoplasm n1=rhabdomyosarcome | n2=en:benign male reproductive system neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:benign muscle neoplasm n1=rhabdomyosarcome | n2=en:benign muscle neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:benign myomatous tumor n1=rhabdomyosarcome | n2=en:benign myomatous tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:benign skeletal muscle neoplasm n1=rhabdomyosarcome | n2=en:benign skeletal muscle neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:benign skin neoplasm n1=rhabdomyosarcome | n2=en:benign skin neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:benign teratoma n1=rhabdomyosarcome | n2=en:benign teratoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:biphasic mesothelioma n1=rhabdomyosarcome | n2=en:biphasic mesothelioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:bizarre leiomyoma n1=rhabdomyosarcome | n2=en:bizarre leiomyoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:bladder carcinoma n1=rhabdomyosarcome | n2=en:bladder carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:bladder neoplasm n1=rhabdomyosarcome | n2=en:bladder neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:bladder urothelial carcinoma n1=rhabdomyosarcome | n2=en:bladder urothelial carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:blood vessel neoplasm n1=rhabdomyosarcome | n2=en:blood vessel neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:bone neoplasm n1=rhabdomyosarcome | n2=en:bone neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:bone sarcoma n1=rhabdomyosarcome | n2=en:bone sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:bone-forming neoplasm n1=rhabdomyosarcome | n2=en:bone-forming neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:brain neoplasm n1=rhabdomyosarcome | n2=en:brain neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:breast cancer (rare) n1=rhabdomyosarcome | n2=en:breast cancer (rare) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:breast cancer, lobular n1=rhabdomyosarcome | n2=en:breast cancer, lobular | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:breast carcinoma n1=rhabdomyosarcome | n2=en:breast carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:breast neoplasms benign (incl nipple) n1=rhabdomyosarcome | n2=en:breast neoplasms benign (incl nipple) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:breast neoplasms malignant and unspecified (incl nipple) n1=rhabdomyosarcome | n2=en:breast neoplasms malignant and unspecified (incl nipple) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:breast sarcoma n1=rhabdomyosarcome | n2=en:breast sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:bronchogenic carcinoma (some) n1=rhabdomyosarcome | n2=en:bronchogenic carcinoma (some) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:burkitt leukemia n1=rhabdomyosarcome | n2=en:burkitt leukemia | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:burkitt lymphoma (b-cell lymphoma) n1=rhabdomyosarcome | n2=en:burkitt lymphoma (b-cell lymphoma) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:carcinofibroma n1=rhabdomyosarcome | n2=en:carcinofibroma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:carcinoma ex pleomorphic adenoma n1=rhabdomyosarcome | n2=en:carcinoma ex pleomorphic adenoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:carcinoma in situ n1=rhabdomyosarcome | n2=en:carcinoma in situ | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:carcinoma in situ of sphincter of oddi n1=rhabdomyosarcome | n2=en:carcinoma in situ of sphincter of oddi | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:carcinoma of bone, connective tissue, skin and breast n1=rhabdomyosarcome | n2=en:carcinoma of bone, connective tissue, skin and breast | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:carcinoma of lip, oral cavity and pharynx n1=rhabdomyosarcome | n2=en:carcinoma of lip, oral cavity and pharynx | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:carcinoma of unknown primary origin n1=rhabdomyosarcome | n2=en:carcinoma of unknown primary origin | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:carcinoma with osteoclast-like giant cells n1=rhabdomyosarcome | n2=en:carcinoma with osteoclast-like giant cells | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:carcinoma with pleomorphic, sarcomatoid or sarcomatous elements n1=rhabdomyosarcome | n2=en:carcinoma with pleomorphic, sarcomatoid or sarcomatous elements | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:carcinosarcoma n1=rhabdomyosarcome | n2=en:carcinosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:carcinosarcoma, embryonal n1=rhabdomyosarcome | n2=en:carcinosarcoma, embryonal | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:carotid body paraganglioma n1=rhabdomyosarcome | n2=en:carotid body paraganglioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:carotid body tumors (most common location) n1=rhabdomyosarcome | n2=en:carotid body tumors (most common location) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:carotid body tumors (most common) n1=rhabdomyosarcome | n2=en:carotid body tumors (most common) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:cdisc send terminology n1=rhabdomyosarcome | n2=en:cdisc send terminology | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:cdisc send tumor findings results terminology n1=rhabdomyosarcome | n2=en:cdisc send tumor findings results terminology | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:cellular leiomyoma n1=rhabdomyosarcome | n2=en:cellular leiomyoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:cellular secretion n1=rhabdomyosarcome | n2=en:cellular secretion | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:cervical cancer (rare) n1=rhabdomyosarcome | n2=en:cervical cancer (rare) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:cervical carcinoma n1=rhabdomyosarcome | n2=en:cervical carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:chemical aspects n1=rhabdomyosarcome | n2=en:chemical aspects | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:chemically induced n1=rhabdomyosarcome | n2=en:chemically induced | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:childhood malignant liver neoplasm n1=rhabdomyosarcome | n2=en:childhood malignant liver neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:chondroblastoma, malignant n1=rhabdomyosarcome | n2=en:chondroblastoma, malignant | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:chondroid chordoma n1=rhabdomyosarcome | n2=en:chondroid chordoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:chondrosarcoma n1=rhabdomyosarcome | n2=en:chondrosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:chordoma n1=rhabdomyosarcome | n2=en:chordoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:choriocarcinoma combined with other germ cell elements n1=rhabdomyosarcome | n2=en:choriocarcinoma combined with other germ cell elements | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:chromaffin cell neoplasm n1=rhabdomyosarcome | n2=en:chromaffin cell neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:chronic lymphocytic leukemia n1=rhabdomyosarcome | n2=en:chronic lymphocytic leukemia | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:chronic lymphocytic leukemia, b-cell, susceptibility to n1=rhabdomyosarcome | n2=en:chronic lymphocytic leukemia, b-cell, susceptibility to | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:chronic myelomonocytic leukemia n1=rhabdomyosarcome | n2=en:chronic myelomonocytic leukemia | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:classic kaposi sarcoma n1=rhabdomyosarcome | n2=en:classic kaposi sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:clear cell acanthoma n1=rhabdomyosarcome | n2=en:clear cell acanthoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:clear cell chondrosarcoma n1=rhabdomyosarcome | n2=en:clear cell chondrosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:clear cell renal cell carcinoma n1=rhabdomyosarcome | n2=en:clear cell renal cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:clear cell sarcoma of soft tissue n1=rhabdomyosarcome | n2=en:clear cell sarcoma of soft tissue | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:clear cell sarcoma of the kidney n1=rhabdomyosarcome | n2=en:clear cell sarcoma of the kidney | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:colon adenocarcinoma n1=rhabdomyosarcome | n2=en:colon adenocarcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:colon carcinoma n1=rhabdomyosarcome | n2=en:colon carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:colorectal cancer (in some patients) n1=rhabdomyosarcome | n2=en:colorectal cancer (in some patients) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:colorectal cancer, early onset n1=rhabdomyosarcome | n2=en:colorectal cancer, early onset | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:colorectal carcinoma n1=rhabdomyosarcome | n2=en:colorectal carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:complication aspects n1=rhabdomyosarcome | n2=en:complication aspects | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:congenital mesh qualifier n1=rhabdomyosarcome | n2=en:congenital mesh qualifier | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:connective and soft tissue n1=rhabdomyosarcome | n2=en:connective and soft tissue | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:connective and soft tissue cell n1=rhabdomyosarcome | n2=en:connective and soft tissue cell | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:conventional osteosarcoma n1=rhabdomyosarcome | n2=en:conventional osteosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:costello syndrome n1=rhabdomyosarcome | n2=en:costello syndrome | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:craniopharyngioma n1=rhabdomyosarcome | n2=en:craniopharyngioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:cutaneous melanoma n1=rhabdomyosarcome | n2=en:cutaneous melanoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:cylindromas may show malignant transformation n1=rhabdomyosarcome | n2=en:cylindromas may show malignant transformation | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:cyst n1=rhabdomyosarcome | n2=en:cyst | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:cystadenoma n1=rhabdomyosarcome | n2=en:cystadenoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:cystic partially differentiated nephroblastoma n1=rhabdomyosarcome | n2=en:cystic partially differentiated nephroblastoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:cystic, mucinous and/or serous neoplasm n1=rhabdomyosarcome | n2=en:cystic, mucinous and/or serous neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:dedifferentiated chondrosarcoma n1=rhabdomyosarcome | n2=en:dedifferentiated chondrosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:dedifferentiated chordoma n1=rhabdomyosarcome | n2=en:dedifferentiated chordoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:dedifferentiated liposarcoma n1=rhabdomyosarcome | n2=en:dedifferentiated liposarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:dermatofibrosarcoma protuberans n1=rhabdomyosarcome | n2=en:dermatofibrosarcoma protuberans | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:desmoplastic melanoma n1=rhabdomyosarcome | n2=en:desmoplastic melanoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:desmoplastic mesothelioma n1=rhabdomyosarcome | n2=en:desmoplastic mesothelioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:desmoplastic small round cell tumor n1=rhabdomyosarcome | n2=en:desmoplastic small round cell tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:development of tumors in adulthood n1=rhabdomyosarcome | n2=en:development of tumors in adulthood | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:diagnosis aspect n1=rhabdomyosarcome | n2=en:diagnosis aspect | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:diffuse embryoma n1=rhabdomyosarcome | n2=en:diffuse embryoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:digestive system carcinoma n1=rhabdomyosarcome | n2=en:digestive system carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:digital papillary eccrine carcinoma n1=rhabdomyosarcome | n2=en:digital papillary eccrine carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:duct carcinoma, desmoplastic type n1=rhabdomyosarcome | n2=en:duct carcinoma, desmoplastic type | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:ductal breast carcinoma n1=rhabdomyosarcome | n2=en:ductal breast carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:ductal, lobular and/or medullary neoplasm n1=rhabdomyosarcome | n2=en:ductal, lobular and/or medullary neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:duodenal carcinoid n1=rhabdomyosarcome | n2=en:duodenal carcinoid | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:duodenal carcinoma n1=rhabdomyosarcome | n2=en:duodenal carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:dysgerminoma n1=rhabdomyosarcome | n2=en:dysgerminoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:ear carcinoma n1=rhabdomyosarcome | n2=en:ear carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:early-onset hepatocellular carcinoma n1=rhabdomyosarcome | n2=en:early-onset hepatocellular carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:ebv-induced b-cell lymphoma n1=rhabdomyosarcome | n2=en:ebv-induced b-cell lymphoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:eccrine adenocarcinoma n1=rhabdomyosarcome | n2=en:eccrine adenocarcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:eccrine porocarcinoma n1=rhabdomyosarcome | n2=en:eccrine porocarcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:ectomesenchymoma n1=rhabdomyosarcome | n2=en:ectomesenchymoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:embryologic n1=rhabdomyosarcome | n2=en:embryologic | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:embryonal carcinoma n1=rhabdomyosarcome | n2=en:embryonal carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:embryonal neoplasm n1=rhabdomyosarcome | n2=en:embryonal neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:embryonal rhabdomyosarcoma n1=rhabdomyosarcome | n2=en:embryonal rhabdomyosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:embryonal rhabdomyosarcoma of the mouse pharynx n1=rhabdomyosarcome | n2=en:embryonal rhabdomyosarcoma of the mouse pharynx | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:embryonal tumor with multilayered rosettes, c19mc-altered n1=rhabdomyosarcome | n2=en:embryonal tumor with multilayered rosettes, c19mc-altered | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:encapsulated papillary carcinoma with invasion n1=rhabdomyosarcome | n2=en:encapsulated papillary carcinoma with invasion | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:endocrine neoplasms malignant and unspecified n1=rhabdomyosarcome | n2=en:endocrine neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:endolymphatic sac tumor n1=rhabdomyosarcome | n2=en:endolymphatic sac tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:endometrial adenocarcinoma n1=rhabdomyosarcome | n2=en:endometrial adenocarcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:endometrial carcinoma n1=rhabdomyosarcome | n2=en:endometrial carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:endometrial stromal sarcoma - category n1=rhabdomyosarcome | n2=en:endometrial stromal sarcoma - category | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:endometrial stromal tumors n1=rhabdomyosarcome | n2=en:endometrial stromal tumors | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:enteropathy-associated t-cell lymphoma n1=rhabdomyosarcome | n2=en:enteropathy-associated t-cell lymphoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:enzymology n1=rhabdomyosarcome | n2=en:enzymology | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:ependymoma n1=rhabdomyosarcome | n2=en:ependymoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:epithelial neoplasm n1=rhabdomyosarcome | n2=en:epithelial neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:epithelial tissue n1=rhabdomyosarcome | n2=en:epithelial tissue | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:epithelial-myoepithelial carcinoma n1=rhabdomyosarcome | n2=en:epithelial-myoepithelial carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:epithelioid cell melanoma n1=rhabdomyosarcome | n2=en:epithelioid cell melanoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:epithelioid cell type gastrointestinal stromal tumor n1=rhabdomyosarcome | n2=en:epithelioid cell type gastrointestinal stromal tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:epithelioid leiomyosarcoma n1=rhabdomyosarcome | n2=en:epithelioid leiomyosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:epithelioid malignant peripheral nerve sheath tumor n1=rhabdomyosarcome | n2=en:epithelioid malignant peripheral nerve sheath tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:epithelioid sarcoma n1=rhabdomyosarcome | n2=en:epithelioid sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:epithelioid sarcoma nci grade 3 n1=rhabdomyosarcome | n2=en:epithelioid sarcoma nci grade 3 | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:epithelioid trophoblastic tumor n1=rhabdomyosarcome | n2=en:epithelioid trophoblastic tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:esophageal carcinoma n1=rhabdomyosarcome | n2=en:esophageal carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:essential thrombocythemia n1=rhabdomyosarcome | n2=en:essential thrombocythemia | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:ethnologic n1=rhabdomyosarcome | n2=en:ethnologic | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:etiology aspects n1=rhabdomyosarcome | n2=en:etiology aspects | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:ewing sarcoma n1=rhabdomyosarcome | n2=en:ewing sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:ewing sarcoma/peripheral primitive neuroectodermal tumor n1=rhabdomyosarcome | n2=en:ewing sarcoma/peripheral primitive neuroectodermal tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:exposure as collected domain n1=rhabdomyosarcome | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:extra-adrenal paraganglioma n1=rhabdomyosarcome | n2=en:extra-adrenal paraganglioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:extra-adrenal sympathetic paraganglioma n1=rhabdomyosarcome | n2=en:extra-adrenal sympathetic paraganglioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:extrarenal rhabdoid tumor n1=rhabdomyosarcome | n2=en:extrarenal rhabdoid tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:eye neoplasm n1=rhabdomyosarcome | n2=en:eye neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:fallopian tube carcinoma n1=rhabdomyosarcome | n2=en:fallopian tube carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:familial letterer-siwe disease n1=rhabdomyosarcome | n2=en:familial letterer-siwe disease | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:fascial fibrosarcoma n1=rhabdomyosarcome | n2=en:fascial fibrosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:fetal rhabdomyoma n1=rhabdomyosarcome | n2=en:fetal rhabdomyoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:fibroblastic liposarcoma n1=rhabdomyosarcome | n2=en:fibroblastic liposarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:fibroblastic osteosarcoma n1=rhabdomyosarcome | n2=en:fibroblastic osteosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:fibroelastoma n1=rhabdomyosarcome | n2=en:fibroelastoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:fibroepithelial neoplasm n1=rhabdomyosarcome | n2=en:fibroepithelial neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:fibroma n1=rhabdomyosarcome | n2=en:fibroma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:fibrosarcoma n1=rhabdomyosarcome | n2=en:fibrosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:fibrosarcoma of connective tissue n1=rhabdomyosarcome | n2=en:fibrosarcoma of connective tissue | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:fibrosarcoma of spleen n1=rhabdomyosarcome | n2=en:fibrosarcoma of spleen | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:fibrous connective tissue neoplasm n1=rhabdomyosarcome | n2=en:fibrous connective tissue neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:fibrous dysplasia of bone with intramuscular myxoma n1=rhabdomyosarcome | n2=en:fibrous dysplasia of bone with intramuscular myxoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:follicular dendritic sarcoma of intraabdominal lymph node n1=rhabdomyosarcome | n2=en:follicular dendritic sarcoma of intraabdominal lymph node | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:follicular dendritic sarcoma of lymph nodes of multiple sites n1=rhabdomyosarcome | n2=en:follicular dendritic sarcoma of lymph nodes of multiple sites | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:follicular lymphoma n1=rhabdomyosarcome | n2=en:follicular lymphoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:follicular neoplasm n1=rhabdomyosarcome | n2=en:follicular neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:frequent skin cancer n1=rhabdomyosarcome | n2=en:frequent skin cancer | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:gallbladder carcinoma n1=rhabdomyosarcome | n2=en:gallbladder carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:ganglioneuroblastoma n1=rhabdomyosarcome | n2=en:ganglioneuroblastoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:ganglioneuroma n1=rhabdomyosarcome | n2=en:ganglioneuroma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:gastric adenocarcinoma n1=rhabdomyosarcome | n2=en:gastric adenocarcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:gastric cancer, diffuse type, poorly differentiated, high-grade submucosal lesions n1=rhabdomyosarcome | n2=en:gastric cancer, diffuse type, poorly differentiated, high-grade submucosal lesions | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:gastrointestinal neoplasms malignant and unspecified n1=rhabdomyosarcome | n2=en:gastrointestinal neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:gastrointestinal stromal tumors (less common) n1=rhabdomyosarcome | n2=en:gastrointestinal stromal tumors (less common) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:genetic aspects n1=rhabdomyosarcome | n2=en:genetic aspects | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:genital rhabdomyoma n1=rhabdomyosarcome | n2=en:genital rhabdomyoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:gestational trophoblastic tumor n1=rhabdomyosarcome | n2=en:gestational trophoblastic tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:giant cell astrocytoma n1=rhabdomyosarcome | n2=en:giant cell astrocytoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:giant cell sarcoma n1=rhabdomyosarcome | n2=en:giant cell sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:giant cell sarcoma (except of bone, m-92503) n1=rhabdomyosarcome | n2=en:giant cell sarcoma (except of bone, m-92503) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:giant cell tumor n1=rhabdomyosarcome | n2=en:giant cell tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:glassy cell carcinoma n1=rhabdomyosarcome | n2=en:glassy cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:glioblastoma n1=rhabdomyosarcome | n2=en:glioblastoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:glomus tympanicum paraganglioma n1=rhabdomyosarcome | n2=en:glomus tympanicum paraganglioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:gonadoblastoma n1=rhabdomyosarcome | n2=en:gonadoblastoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:grade 3 n1=rhabdomyosarcome | n2=en:grade 3 | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:granular cell tumor and/or alveolar soft part sarcoma n1=rhabdomyosarcome | n2=en:granular cell tumor and/or alveolar soft part sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:granulocytic sarcoma n1=rhabdomyosarcome | n2=en:granulocytic sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:haematopoietic neoplasms (excl leukaemias and lymphomas) n1=rhabdomyosarcome | n2=en:haematopoietic neoplasms (excl leukaemias and lymphomas) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:hamartoma n1=rhabdomyosarcome | n2=en:hamartoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:head and neck paraganglioma n1=rhabdomyosarcome | n2=en:head and neck paraganglioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:heavy chain disease n1=rhabdomyosarcome | n2=en:heavy chain disease | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:hemangioblastoma, sporadic cerebellar (e.g., 193300.0007) n1=rhabdomyosarcome | n2=en:hemangioblastoma, sporadic cerebellar (e.g., 193300.0007) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:hematopoietic and lymphoid cell neoplasm n1=rhabdomyosarcome | n2=en:hematopoietic and lymphoid cell neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:hemophagocytic lymphohistiocytosis n1=rhabdomyosarcome | n2=en:hemophagocytic lymphohistiocytosis | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:hemophagocytic lymphohistiocytosis (in some patients) n1=rhabdomyosarcome | n2=en:hemophagocytic lymphohistiocytosis (in some patients) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:hepatic and biliary neoplasms benign n1=rhabdomyosarcome | n2=en:hepatic and biliary neoplasms benign | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:hepatobiliary neoplasms malignant and unspecified n1=rhabdomyosarcome | n2=en:hepatobiliary neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:hepatoid adenocarcinoma n1=rhabdomyosarcome | n2=en:hepatoid adenocarcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:hereditary neoplastic syndrome n1=rhabdomyosarcome | n2=en:hereditary neoplastic syndrome | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:high grade surface osteosarcoma n1=rhabdomyosarcome | n2=en:high grade surface osteosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:high risk gastrointestinal stromal tumor n1=rhabdomyosarcome | n2=en:high risk gastrointestinal stromal tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:histiocytic and dendritic cell neoplasm n1=rhabdomyosarcome | n2=en:histiocytic and dendritic cell neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:histiocytic sarcoma n1=rhabdomyosarcome | n2=en:histiocytic sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:historical aspects qualifier n1=rhabdomyosarcome | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:history of rhabdomyosarcoma n1=rhabdomyosarcome | n2=en:history of rhabdomyosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:hodgkin lymphoma n1=rhabdomyosarcome | n2=en:hodgkin lymphoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:hypereosinophilic syndrome n1=rhabdomyosarcome | n2=en:hypereosinophilic syndrome | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:hypersensitivity to chemotherapy n1=rhabdomyosarcome | n2=en:hypersensitivity to chemotherapy | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:hypothalamic neoplasm n1=rhabdomyosarcome | n2=en:hypothalamic neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:idiopathic hypereosinophilic syndrome n1=rhabdomyosarcome | n2=en:idiopathic hypereosinophilic syndrome | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:ileal, cecal, ovarian, and breast tumors, occasionally (endemic form) n1=rhabdomyosarcome | n2=en:ileal, cecal, ovarian, and breast tumors, occasionally (endemic form) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:immunology aspects n1=rhabdomyosarcome | n2=en:immunology aspects | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:in blood n1=rhabdomyosarcome | n2=en:in blood | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:in cerebrospinal fluid n1=rhabdomyosarcome | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:in situ neoplasm (morphology) n1=rhabdomyosarcome | n2=en:in situ neoplasm (morphology) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:in urine n1=rhabdomyosarcome | n2=en:in urine | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:increased hepatocellular carcinoma risk n1=rhabdomyosarcome | n2=en:increased hepatocellular carcinoma risk | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:increased incidence of hepatocellular carcinoma n1=rhabdomyosarcome | n2=en:increased incidence of hepatocellular carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:increased incidence of rectosigmoid cancer n1=rhabdomyosarcome | n2=en:increased incidence of rectosigmoid cancer | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:increased risk for hematologic cancer, particularly acute myeloid leukemia n1=rhabdomyosarcome | n2=en:increased risk for hematologic cancer, particularly acute myeloid leukemia | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:increased risk for lymphoma hodgkin disease n1=rhabdomyosarcome | n2=en:increased risk for lymphoma hodgkin disease | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:increased risk for multiple myeloma n1=rhabdomyosarcome | n2=en:increased risk for multiple myeloma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:increased risk for wilms tumor n1=rhabdomyosarcome | n2=en:increased risk for wilms tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:increased risk of breast cancer in women n1=rhabdomyosarcome | n2=en:increased risk of breast cancer in women | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:increased risk of chondrosarcoma n1=rhabdomyosarcome | n2=en:increased risk of chondrosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:increased risk of chondrosarcoma (mean age of onset 31 years) n1=rhabdomyosarcome | n2=en:increased risk of chondrosarcoma (mean age of onset 31 years) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:increased risk of gastrointestinal cancer n1=rhabdomyosarcome | n2=en:increased risk of gastrointestinal cancer | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:increased risk of hematologic malignancy (1 patient) n1=rhabdomyosarcome | n2=en:increased risk of hematologic malignancy (1 patient) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:increased risk of leukemia n1=rhabdomyosarcome | n2=en:increased risk of leukemia | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:increased risk of malignancy n1=rhabdomyosarcome | n2=en:increased risk of malignancy | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:increased risk of malignancy (classic feature) n1=rhabdomyosarcome | n2=en:increased risk of malignancy (classic feature) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:increased risk of malignant lymphoma n1=rhabdomyosarcome | n2=en:increased risk of malignant lymphoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:increased risk of medulloblastoma (rare) n1=rhabdomyosarcome | n2=en:increased risk of medulloblastoma (rare) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:increased risk of meningioma n1=rhabdomyosarcome | n2=en:increased risk of meningioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:increased risk of myelodysplastic syndrome or leukemia (in some patients) n1=rhabdomyosarcome | n2=en:increased risk of myelodysplastic syndrome or leukemia (in some patients) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:increased risk of myelodysplastic syndromes n1=rhabdomyosarcome | n2=en:increased risk of myelodysplastic syndromes | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:increased risk of pancreatic cancer n1=rhabdomyosarcome | n2=en:increased risk of pancreatic cancer | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:increased susceptibility to b-cell lymphoma n1=rhabdomyosarcome | n2=en:increased susceptibility to b-cell lymphoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:increased susceptibility to cancer n1=rhabdomyosarcome | n2=en:increased susceptibility to cancer | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:increased susceptibility to carcinomas, especially cancers related to cutaneous viral infections n1=rhabdomyosarcome | n2=en:increased susceptibility to carcinomas, especially cancers related to cutaneous viral infections | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:index tumor n1=rhabdomyosarcome | n2=en:index tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:indolent clinical course n1=rhabdomyosarcome | n2=en:indolent clinical course | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:indolent systemic mastocytosis n1=rhabdomyosarcome | n2=en:indolent systemic mastocytosis | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:infantile fibrosarcoma n1=rhabdomyosarcome | n2=en:infantile fibrosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:infiltrating carcinoma with ductal and lobular features n1=rhabdomyosarcome | n2=en:infiltrating carcinoma with ductal and lobular features | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:infiltrating duct mixed with other types of carcinoma n1=rhabdomyosarcome | n2=en:infiltrating duct mixed with other types of carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:infiltrating lobular mixed with other types of carcinoma n1=rhabdomyosarcome | n2=en:infiltrating lobular mixed with other types of carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:interdigitating dendritic cell sarcoma n1=rhabdomyosarcome | n2=en:interdigitating dendritic cell sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:intracytoplasmic eosinophilic inclusion n1=rhabdomyosarcome | n2=en:intracytoplasmic eosinophilic inclusion | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:intraductal papillary adenocarcinoma with invasion n1=rhabdomyosarcome | n2=en:intraductal papillary adenocarcinoma with invasion | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:invasive ductal and lobular carcinoma in situ n1=rhabdomyosarcome | n2=en:invasive ductal and lobular carcinoma in situ | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:invasive micropapillary breast carcinoma n1=rhabdomyosarcome | n2=en:invasive micropapillary breast carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:jaw and kidney tumor (endemic form) n1=rhabdomyosarcome | n2=en:jaw and kidney tumor (endemic form) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:jugulotympanic paraganglioma n1=rhabdomyosarcome | n2=en:jugulotympanic paraganglioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:juvenile ovarian granulosa cell tumor n1=rhabdomyosarcome | n2=en:juvenile ovarian granulosa cell tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:kaposi sarcoma n1=rhabdomyosarcome | n2=en:kaposi sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:kaposi sarcoma (1 patient) n1=rhabdomyosarcome | n2=en:kaposi sarcoma (1 patient) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:kaposi sarcoma nci grade 3 n1=rhabdomyosarcome | n2=en:kaposi sarcoma nci grade 3 | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:kidney sarcoma n1=rhabdomyosarcome | n2=en:kidney sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:large cell carcinoma n1=rhabdomyosarcome | n2=en:large cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:large cell neuroendocrine carcinoma n1=rhabdomyosarcome | n2=en:large cell neuroendocrine carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:laryngeal carcinoma n1=rhabdomyosarcome | n2=en:laryngeal carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:leiomyoma n1=rhabdomyosarcome | n2=en:leiomyoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:leiomyomatosis n1=rhabdomyosarcome | n2=en:leiomyomatosis | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:leiomyosarcoma n1=rhabdomyosarcome | n2=en:leiomyosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:leiomyosarcoma nci grade 3 n1=rhabdomyosarcome | n2=en:leiomyosarcoma nci grade 3 | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:leukemia (both all and aml) n1=rhabdomyosarcome | n2=en:leukemia (both all and aml) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:leukemia (category) n1=rhabdomyosarcome | n2=en:leukemia (category) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:lipoma n1=rhabdomyosarcome | n2=en:lipoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:lipomatous neoplasm n1=rhabdomyosarcome | n2=en:lipomatous neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:liposarcoma n1=rhabdomyosarcome | n2=en:liposarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:liposarcoma of connective tissue n1=rhabdomyosarcome | n2=en:liposarcoma of connective tissue | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:liver sarcoma n1=rhabdomyosarcome | n2=en:liver sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:lobular breast carcinoma n1=rhabdomyosarcome | n2=en:lobular breast carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:low grade central osteosarcoma n1=rhabdomyosarcome | n2=en:low grade central osteosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:low grade myofibroblastic sarcoma n1=rhabdomyosarcome | n2=en:low grade myofibroblastic sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:low grade serous carcinoma n1=rhabdomyosarcome | n2=en:low grade serous carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:low incidence of plexiform neurofibromas n1=rhabdomyosarcome | n2=en:low incidence of plexiform neurofibromas | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:lung adenocarcinoma n1=rhabdomyosarcome | n2=en:lung adenocarcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:lymphangiosarcoma n1=rhabdomyosarcome | n2=en:lymphangiosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:lymphatic vessel neoplasm n1=rhabdomyosarcome | n2=en:lymphatic vessel neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:lymphoma n1=rhabdomyosarcome | n2=en:lymphoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:lymphomas nec n1=rhabdomyosarcome | n2=en:lymphomas nec | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:lymphoproliferative disorder (in some patients) n1=rhabdomyosarcome | n2=en:lymphoproliferative disorder (in some patients) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:lymphosarcoma n1=rhabdomyosarcome | n2=en:lymphosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:lymphosarcoma of lymph nodes of multiple sites n1=rhabdomyosarcome | n2=en:lymphosarcoma of lymph nodes of multiple sites | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignancy (34%) n1=rhabdomyosarcome | n2=en:malignancy (34%) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignancy in approximately 10% n1=rhabdomyosarcome | n2=en:malignancy in approximately 10% | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignancy in giant cell tumor of bone n1=rhabdomyosarcome | n2=en:malignancy in giant cell tumor of bone | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant adrenal gland pheochromocytoma n1=rhabdomyosarcome | n2=en:malignant adrenal gland pheochromocytoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant aortic body tumor n1=rhabdomyosarcome | n2=en:malignant aortic body tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant blood vessel neoplasm n1=rhabdomyosarcome | n2=en:malignant blood vessel neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant bone neoplasm n1=rhabdomyosarcome | n2=en:malignant bone neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant breast neoplasm n1=rhabdomyosarcome | n2=en:malignant breast neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant carotid body paraganglioma n1=rhabdomyosarcome | n2=en:malignant carotid body paraganglioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant central nervous system neoplasm n1=rhabdomyosarcome | n2=en:malignant central nervous system neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant digestive system neoplasm n1=rhabdomyosarcome | n2=en:malignant digestive system neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant epithelioma n1=rhabdomyosarcome | n2=en:malignant epithelioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant esophageal neoplasm n1=rhabdomyosarcome | n2=en:malignant esophageal neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant extra-adrenal paraganglioma n1=rhabdomyosarcome | n2=en:malignant extra-adrenal paraganglioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant fibrous histiocytoma (in about 35% of patients) n1=rhabdomyosarcome | n2=en:malignant fibrous histiocytoma (in about 35% of patients) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant giant cell neoplasm n1=rhabdomyosarcome | n2=en:malignant giant cell neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant glioma n1=rhabdomyosarcome | n2=en:malignant glioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant glomus tumor n1=rhabdomyosarcome | n2=en:malignant glomus tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant granulosa cell tumor n1=rhabdomyosarcome | n2=en:malignant granulosa cell tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant histiocytosis n1=rhabdomyosarcome | n2=en:malignant histiocytosis | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant immunoproliferative disease (clinical) n1=rhabdomyosarcome | n2=en:malignant immunoproliferative disease (clinical) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant immunoproliferative neoplasm n1=rhabdomyosarcome | n2=en:malignant immunoproliferative neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant leydig cell tumor n1=rhabdomyosarcome | n2=en:malignant leydig cell tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant mast cell neoplasm n1=rhabdomyosarcome | n2=en:malignant mast cell neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant mesenchymoma n1=rhabdomyosarcome | n2=en:malignant mesenchymoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant mesenchymoma metastatic n1=rhabdomyosarcome | n2=en:malignant mesenchymoma metastatic | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant mesenchymoma recurrent n1=rhabdomyosarcome | n2=en:malignant mesenchymoma recurrent | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant mesothelioma n1=rhabdomyosarcome | n2=en:malignant mesothelioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant mixed neoplasm n1=rhabdomyosarcome | n2=en:malignant mixed neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant mixed tumor, carcinomatous type n1=rhabdomyosarcome | n2=en:malignant mixed tumor, carcinomatous type | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant mixed tumor, chondrosarcomatous type n1=rhabdomyosarcome | n2=en:malignant mixed tumor, chondrosarcomatous type | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant mixed tumor, osteosarcomatous type n1=rhabdomyosarcome | n2=en:malignant mixed tumor, osteosarcomatous type | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant musculoskeletal and connective tissue neoplasms n1=rhabdomyosarcome | n2=en:malignant musculoskeletal and connective tissue neoplasms | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant myoepithelioma n1=rhabdomyosarcome | n2=en:malignant myoepithelioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant myomatous tumor n1=rhabdomyosarcome | n2=en:malignant myomatous tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant neoplasm n1=rhabdomyosarcome | n2=en:malignant neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant neoplasm (morphology) n1=rhabdomyosarcome | n2=en:malignant neoplasm (morphology) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant neoplasm musculoskeletal n1=rhabdomyosarcome | n2=en:malignant neoplasm musculoskeletal | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant neoplasm of connective tissue n1=rhabdomyosarcome | n2=en:malignant neoplasm of connective tissue | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant neoplasm of digestive organs and peritoneum n1=rhabdomyosarcome | n2=en:malignant neoplasm of digestive organs and peritoneum | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant neoplasm of lip, oral cavity and pharynx n1=rhabdomyosarcome | n2=en:malignant neoplasm of lip, oral cavity and pharynx | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant neoplasm of nail apparatus n1=rhabdomyosarcome | n2=en:malignant neoplasm of nail apparatus | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant neoplasm of other and unspecified sites n1=rhabdomyosarcome | n2=en:malignant neoplasm of other and unspecified sites | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant neoplasm, uncertain whether primary or metastatic n1=rhabdomyosarcome | n2=en:malignant neoplasm, uncertain whether primary or metastatic | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant neoplasms of respiratory and intrathoracic organs n1=rhabdomyosarcome | n2=en:malignant neoplasms of respiratory and intrathoracic organs | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant neuroendocrine neoplasm, epithelial n1=rhabdomyosarcome | n2=en:malignant neuroendocrine neoplasm, epithelial | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant neuroendocrine neoplasm, neural n1=rhabdomyosarcome | n2=en:malignant neuroendocrine neoplasm, neural | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant neuroendocrine tumor n1=rhabdomyosarcome | n2=en:malignant neuroendocrine tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant odontogenic ghost cell tumor n1=rhabdomyosarcome | n2=en:malignant odontogenic ghost cell tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant ossifying fibromyxoid tumor n1=rhabdomyosarcome | n2=en:malignant ossifying fibromyxoid tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant ovarian brenner tumor n1=rhabdomyosarcome | n2=en:malignant ovarian brenner tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant ovarian neoplasm n1=rhabdomyosarcome | n2=en:malignant ovarian neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant ovarian thecoma n1=rhabdomyosarcome | n2=en:malignant ovarian thecoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant pecoma n1=rhabdomyosarcome | n2=en:malignant pecoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant peripheral nerve sheath tumor with perineurial differentiation n1=rhabdomyosarcome | n2=en:malignant peripheral nerve sheath tumor with perineurial differentiation | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant peripheral nerve sheath tumors (21%) n1=rhabdomyosarcome | n2=en:malignant peripheral nerve sheath tumors (21%) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant pharyngeal neoplasm n1=rhabdomyosarcome | n2=en:malignant pharyngeal neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant phyllodes tumor n1=rhabdomyosarcome | n2=en:malignant phyllodes tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant rhabdomyoblast n1=rhabdomyosarcome | n2=en:malignant rhabdomyoblast | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant sebaceous neoplasm n1=rhabdomyosarcome | n2=en:malignant sebaceous neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant sertoli cell tumor n1=rhabdomyosarcome | n2=en:malignant sertoli cell tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant sex cord-stromal tumor n1=rhabdomyosarcome | n2=en:malignant sex cord-stromal tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant skeletal muscle cell n1=rhabdomyosarcome | n2=en:malignant skeletal muscle cell | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant skeletal muscle neoplasm n1=rhabdomyosarcome | n2=en:malignant skeletal muscle neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant skin neoplasm n1=rhabdomyosarcome | n2=en:malignant skin neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant solitary fibrous tumor n1=rhabdomyosarcome | n2=en:malignant solitary fibrous tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant spindle cell neoplasm n1=rhabdomyosarcome | n2=en:malignant spindle cell neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant struma ovarii n1=rhabdomyosarcome | n2=en:malignant struma ovarii | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant tenosynovial giant cell tumor n1=rhabdomyosarcome | n2=en:malignant tenosynovial giant cell tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant thymoma n1=rhabdomyosarcome | n2=en:malignant thymoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant thyroid gland neoplasm n1=rhabdomyosarcome | n2=en:malignant thyroid gland neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant triton tumor n1=rhabdomyosarcome | n2=en:malignant triton tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant tumor of lymphoid hemopoietic and related tissue n1=rhabdomyosarcome | n2=en:malignant tumor of lymphoid hemopoietic and related tissue | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant tumor, clear cell type n1=rhabdomyosarcome | n2=en:malignant tumor, clear cell type | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant tumor, small cell type n1=rhabdomyosarcome | n2=en:malignant tumor, small cell type | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant type b1 thymoma n1=rhabdomyosarcome | n2=en:malignant type b1 thymoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:malignant uterine neoplasm n1=rhabdomyosarcome | n2=en:malignant uterine neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:mammary ductal fibroadenoma n1=rhabdomyosarcome | n2=en:mammary ductal fibroadenoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:mast cell neoplasm n1=rhabdomyosarcome | n2=en:mast cell neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:mast cell sarcoma n1=rhabdomyosarcome | n2=en:mast cell sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:medullary carcinoma with lymphoid stroma n1=rhabdomyosarcome | n2=en:medullary carcinoma with lymphoid stroma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:medulloepithelioma n1=rhabdomyosarcome | n2=en:medulloepithelioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:melanocytic neoplasm n1=rhabdomyosarcome | n2=en:melanocytic neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:melanoma arising from blue nevus n1=rhabdomyosarcome | n2=en:melanoma arising from blue nevus | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:melanoma in junctional nevus n1=rhabdomyosarcome | n2=en:melanoma in junctional nevus | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:meningeal melanomatosis n1=rhabdomyosarcome | n2=en:meningeal melanomatosis | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:meningeal sarcomatosis n1=rhabdomyosarcome | n2=en:meningeal sarcomatosis | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:meningioma n1=rhabdomyosarcome | n2=en:meningioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:merkel cell carcinoma n1=rhabdomyosarcome | n2=en:merkel cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:mesenchymal chondrosarcoma n1=rhabdomyosarcome | n2=en:mesenchymal chondrosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:mesonephric adenocarcinoma n1=rhabdomyosarcome | n2=en:mesonephric adenocarcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:mesonephric neoplasm n1=rhabdomyosarcome | n2=en:mesonephric neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:mesothelial neoplasm n1=rhabdomyosarcome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:mesothelioma n1=rhabdomyosarcome | n2=en:mesothelioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:mesothelioma, malignant, after asbestos exposure n1=rhabdomyosarcome | n2=en:mesothelioma, malignant, after asbestos exposure | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:metabolic aspects n1=rhabdomyosarcome | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:metaplastic carcinoma n1=rhabdomyosarcome | n2=en:metaplastic carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:metastases to muscle n1=rhabdomyosarcome | n2=en:metastases to muscle | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:metastases to perineum n1=rhabdomyosarcome | n2=en:metastases to perineum | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:metastasis to lymph node from adenocarcinoma n1=rhabdomyosarcome | n2=en:metastasis to lymph node from adenocarcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:metastasizing ameloblastoma n1=rhabdomyosarcome | n2=en:metastasizing ameloblastoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:metastasizing leiomyoma n1=rhabdomyosarcome | n2=en:metastasizing leiomyoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:metastatic alveolar soft part sarcoma n1=rhabdomyosarcome | n2=en:metastatic alveolar soft part sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:metastatic angiosarcoma n1=rhabdomyosarcome | n2=en:metastatic angiosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:metastatic chondrosarcoma n1=rhabdomyosarcome | n2=en:metastatic chondrosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:metastatic epithelioid sarcoma n1=rhabdomyosarcome | n2=en:metastatic epithelioid sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:metastatic extraskeletal ewing sarcoma n1=rhabdomyosarcome | n2=en:metastatic extraskeletal ewing sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:metastatic extraskeletal osteosarcoma n1=rhabdomyosarcome | n2=en:metastatic extraskeletal osteosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:metastatic fibrosarcoma n1=rhabdomyosarcome | n2=en:metastatic fibrosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:metastatic leiomyosarcoma n1=rhabdomyosarcome | n2=en:metastatic leiomyosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:metastatic liposarcoma n1=rhabdomyosarcome | n2=en:metastatic liposarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:metastatic malignant neoplasm in the bone n1=rhabdomyosarcome | n2=en:metastatic malignant neoplasm in the bone | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:metastatic malignant neoplasm in the chest wall n1=rhabdomyosarcome | n2=en:metastatic malignant neoplasm in the chest wall | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:metastatic malignant peripheral nerve sheath tumor n1=rhabdomyosarcome | n2=en:metastatic malignant peripheral nerve sheath tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:metastatic neoplasm n1=rhabdomyosarcome | n2=en:metastatic neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:metastatic osteosarcoma n1=rhabdomyosarcome | n2=en:metastatic osteosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:metastatic peripheral primitive neuroectodermal tumor of bone n1=rhabdomyosarcome | n2=en:metastatic peripheral primitive neuroectodermal tumor of bone | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:metastatic qualifier n1=rhabdomyosarcome | n2=en:metastatic qualifier | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:microbiological n1=rhabdomyosarcome | n2=en:microbiological | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:micropapillary transitional cell carcinoma n1=rhabdomyosarcome | n2=en:micropapillary transitional cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:minimal deviation malignant melanoma n1=rhabdomyosarcome | n2=en:minimal deviation malignant melanoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:mir29b2 gene n1=rhabdomyosarcome | n2=en:mir29b2 gene | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:mir29b2 wt allele n1=rhabdomyosarcome | n2=en:mir29b2 wt allele | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:mir29c gene n1=rhabdomyosarcome | n2=en:mir29c gene | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:miscellaneous and site unspecified neoplasms malignant and unspecified n1=rhabdomyosarcome | n2=en:miscellaneous and site unspecified neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:mixed acinar-ductal carcinoma n1=rhabdomyosarcome | n2=en:mixed acinar-ductal carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:mixed epithelioid and spindle cell melanoma n1=rhabdomyosarcome | n2=en:mixed epithelioid and spindle cell melanoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:mixed glioma n1=rhabdomyosarcome | n2=en:mixed glioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:mixed liposarcoma n1=rhabdomyosarcome | n2=en:mixed liposarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:mixed mesodermal (mullerian) tumor n1=rhabdomyosarcome | n2=en:mixed mesodermal (mullerian) tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:mixed tumor, mesodermal n1=rhabdomyosarcome | n2=en:mixed tumor, mesodermal | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:monomorphic cells, medium-sized, with round nuclei, multiple nucleoli, and moderate amount of cytoplasm n1=rhabdomyosarcome | n2=en:monomorphic cells, medium-sized, with round nuclei, multiple nucleoli, and moderate amount of cytoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:mosaic variegated aneuploidy syndrome n1=rhabdomyosarcome | n2=en:mosaic variegated aneuploidy syndrome | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:mouse cardiac rhabdomyosarcoma n1=rhabdomyosarcome | n2=en:mouse cardiac rhabdomyosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:mouse rhabdomyosarcoma n1=rhabdomyosarcome | n2=en:mouse rhabdomyosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:mucoepidermoid carcinoma n1=rhabdomyosarcome | n2=en:mucoepidermoid carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:mucosal lentiginous melanoma n1=rhabdomyosarcome | n2=en:mucosal lentiginous melanoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:mucosal neuromas n1=rhabdomyosarcome | n2=en:mucosal neuromas | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:multiple bilateral renal angiomyolipoma n1=rhabdomyosarcome | n2=en:multiple bilateral renal angiomyolipoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:multiple giant cell granulomas (bones, joints, soft tissues) n1=rhabdomyosarcome | n2=en:multiple giant cell granulomas (bones, joints, soft tissues) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:multiple schwannomas n1=rhabdomyosarcome | n2=en:multiple schwannomas | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:multiple tumors in 28% of patients n1=rhabdomyosarcome | n2=en:multiple tumors in 28% of patients | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:multiple tumors in 74% of patients n1=rhabdomyosarcome | n2=en:multiple tumors in 74% of patients | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:muscle cell n1=rhabdomyosarcome | n2=en:muscle cell | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:muscle tissue n1=rhabdomyosarcome | n2=en:muscle tissue | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:muscle tumor, special type n1=rhabdomyosarcome | n2=en:muscle tumor, special type | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:muscle tumors (all subtypes) n1=rhabdomyosarcome | n2=en:muscle tumors (all subtypes) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:myelodysplastic syndrome n1=rhabdomyosarcome | n2=en:myelodysplastic syndrome | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:myelodysplastic syndrome with isolated del(5q) n1=rhabdomyosarcome | n2=en:myelodysplastic syndrome with isolated del(5q) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:myelodysplastic syndrome, no icd-o subtype n1=rhabdomyosarcome | n2=en:myelodysplastic syndrome, no icd-o subtype | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:myeloid sarcoma n1=rhabdomyosarcome | n2=en:myeloid sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:myeloliposarcoma n1=rhabdomyosarcome | n2=en:myeloliposarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:myeloproliferative neoplasm n1=rhabdomyosarcome | n2=en:myeloproliferative neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:myocardial rhabdomyoma n1=rhabdomyosarcome | n2=en:myocardial rhabdomyoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:myogenic sarcoma, nos n1=rhabdomyosarcome | n2=en:myogenic sarcoma, nos | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:myxofibrosarcoma n1=rhabdomyosarcome | n2=en:myxofibrosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:myxoid chondrosarcoma n1=rhabdomyosarcome | n2=en:myxoid chondrosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:myxoid leiomyosarcoma n1=rhabdomyosarcome | n2=en:myxoid leiomyosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:myxoid liposarcoma n1=rhabdomyosarcome | n2=en:myxoid liposarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:myxoid subcutaneous tumors n1=rhabdomyosarcome | n2=en:myxoid subcutaneous tumors | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:myxomatous neoplasm n1=rhabdomyosarcome | n2=en:myxomatous neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:myxosarcoma n1=rhabdomyosarcome | n2=en:myxosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:nci ctep sdc rhabdomyosarcoma sub-category terminology n1=rhabdomyosarcome | n2=en:nci ctep sdc rhabdomyosarcoma sub-category terminology | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:ncit neoplasm core terminology n1=rhabdomyosarcome | n2=en:ncit neoplasm core terminology | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:ncoa1 gene n1=rhabdomyosarcome | n2=en:ncoa1 gene | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:ncoa1 wt allele n1=rhabdomyosarcome | n2=en:ncoa1 wt allele | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neonatal research network terminology n1=rhabdomyosarcome | n2=en:neonatal research network terminology | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasm n1=rhabdomyosarcome | n2=en:neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasm by morphology n1=rhabdomyosarcome | n2=en:neoplasm by morphology | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasm by special category n1=rhabdomyosarcome | n2=en:neoplasm by special category | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasm of muscle of head n1=rhabdomyosarcome | n2=en:neoplasm of muscle of head | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasm of muscle of lower limb n1=rhabdomyosarcome | n2=en:neoplasm of muscle of lower limb | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasm of muscle of neck n1=rhabdomyosarcome | n2=en:neoplasm of muscle of neck | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasm of muscle of trunk n1=rhabdomyosarcome | n2=en:neoplasm of muscle of trunk | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasm of muscle of upper limb n1=rhabdomyosarcome | n2=en:neoplasm of muscle of upper limb | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasm of perivascular myoid type - category n1=rhabdomyosarcome | n2=en:neoplasm of perivascular myoid type - category | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasm of uncertain behavior of endocrine glands and nervous system n1=rhabdomyosarcome | n2=en:neoplasm of uncertain behavior of endocrine glands and nervous system | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasm of uncertain behavior of muscle n1=rhabdomyosarcome | n2=en:neoplasm of uncertain behavior of muscle | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasm of uncertain behavior of other and unspecified sites and tissues n1=rhabdomyosarcome | n2=en:neoplasm of uncertain behavior of other and unspecified sites and tissues | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasm of uncertain behavior of other specified sites n1=rhabdomyosarcome | n2=en:neoplasm of uncertain behavior of other specified sites | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasm of uncertain behavior, site unspecified n1=rhabdomyosarcome | n2=en:neoplasm of uncertain behavior, site unspecified | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasm of unspecified nature of bone, soft tissue, and skin n1=rhabdomyosarcome | n2=en:neoplasm of unspecified nature of bone, soft tissue, and skin | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasm of unspecified nature of endocrine glands and other parts of nervous system n1=rhabdomyosarcome | n2=en:neoplasm of unspecified nature of endocrine glands and other parts of nervous system | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasm of unspecified nature of other genitourinary organs n1=rhabdomyosarcome | n2=en:neoplasm of unspecified nature of other genitourinary organs | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasm of unspecified nature of other specified sites n1=rhabdomyosarcome | n2=en:neoplasm of unspecified nature of other specified sites | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasm of unspecified nature of respiratory system n1=rhabdomyosarcome | n2=en:neoplasm of unspecified nature of respiratory system | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasm, uncertain whether benign or malignant n1=rhabdomyosarcome | n2=en:neoplasm, uncertain whether benign or malignant | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasm/cancer invasiveness n1=rhabdomyosarcome | n2=en:neoplasm/cancer invasiveness | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasms, experimental n1=rhabdomyosarcome | n2=en:neoplasms, experimental | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasms, hormone-dependent n1=rhabdomyosarcome | n2=en:neoplasms, hormone-dependent | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasms, multiple primary n1=rhabdomyosarcome | n2=en:neoplasms, multiple primary | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasms, post-traumatic n1=rhabdomyosarcome | n2=en:neoplasms, post-traumatic | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplasms, second primary n1=rhabdomyosarcome | n2=en:neoplasms, second primary | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplastic cell n1=rhabdomyosarcome | n2=en:neoplastic cell | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplastic connective and soft tissue cell n1=rhabdomyosarcome | n2=en:neoplastic connective and soft tissue cell | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplastic muscle cell n1=rhabdomyosarcome | n2=en:neoplastic muscle cell | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neoplastic processes n1=rhabdomyosarcome | n2=en:neoplastic processes | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:nervous system neoplasms malignant and unspecified nec n1=rhabdomyosarcome | n2=en:nervous system neoplasms malignant and unspecified nec | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:nervous system tumor morphology n1=rhabdomyosarcome | n2=en:nervous system tumor morphology | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neural tissue tumors n1=rhabdomyosarcome | n2=en:neural tissue tumors | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neuroblastoma, arises anywhere along the sympathetic chain (including intracranially) n1=rhabdomyosarcome | n2=en:neuroblastoma, arises anywhere along the sympathetic chain (including intracranially) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neuroendocrine neoplasm n1=rhabdomyosarcome | n2=en:neuroendocrine neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neuroepithelioma n1=rhabdomyosarcome | n2=en:neuroepithelioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neurofibroma n1=rhabdomyosarcome | n2=en:neurofibroma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neurofibromatosis type 1 n1=rhabdomyosarcome | n2=en:neurofibromatosis type 1 | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neuron, neuroepithelial cell, and supporting cell of the nervous system n1=rhabdomyosarcome | n2=en:neuron, neuroepithelial cell, and supporting cell of the nervous system | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:neuronal or mixed neuronal-glial neoplasm n1=rhabdomyosarcome | n2=en:neuronal or mixed neuronal-glial neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:nijmegen breakage syndrome n1=rhabdomyosarcome | n2=en:nijmegen breakage syndrome | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:no cancer despite harboring complete deletions of the tp53 gene n1=rhabdomyosarcome | n2=en:no cancer despite harboring complete deletions of the tp53 gene | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:nodular melanoma n1=rhabdomyosarcome | n2=en:nodular melanoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:non-hodgkin lymphoma n1=rhabdomyosarcome | n2=en:non-hodgkin lymphoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:non-keratinizing sinonasal squamous cell carcinoma n1=rhabdomyosarcome | n2=en:non-keratinizing sinonasal squamous cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:non-small cell carcinoma n1=rhabdomyosarcome | n2=en:non-small cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:nonmelanoma skin cancer (in some patients) n1=rhabdomyosarcome | n2=en:nonmelanoma skin cancer (in some patients) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:nonseminoma (embryonal carcinoma, teratoma, choriocarcinoma, endodermal sinus tumor) n1=rhabdomyosarcome | n2=en:nonseminoma (embryonal carcinoma, teratoma, choriocarcinoma, endodermal sinus tumor) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:nursing therapy n1=rhabdomyosarcome | n2=en:nursing therapy | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:nutritional management n1=rhabdomyosarcome | n2=en:nutritional management | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:odontogenic neoplasm n1=rhabdomyosarcome | n2=en:odontogenic neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:oncocytic adenoma n1=rhabdomyosarcome | n2=en:oncocytic adenoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:optic nerve glioma n1=rhabdomyosarcome | n2=en:optic nerve glioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:oropharyngeal carcinoma n1=rhabdomyosarcome | n2=en:oropharyngeal carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:oropharyngeal squamous cell carcinoma n1=rhabdomyosarcome | n2=en:oropharyngeal squamous cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:osseous and/or chondromatous neoplasm n1=rhabdomyosarcome | n2=en:osseous and/or chondromatous neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:osteosarcoma n1=rhabdomyosarcome | n2=en:osteosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:osteosarcoma and meningioma especially n1=rhabdomyosarcome | n2=en:osteosarcoma and meningioma especially | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:ovarian carcinoma n1=rhabdomyosarcome | n2=en:ovarian carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:ovarian cystadenoma n1=rhabdomyosarcome | n2=en:ovarian cystadenoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:ovarian sex cord-stromal tumor n1=rhabdomyosarcome | n2=en:ovarian sex cord-stromal tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:overlapping malignant melanoma of skin n1=rhabdomyosarcome | n2=en:overlapping malignant melanoma of skin | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:overlapping malignant neoplasm of gastrointestinal tract n1=rhabdomyosarcome | n2=en:overlapping malignant neoplasm of gastrointestinal tract | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:overlapping malignant neoplasm of ill-defined site n1=rhabdomyosarcome | n2=en:overlapping malignant neoplasm of ill-defined site | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:overlapping malignant neoplasm of lip, oral cavity and pharynx n1=rhabdomyosarcome | n2=en:overlapping malignant neoplasm of lip, oral cavity and pharynx | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:oxyphilic adenocarcinoma n1=rhabdomyosarcome | n2=en:oxyphilic adenocarcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:paget disease and intraductal carcinoma of the breast n1=rhabdomyosarcome | n2=en:paget disease and intraductal carcinoma of the breast | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:paget's disease and infiltrating duct carcinoma of breast n1=rhabdomyosarcome | n2=en:paget's disease and infiltrating duct carcinoma of breast | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:paired box protein pax-3 n1=rhabdomyosarcome | n2=en:paired box protein pax-3 | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:pancreatic acinar cell cystadenocarcinoma n1=rhabdomyosarcome | n2=en:pancreatic acinar cell cystadenocarcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:pancreatic adenocarcinoma n1=rhabdomyosarcome | n2=en:pancreatic adenocarcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:pancreatic carcinoma n1=rhabdomyosarcome | n2=en:pancreatic carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:pancreatoblastoma n1=rhabdomyosarcome | n2=en:pancreatoblastoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:papillary meningioma n1=rhabdomyosarcome | n2=en:papillary meningioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:papillary neoplasm n1=rhabdomyosarcome | n2=en:papillary neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:papillary renal cell carcinoma n1=rhabdomyosarcome | n2=en:papillary renal cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:papillary thyroid carcinoma (rare) n1=rhabdomyosarcome | n2=en:papillary thyroid carcinoma (rare) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:papillary transitional cell carcinoma n1=rhabdomyosarcome | n2=en:papillary transitional cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:paraganglioma n1=rhabdomyosarcome | n2=en:paraganglioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:paraganglioma, catecholamine-secreting n1=rhabdomyosarcome | n2=en:paraganglioma, catecholamine-secreting | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:paragangliomas, head and neck (31%) n1=rhabdomyosarcome | n2=en:paragangliomas, head and neck (31%) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:paragangliomas, head and neck (79%) n1=rhabdomyosarcome | n2=en:paragangliomas, head and neck (79%) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:paraneoplastic sps is associated with autoantibodies to amphiphysin (amph, 600418) n1=rhabdomyosarcome | n2=en:paraneoplastic sps is associated with autoantibodies to amphiphysin (amph, 600418) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:paraneoplastic sps is associated with breast cancer and other malignancies n1=rhabdomyosarcome | n2=en:paraneoplastic sps is associated with breast cancer and other malignancies | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:paraneoplastic syndrome n1=rhabdomyosarcome | n2=en:paraneoplastic syndrome | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:parasitology n1=rhabdomyosarcome | n2=en:parasitology | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:parathyroid gland adenoma n1=rhabdomyosarcome | n2=en:parathyroid gland adenoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:parosteal osteosarcoma n1=rhabdomyosarcome | n2=en:parosteal osteosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:parotid gland adenoma and adenocarcinoma n1=rhabdomyosarcome | n2=en:parotid gland adenoma and adenocarcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:parotid gland monomorphic adenoma n1=rhabdomyosarcome | n2=en:parotid gland monomorphic adenoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:parotid oncocytomas n1=rhabdomyosarcome | n2=en:parotid oncocytomas | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:pediatric adverse events terminology n1=rhabdomyosarcome | n2=en:pediatric adverse events terminology | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:periosteal osteosarcoma n1=rhabdomyosarcome | n2=en:periosteal osteosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:peripheral primitive neuroectodermal tumor of bone n1=rhabdomyosarcome | n2=en:peripheral primitive neuroectodermal tumor of bone | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:peripheral primitive neuroectodermal tumor of soft tissues n1=rhabdomyosarcome | n2=en:peripheral primitive neuroectodermal tumor of soft tissues | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:pharmacotherapeutic n1=rhabdomyosarcome | n2=en:pharmacotherapeutic | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:pheochromocytoma, adrenal (53%) n1=rhabdomyosarcome | n2=en:pheochromocytoma, adrenal (53%) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:pheochromocytoma, extraadrenal (21%) n1=rhabdomyosarcome | n2=en:pheochromocytoma, extraadrenal (21%) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:pheochromocytomas, adrenal (28%) n1=rhabdomyosarcome | n2=en:pheochromocytomas, adrenal (28%) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:pheochromocytomas, extraadrenal (48%) n1=rhabdomyosarcome | n2=en:pheochromocytomas, extraadrenal (48%) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:phyllodes tumor n1=rhabdomyosarcome | n2=en:phyllodes tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:physiopathological n1=rhabdomyosarcome | n2=en:physiopathological | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:pilocytic astrocytoma n1=rhabdomyosarcome | n2=en:pilocytic astrocytoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:pilomatrical carcinoma n1=rhabdomyosarcome | n2=en:pilomatrical carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:pinealoma (trilateral retinoblastoma) n1=rhabdomyosarcome | n2=en:pinealoma (trilateral retinoblastoma) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:pituitary gland adenoma n1=rhabdomyosarcome | n2=en:pituitary gland adenoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:pituitary gland carcinoma n1=rhabdomyosarcome | n2=en:pituitary gland carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:plasma cell myeloma n1=rhabdomyosarcome | n2=en:plasma cell myeloma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:pleomorphic liposarcoma n1=rhabdomyosarcome | n2=en:pleomorphic liposarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:pleomorphic rhabdomyosarcoma n1=rhabdomyosarcome | n2=en:pleomorphic rhabdomyosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:pleuropulmonary blastoma n1=rhabdomyosarcome | n2=en:pleuropulmonary blastoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:polyembryoma n1=rhabdomyosarcome | n2=en:polyembryoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:polygonal cell carcinoma n1=rhabdomyosarcome | n2=en:polygonal cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:polymorphous low grade adenocarcinoma n1=rhabdomyosarcome | n2=en:polymorphous low grade adenocarcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:poorly differentiated fibrosarcoma n1=rhabdomyosarcome | n2=en:poorly differentiated fibrosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:possibly increased risk for other cancers n1=rhabdomyosarcome | n2=en:possibly increased risk for other cancers | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:possibly increased risk of cancer n1=rhabdomyosarcome | n2=en:possibly increased risk of cancer | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:precursor b-lymphoblastic leukemia/lymphoblastic lymphoma n1=rhabdomyosarcome | n2=en:precursor b-lymphoblastic leukemia/lymphoblastic lymphoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:predisposition to uv-induced malignancies n1=rhabdomyosarcome | n2=en:predisposition to uv-induced malignancies | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:pregnancy complications, neoplastic n1=rhabdomyosarcome | n2=en:pregnancy complications, neoplastic | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:primary adrenocortical nodular hyperplasia n1=rhabdomyosarcome | n2=en:primary adrenocortical nodular hyperplasia | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:primary malignant adenomatous neoplasm n1=rhabdomyosarcome | n2=en:primary malignant adenomatous neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:primary malignant liver neoplasm n1=rhabdomyosarcome | n2=en:primary malignant liver neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:primary malignant neoplasm of articular cartilage n1=rhabdomyosarcome | n2=en:primary malignant neoplasm of articular cartilage | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:primary malignant neoplasm of ear, nose and/or throat n1=rhabdomyosarcome | n2=en:primary malignant neoplasm of ear, nose and/or throat | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:primary malignant neoplasm of endocrine gland n1=rhabdomyosarcome | n2=en:primary malignant neoplasm of endocrine gland | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:primary malignant neoplasm of gastrointestinal tract n1=rhabdomyosarcome | n2=en:primary malignant neoplasm of gastrointestinal tract | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:primary malignant neoplasm of head n1=rhabdomyosarcome | n2=en:primary malignant neoplasm of head | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:primary malignant neoplasm of ill-defined site n1=rhabdomyosarcome | n2=en:primary malignant neoplasm of ill-defined site | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:primary malignant neoplasm of independent multiple sites n1=rhabdomyosarcome | n2=en:primary malignant neoplasm of independent multiple sites | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:primary malignant neoplasm of lower limb n1=rhabdomyosarcome | n2=en:primary malignant neoplasm of lower limb | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:primary malignant neoplasm of muscle n1=rhabdomyosarcome | n2=en:primary malignant neoplasm of muscle | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:primary malignant neoplasm of nervous system n1=rhabdomyosarcome | n2=en:primary malignant neoplasm of nervous system | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:primary malignant neoplasm of respiratory tract n1=rhabdomyosarcome | n2=en:primary malignant neoplasm of respiratory tract | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:primary malignant neoplasm of trunk n1=rhabdomyosarcome | n2=en:primary malignant neoplasm of trunk | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:primary malignant neoplasm of unknown site n1=rhabdomyosarcome | n2=en:primary malignant neoplasm of unknown site | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:primary malignant neoplasm of unspecified site (clinical) n1=rhabdomyosarcome | n2=en:primary malignant neoplasm of unspecified site (clinical) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:primary malignant neoplasm of upper limb (disorder) n1=rhabdomyosarcome | n2=en:primary malignant neoplasm of upper limb (disorder) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:primary myelofibrosis n1=rhabdomyosarcome | n2=en:primary myelofibrosis | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:primary undifferentiated large cell carcinoma n1=rhabdomyosarcome | n2=en:primary undifferentiated large cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:primitive neuroectodermal tumor n1=rhabdomyosarcome | n2=en:primitive neuroectodermal tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:propensity to tumor development n1=rhabdomyosarcome | n2=en:propensity to tumor development | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:prostate carcinoma n1=rhabdomyosarcome | n2=en:prostate carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:psammomatous melanotic schwannomas n1=rhabdomyosarcome | n2=en:psammomatous melanotic schwannomas | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:pseudoglandular squamous cell carcinoma n1=rhabdomyosarcome | n2=en:pseudoglandular squamous cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:psychology qualifier n1=rhabdomyosarcome | n2=en:psychology qualifier | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:radiation-related neoplasm n1=rhabdomyosarcome | n2=en:radiation-related neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:radiation-related sarcoma n1=rhabdomyosarcome | n2=en:radiation-related sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:rarely malignant n1=rhabdomyosarcome | n2=en:rarely malignant | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:recurrent chondrosarcoma n1=rhabdomyosarcome | n2=en:recurrent chondrosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:recurrent ewing sarcoma n1=rhabdomyosarcome | n2=en:recurrent ewing sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:recurrent extraskeletal ewing sarcoma n1=rhabdomyosarcome | n2=en:recurrent extraskeletal ewing sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:recurrent extraskeletal osteosarcoma n1=rhabdomyosarcome | n2=en:recurrent extraskeletal osteosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:recurrent leiomyosarcoma n1=rhabdomyosarcome | n2=en:recurrent leiomyosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:recurrent malignant mesothelioma n1=rhabdomyosarcome | n2=en:recurrent malignant mesothelioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:recurrent malignant peripheral nerve sheath tumor n1=rhabdomyosarcome | n2=en:recurrent malignant peripheral nerve sheath tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:recurrent osteosarcoma n1=rhabdomyosarcome | n2=en:recurrent osteosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:recurrent peripheral primitive neuroectodermal tumor of bone n1=rhabdomyosarcome | n2=en:recurrent peripheral primitive neuroectodermal tumor of bone | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:recurrent rhabdomyosarcoma n1=rhabdomyosarcome | n2=en:recurrent rhabdomyosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:recurrent synovial sarcoma n1=rhabdomyosarcome | n2=en:recurrent synovial sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:refractory anemia n1=rhabdomyosarcome | n2=en:refractory anemia | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:refractory anemia with excess blasts n1=rhabdomyosarcome | n2=en:refractory anemia with excess blasts | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:refractory anemia with ring sideroblasts n1=rhabdomyosarcome | n2=en:refractory anemia with ring sideroblasts | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:refractory cytopenia with multilineage dysplasia n1=rhabdomyosarcome | n2=en:refractory cytopenia with multilineage dysplasia | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:refractory cytopenia with multilineage dysplasia and ring sideroblasts n1=rhabdomyosarcome | n2=en:refractory cytopenia with multilineage dysplasia and ring sideroblasts | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:regressing melanoma n1=rhabdomyosarcome | n2=en:regressing melanoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:rehabilitation aspects n1=rhabdomyosarcome | n2=en:rehabilitation aspects | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:renal and urinary tract neoplasms benign n1=rhabdomyosarcome | n2=en:renal and urinary tract neoplasms benign | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:renal and urinary tract neoplasms malignant and unspecified n1=rhabdomyosarcome | n2=en:renal and urinary tract neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:renal cell carcinoma n1=rhabdomyosarcome | n2=en:renal cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:renal cell carcinoma (less common) n1=rhabdomyosarcome | n2=en:renal cell carcinoma (less common) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:renal cell carcinoma, solitary papillary type 2 (about 20% of patients) n1=rhabdomyosarcome | n2=en:renal cell carcinoma, solitary papillary type 2 (about 20% of patients) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:renal cortical adenoma n1=rhabdomyosarcome | n2=en:renal cortical adenoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:reproductive neoplasms female malignant and unspecified n1=rhabdomyosarcome | n2=en:reproductive neoplasms female malignant and unspecified | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:reproductive neoplasms male malignant and unspecified n1=rhabdomyosarcome | n2=en:reproductive neoplasms male malignant and unspecified | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:respiratory and mediastinal neoplasms malignant and unspecified n1=rhabdomyosarcome | n2=en:respiratory and mediastinal neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:retinoblastoma n1=rhabdomyosarcome | n2=en:retinoblastoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:retroperitoneal sarcoma n1=rhabdomyosarcome | n2=en:retroperitoneal sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:rhabdoid tumor n1=rhabdomyosarcome | n2=en:rhabdoid tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:rhabdomyoma n1=rhabdomyosarcome | n2=en:rhabdomyoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:rhabdomyomatous neoplasm - category n1=rhabdomyosarcome | n2=en:rhabdomyomatous neoplasm - category | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:rhabdomyosarcoma - category n1=rhabdomyosarcome | n2=en:rhabdomyosarcoma - category | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:rhabdomyosarcoma 1 n1=rhabdomyosarcome | n2=en:rhabdomyosarcoma 1 | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:rhabdomyosarcoma of the mouse prostate gland n1=rhabdomyosarcome | n2=en:rhabdomyosarcoma of the mouse prostate gland | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:rhabdomyosarcoma of the mouse skin n1=rhabdomyosarcome | n2=en:rhabdomyosarcoma of the mouse skin | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:rhabdomyosarcoma previously treated n1=rhabdomyosarcome | n2=en:rhabdomyosarcoma previously treated | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:rhabdomyosarcoma previously untreated n1=rhabdomyosarcome | n2=en:rhabdomyosarcoma previously untreated | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:roentgenographic n1=rhabdomyosarcome | n2=en:roentgenographic | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sacrococcygeal teratoma n1=rhabdomyosarcome | n2=en:sacrococcygeal teratoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sarcoma n1=rhabdomyosarcome | n2=en:sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sarcoma by ajcc grade n1=rhabdomyosarcome | n2=en:sarcoma by ajcc grade | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sarcoma by fnclcc grade n1=rhabdomyosarcome | n2=en:sarcoma by fnclcc grade | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sarcoma by nci grade n1=rhabdomyosarcome | n2=en:sarcoma by nci grade | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sarcoma of back n1=rhabdomyosarcome | n2=en:sarcoma of back | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sarcoma of head and neck n1=rhabdomyosarcome | n2=en:sarcoma of head and neck | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sarcoma of pelvis n1=rhabdomyosarcome | n2=en:sarcoma of pelvis | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sarcoma of posterior mediastinum n1=rhabdomyosarcome | n2=en:sarcoma of posterior mediastinum | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sarcoma, experimental n1=rhabdomyosarcome | n2=en:sarcoma, experimental | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sarcoma, metastatic n1=rhabdomyosarcome | n2=en:sarcoma, metastatic | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sarcomatoid carcinoma n1=rhabdomyosarcome | n2=en:sarcomatoid carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sarcomatoid mesothelioma n1=rhabdomyosarcome | n2=en:sarcomatoid mesothelioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sarcomatoid squamous cell carcinoma n1=rhabdomyosarcome | n2=en:sarcomatoid squamous cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sarcomatoid transitional cell carcinoma n1=rhabdomyosarcome | n2=en:sarcomatoid transitional cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sarcomatosis n1=rhabdomyosarcome | n2=en:sarcomatosis | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:schwannoma n1=rhabdomyosarcome | n2=en:schwannoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sebaceous adenoma n1=rhabdomyosarcome | n2=en:sebaceous adenoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sebaceous carcinoma n1=rhabdomyosarcome | n2=en:sebaceous carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sebaceous epithelioma n1=rhabdomyosarcome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:secondary malignant neoplasm of soft tissues n1=rhabdomyosarcome | n2=en:secondary malignant neoplasm of soft tissues | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:secondary osteosarcoma n1=rhabdomyosarcome | n2=en:secondary osteosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:secretory breast carcinoma n1=rhabdomyosarcome | n2=en:secretory breast carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:seminoma n1=rhabdomyosarcome | n2=en:seminoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sensitivity to genotoxic agents n1=rhabdomyosarcome | n2=en:sensitivity to genotoxic agents | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sertoli cell carcinoma n1=rhabdomyosarcome | n2=en:sertoli cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sertoli cell tumor n1=rhabdomyosarcome | n2=en:sertoli cell tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sertoli-leydig cell ovarian tumors may occur n1=rhabdomyosarcome | n2=en:sertoli-leydig cell ovarian tumors may occur | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sertoli-leydig cell tumor, poorly differentiated n1=rhabdomyosarcome | n2=en:sertoli-leydig cell tumor, poorly differentiated | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sertoli-leydig cell tumor, poorly differentiated, with heterologous elements n1=rhabdomyosarcome | n2=en:sertoli-leydig cell tumor, poorly differentiated, with heterologous elements | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sex cord-stromal tumor n1=rhabdomyosarcome | n2=en:sex cord-stromal tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sinonasal undifferentiated carcinoma n1=rhabdomyosarcome | n2=en:sinonasal undifferentiated carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:skeletal muscle cell n1=rhabdomyosarcome | n2=en:skeletal muscle cell | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:skeletal neoplasms benign n1=rhabdomyosarcome | n2=en:skeletal neoplasms benign | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:skin adenoid basal cell carcinoma n1=rhabdomyosarcome | n2=en:skin adenoid basal cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:skin basosquamous cell carcinoma n1=rhabdomyosarcome | n2=en:skin basosquamous cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:skin cancer susceptibility n1=rhabdomyosarcome | n2=en:skin cancer susceptibility | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:skin fibroepithelial basal cell carcinoma n1=rhabdomyosarcome | n2=en:skin fibroepithelial basal cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:skin infiltrating basal cell carcinoma n1=rhabdomyosarcome | n2=en:skin infiltrating basal cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:skin metatypical carcinoma n1=rhabdomyosarcome | n2=en:skin metatypical carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:skin nodular basal cell carcinoma n1=rhabdomyosarcome | n2=en:skin nodular basal cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:skin sarcoma n1=rhabdomyosarcome | n2=en:skin sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:skin squamous cell carcinoma n1=rhabdomyosarcome | n2=en:skin squamous cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:slc22a18 gene n1=rhabdomyosarcome | n2=en:slc22a18 gene | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:slc22a18 wt allele n1=rhabdomyosarcome | n2=en:slc22a18 wt allele | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:small cell carcinoma n1=rhabdomyosarcome | n2=en:small cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:small cell carcinoma of the ovary, hypercalcemic type n1=rhabdomyosarcome | n2=en:small cell carcinoma of the ovary, hypercalcemic type | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:small cell carcinoma, fusiform cell type n1=rhabdomyosarcome | n2=en:small cell carcinoma, fusiform cell type | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:small cell intermediate cell carcinoma n1=rhabdomyosarcome | n2=en:small cell intermediate cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:small cell osteosarcoma n1=rhabdomyosarcome | n2=en:small cell osteosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:small cell sarcoma n1=rhabdomyosarcome | n2=en:small cell sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:small intestine carcinoid n1=rhabdomyosarcome | n2=en:small intestine carcinoid | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:smooth muscle tumor of uncertain malignant potential n1=rhabdomyosarcome | n2=en:smooth muscle tumor of uncertain malignant potential | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:soft tissue neoplasm n1=rhabdomyosarcome | n2=en:soft tissue neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:soft tissue sarcoma n1=rhabdomyosarcome | n2=en:soft tissue sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:soft tissue sarcomas histology unspecified n1=rhabdomyosarcome | n2=en:soft tissue sarcomas histology unspecified | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:soft tissue tumor and/or sarcoma n1=rhabdomyosarcome | n2=en:soft tissue tumor and/or sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:solid papillary carcinoma with invasion n1=rhabdomyosarcome | n2=en:solid papillary carcinoma with invasion | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:solid pseudopapillary carcinoma n1=rhabdomyosarcome | n2=en:solid pseudopapillary carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:somatostatin-producing neuroendocrine tumor n1=rhabdomyosarcome | n2=en:somatostatin-producing neuroendocrine tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:spindle cell sarcoma n1=rhabdomyosarcome | n2=en:spindle cell sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:spiradenocarcinoma n1=rhabdomyosarcome | n2=en:spiradenocarcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:squamous cell carcinoma (1 patient) n1=rhabdomyosarcome | n2=en:squamous cell carcinoma (1 patient) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:squamous cell carcinoma (skin or mucosa) n1=rhabdomyosarcome | n2=en:squamous cell carcinoma (skin or mucosa) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:squamous cell carcinoma in area of palmoplantar keratoderma (rare) n1=rhabdomyosarcome | n2=en:squamous cell carcinoma in area of palmoplantar keratoderma (rare) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:squamous epitheliomas, multiple n1=rhabdomyosarcome | n2=en:squamous epitheliomas, multiple | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:starry sky pattern n1=rhabdomyosarcome | n2=en:starry sky pattern | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:statistical association of extensive metabolism (em, wildtype) and malignancy, especially smoking-induced lung cancer n1=rhabdomyosarcome | n2=en:statistical association of extensive metabolism (em, wildtype) and malignancy, especially smoking-induced lung cancer | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:steroid cell tumor, malignant n1=rhabdomyosarcome | n2=en:steroid cell tumor, malignant | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:stim1 gene n1=rhabdomyosarcome | n2=en:stim1 gene | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:stim1 wt allele n1=rhabdomyosarcome | n2=en:stim1 wt allele | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:stromal interaction molecule 1 n1=rhabdomyosarcome | n2=en:stromal interaction molecule 1 | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:stromal sarcoma n1=rhabdomyosarcome | n2=en:stromal sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:subependymoma n1=rhabdomyosarcome | n2=en:subependymoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:superficial multifocal basal cell carcinoma n1=rhabdomyosarcome | n2=en:superficial multifocal basal cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:superficial spreading melanoma n1=rhabdomyosarcome | n2=en:superficial spreading melanoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:surgical aspects n1=rhabdomyosarcome | n2=en:surgical aspects | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:susceptibility to myelodysplasia n1=rhabdomyosarcome | n2=en:susceptibility to myelodysplasia | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:susceptibility to myeloid leukemia n1=rhabdomyosarcome | n2=en:susceptibility to myeloid leukemia | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:sweat gland adenocarcinoma n1=rhabdomyosarcome | n2=en:sweat gland adenocarcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:synovial sarcoma n1=rhabdomyosarcome | n2=en:synovial sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:synovial sarcoma - category n1=rhabdomyosarcome | n2=en:synovial sarcoma - category | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:synovial-like neoplasm n1=rhabdomyosarcome | n2=en:synovial-like neoplasm | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:syringocystadenoma papilliferum n1=rhabdomyosarcome | n2=en:syringocystadenoma papilliferum | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:t lymphoblastic leukemia/lymphoma n1=rhabdomyosarcome | n2=en:t lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:taxonomic n1=rhabdomyosarcome | n2=en:taxonomic | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:telangiectatic osteosarcoma n1=rhabdomyosarcome | n2=en:telangiectatic osteosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:teratoid medulloepithelioma n1=rhabdomyosarcome | n2=en:teratoid medulloepithelioma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:teratoid tumor, atypical n1=rhabdomyosarcome | n2=en:teratoid tumor, atypical | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:testicular sertoli cell tumor n1=rhabdomyosarcome | n2=en:testicular sertoli cell tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:testicular sertoli cell tumor, calcified n1=rhabdomyosarcome | n2=en:testicular sertoli cell tumor, calcified | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:testicular spermatocytic seminoma n1=rhabdomyosarcome | n2=en:testicular spermatocytic seminoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:tetraspanin-32 n1=rhabdomyosarcome | n2=en:tetraspanin-32 | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:therapeutic aspects n1=rhabdomyosarcome | n2=en:therapeutic aspects | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:therapy-related myelodysplastic syndrome n1=rhabdomyosarcome | n2=en:therapy-related myelodysplastic syndrome | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:thymoma n1=rhabdomyosarcome | n2=en:thymoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:thymoma type b3 n1=rhabdomyosarcome | n2=en:thymoma type b3 | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:thyroid cancer (follicular cell) n1=rhabdomyosarcome | n2=en:thyroid cancer (follicular cell) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:thyroid follicular cell tumor n1=rhabdomyosarcome | n2=en:thyroid follicular cell tumor | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:thyroid gland carcinoma n1=rhabdomyosarcome | n2=en:thyroid gland carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:thyroid gland carcinoma showing thymus-like differentiation n1=rhabdomyosarcome | n2=en:thyroid gland carcinoma showing thymus-like differentiation | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:thyroid gland diffuse sclerosing papillary carcinoma n1=rhabdomyosarcome | n2=en:thyroid gland diffuse sclerosing papillary carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:thyroid gland medullary carcinoma n1=rhabdomyosarcome | n2=en:thyroid gland medullary carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:tracheal carcinoma n1=rhabdomyosarcome | n2=en:tracheal carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:transitional cell carcinoma n1=rhabdomyosarcome | n2=en:transitional cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:trichilemmocarcinoma n1=rhabdomyosarcome | n2=en:trichilemmocarcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:trichoblastoma n1=rhabdomyosarcome | n2=en:trichoblastoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:trichoepitheliomas may rarely show malignant transformation to basal cell carcinoma n1=rhabdomyosarcome | n2=en:trichoepitheliomas may rarely show malignant transformation to basal cell carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:tspan32 gene n1=rhabdomyosarcome | n2=en:tspan32 gene | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:tssc4 protein n1=rhabdomyosarcome | n2=en:tssc4 protein | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:tumor cells, benign n1=rhabdomyosarcome | n2=en:tumor cells, benign | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:tumors of the sympathetic nervous system (5 to 10%) n1=rhabdomyosarcome | n2=en:tumors of the sympathetic nervous system (5 to 10%) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:turcot syndrome n1=rhabdomyosarcome | n2=en:turcot syndrome | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:type a spindle cell melanoma n1=rhabdomyosarcome | n2=en:type a spindle cell melanoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:type b spindle cell melanoma n1=rhabdomyosarcome | n2=en:type b spindle cell melanoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:ultrastructure n1=rhabdomyosarcome | n2=en:ultrastructure | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:undifferentiated carcinoma n1=rhabdomyosarcome | n2=en:undifferentiated carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:undifferentiated high grade pleomorphic sarcoma of bone n1=rhabdomyosarcome | n2=en:undifferentiated high grade pleomorphic sarcoma of bone | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:undifferentiated pleomorphic sarcoma with osteoclast-like giant cells n1=rhabdomyosarcome | n2=en:undifferentiated pleomorphic sarcoma with osteoclast-like giant cells | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:undifferentiated pleomorphic sarcoma, inflammatory variant n1=rhabdomyosarcome | n2=en:undifferentiated pleomorphic sarcoma, inflammatory variant | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:undifferentiated sarcoma, not otherwise specified n1=rhabdomyosarcome | n2=en:undifferentiated sarcoma, not otherwise specified | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:unilateral vestibular schwannoma n1=rhabdomyosarcome | n2=en:unilateral vestibular schwannoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:urethral carcinoma n1=rhabdomyosarcome | n2=en:urethral carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:uterine leiomyosarcoma (less common) n1=rhabdomyosarcome | n2=en:uterine leiomyosarcoma (less common) | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:uveal melanoma n1=rhabdomyosarcome | n2=en:uveal melanoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:vaccine-induced fibrosarcoma n1=rhabdomyosarcome | n2=en:vaccine-induced fibrosarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:verrucous carcinoma n1=rhabdomyosarcome | n2=en:verrucous carcinoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:viruses n1=rhabdomyosarcome | n2=en:viruses | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 175 / 0.357 -> en:vulvar sarcoma n1=rhabdomyosarcome | n2=en:vulvar sarcoma | rel=r_associated | relid=0 | w=175 rhabdomyosarcome -- r_associated #0: 139 / 0.284 -> oncologie n1=rhabdomyosarcome | n2=oncologie | rel=r_associated | relid=0 | w=139 rhabdomyosarcome -- r_associated #0: 138 / 0.282 -> maladie tumorale de l'appareil locomoteur n1=rhabdomyosarcome | n2=maladie tumorale de l'appareil locomoteur | rel=r_associated | relid=0 | w=138 rhabdomyosarcome -- r_associated #0: 135 / 0.276 -> tissu musculaire strié squelettique n1=rhabdomyosarcome | n2=tissu musculaire strié squelettique | rel=r_associated | relid=0 | w=135 rhabdomyosarcome -- r_associated #0: 134 / 0.273 -> carcinologie n1=rhabdomyosarcome | n2=carcinologie | rel=r_associated | relid=0 | w=134 rhabdomyosarcome -- r_associated #0: 130 / 0.265 -> sarcome n1=rhabdomyosarcome | n2=sarcome | rel=r_associated | relid=0 | w=130 rhabdomyosarcome -- r_associated #0: 111 / 0.227 -> cancers n1=rhabdomyosarcome | n2=cancers | rel=r_associated | relid=0 | w=111 rhabdomyosarcome -- r_associated #0: 97 / 0.198 -> tumeur n1=rhabdomyosarcome | n2=tumeur | rel=r_associated | relid=0 | w=97 rhabdomyosarcome -- r_associated #0: 67 / 0.137 -> cancer de la prostate n1=rhabdomyosarcome | n2=cancer de la prostate | rel=r_associated | relid=0 | w=67 rhabdomyosarcome -- r_associated #0: 65 / 0.133 -> en:primary malignant neoplasm n1=rhabdomyosarcome | n2=en:primary malignant neoplasm | rel=r_associated | relid=0 | w=65 rhabdomyosarcome -- r_associated #0: 62 / 0.127 -> rhabdomyosarcome, sai n1=rhabdomyosarcome | n2=rhabdomyosarcome, sai | rel=r_associated | relid=0 | w=62 rhabdomyosarcome -- r_associated #0: 61 / 0.124 -> muscle n1=rhabdomyosarcome | n2=muscle | rel=r_associated | relid=0 | w=61 rhabdomyosarcome -- r_associated #0: 61 / 0.124 -> pathologie du muscle strié n1=rhabdomyosarcome | n2=pathologie du muscle strié | rel=r_associated | relid=0 | w=61 rhabdomyosarcome -- r_associated #0: 57 / 0.116 -> en:rhabdomyosarcoma n1=rhabdomyosarcome | n2=en:rhabdomyosarcoma | rel=r_associated | relid=0 | w=57 rhabdomyosarcome -- r_associated #0: 55 / 0.112 -> vincristine n1=rhabdomyosarcome | n2=vincristine | rel=r_associated | relid=0 | w=55 rhabdomyosarcome -- r_associated #0: 53 / 0.108 -> en:rhabdosarcoma n1=rhabdomyosarcome | n2=en:rhabdosarcoma | rel=r_associated | relid=0 | w=53 rhabdomyosarcome -- r_associated #0: 50 / 0.102 -> IGF2 gene n1=rhabdomyosarcome | n2=IGF2 gene | rel=r_associated | relid=0 | w=50 rhabdomyosarcome -- r_associated #0: 50 / 0.102 -> prostate n1=rhabdomyosarcome | n2=prostate | rel=r_associated | relid=0 | w=50 rhabdomyosarcome -- r_associated #0: 50 / 0.102 -> sarcome botryoïde n1=rhabdomyosarcome | n2=sarcome botryoïde | rel=r_associated | relid=0 | w=50 rhabdomyosarcome -- r_associated #0: 50 / 0.102 -> syndrome de Costello n1=rhabdomyosarcome | n2=syndrome de Costello | rel=r_associated | relid=0 | w=50 rhabdomyosarcome -- r_associated #0: 48 / 0.098 -> pathologie n1=rhabdomyosarcome | n2=pathologie | rel=r_associated | relid=0 | w=48 rhabdomyosarcome -- r_associated #0: 45 / 0.092 -> myosarcome cutané n1=rhabdomyosarcome | n2=myosarcome cutané | rel=r_associated | relid=0 | w=45 rhabdomyosarcome -- r_associated #0: 45 / 0.092 -> rhabdomyome embryonnaire n1=rhabdomyosarcome | n2=rhabdomyome embryonnaire | rel=r_associated | relid=0 | w=45 rhabdomyosarcome -- r_associated #0: 45 / 0.092 -> sarcome de la vessie n1=rhabdomyosarcome | n2=sarcome de la vessie | rel=r_associated | relid=0 | w=45 rhabdomyosarcome -- r_associated #0: 45 / 0.092 -> sarcome musculaire n1=rhabdomyosarcome | n2=sarcome musculaire | rel=r_associated | relid=0 | w=45 rhabdomyosarcome -- r_associated #0: 40 / 0.082 -> cancérologie n1=rhabdomyosarcome | n2=cancérologie | rel=r_associated | relid=0 | w=40 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:abdominal tumors (immunodeficiency-associated form) n1=rhabdomyosarcome | n2=en:abdominal tumors (immunodeficiency-associated form) | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:accelerated neoplasm growth n1=rhabdomyosarcome | n2=en:accelerated neoplasm growth | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:acoustic schwannoma n1=rhabdomyosarcome | n2=en:acoustic schwannoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:acute monocytic leukemia n1=rhabdomyosarcome | n2=en:acute monocytic leukemia | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:adenocarcinoma n1=rhabdomyosarcome | n2=en:adenocarcinoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:adenocarcinoma in adenomatous polyp n1=rhabdomyosarcome | n2=en:adenocarcinoma in adenomatous polyp | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:adenosarcoma n1=rhabdomyosarcome | n2=en:adenosarcoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:alpha heavy chain disease n1=rhabdomyosarcome | n2=en:alpha heavy chain disease | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:alveolar cell carcinoma (some) n1=rhabdomyosarcome | n2=en:alveolar cell carcinoma (some) | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:ampulla of vater adenocarcinoma n1=rhabdomyosarcome | n2=en:ampulla of vater adenocarcinoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:angiolipoma n1=rhabdomyosarcome | n2=en:angiolipoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:approximately 10% of cases are paraneoplastic n1=rhabdomyosarcome | n2=en:approximately 10% of cases are paraneoplastic | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:aspects of radionuclide imaging n1=rhabdomyosarcome | n2=en:aspects of radionuclide imaging | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:balloon cell melanoma n1=rhabdomyosarcome | n2=en:balloon cell melanoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:benign female reproductive system neoplasm n1=rhabdomyosarcome | n2=en:benign female reproductive system neoplasm | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:benign neoplasm n1=rhabdomyosarcome | n2=en:benign neoplasm | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:benign nervous system neoplasm n1=rhabdomyosarcome | n2=en:benign nervous system neoplasm | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:blood supply aspects n1=rhabdomyosarcome | n2=en:blood supply aspects | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:breast neoplasm n1=rhabdomyosarcome | n2=en:breast neoplasm | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:carcinoid tumor n1=rhabdomyosarcome | n2=en:carcinoid tumor | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:carcinoma n1=rhabdomyosarcome | n2=en:carcinoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:cartilage-forming neoplasm n1=rhabdomyosarcome | n2=en:cartilage-forming neoplasm | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:chief cell adenocarcinoma n1=rhabdomyosarcome | n2=en:chief cell adenocarcinoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:choroid plexus carcinoma n1=rhabdomyosarcome | n2=en:choroid plexus carcinoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:clear cell neoplasm n1=rhabdomyosarcome | n2=en:clear cell neoplasm | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:clinical data interchange standards consortium terminology n1=rhabdomyosarcome | n2=en:clinical data interchange standards consortium terminology | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:complex mixed and/or stromal neoplasm n1=rhabdomyosarcome | n2=en:complex mixed and/or stromal neoplasm | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:composite hodgkin and non-hodgkin lymphoma n1=rhabdomyosarcome | n2=en:composite hodgkin and non-hodgkin lymphoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:congenital rhabdomyoma of heart n1=rhabdomyosarcome | n2=en:congenital rhabdomyoma of heart | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:cutaneous leiomyosarcoma (less common) n1=rhabdomyosarcome | n2=en:cutaneous leiomyosarcoma (less common) | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:ductal carcinoma n1=rhabdomyosarcome | n2=en:ductal carcinoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:epidemiologic n1=rhabdomyosarcome | n2=en:epidemiologic | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:epithelial cell n1=rhabdomyosarcome | n2=en:epithelial cell | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:epithelioid mesothelioma n1=rhabdomyosarcome | n2=en:epithelioid mesothelioma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:extramammary paget disease n1=rhabdomyosarcome | n2=en:extramammary paget disease | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:extraskeletal chondrosarcoma metastatic n1=rhabdomyosarcome | n2=en:extraskeletal chondrosarcoma metastatic | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:extraskeletal chondrosarcoma recurrent n1=rhabdomyosarcome | n2=en:extraskeletal chondrosarcoma recurrent | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:extraskeletal ewing sarcoma n1=rhabdomyosarcome | n2=en:extraskeletal ewing sarcoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:germinoma n1=rhabdomyosarcome | n2=en:germinoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:glioma n1=rhabdomyosarcome | n2=en:glioma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:growth hormone-producing pituitary gland neoplasm n1=rhabdomyosarcome | n2=en:growth hormone-producing pituitary gland neoplasm | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:high grade serous carcinoma n1=rhabdomyosarcome | n2=en:high grade serous carcinoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:increased malignancy risk, especially lymphoma and skin neoplasm n1=rhabdomyosarcome | n2=en:increased malignancy risk, especially lymphoma and skin neoplasm | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:increased risk for cancer n1=rhabdomyosarcome | n2=en:increased risk for cancer | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:increased risk for monoclonal gammopathy n1=rhabdomyosarcome | n2=en:increased risk for monoclonal gammopathy | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:increased risk in heterozygotes n1=rhabdomyosarcome | n2=en:increased risk in heterozygotes | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:increased susceptibility to hematologic malignancies n1=rhabdomyosarcome | n2=en:increased susceptibility to hematologic malignancies | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:intermediate filaments present n1=rhabdomyosarcome | n2=en:intermediate filaments present | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:invasive ductal carcinoma, not otherwise specified n1=rhabdomyosarcome | n2=en:invasive ductal carcinoma, not otherwise specified | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:kidney wilms tumor n1=rhabdomyosarcome | n2=en:kidney wilms tumor | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:langerhans cell histiocytosis n1=rhabdomyosarcome | n2=en:langerhans cell histiocytosis | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:langerhans cell sarcoma n1=rhabdomyosarcome | n2=en:langerhans cell sarcoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:leiomyomatous neoplasm - category n1=rhabdomyosarcome | n2=en:leiomyomatous neoplasm - category | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:liver carcinoma n1=rhabdomyosarcome | n2=en:liver carcinoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:low-grade neuroendocrine carcinoma (submandibular glands, salivary glands, maxillary sinus, nasal cavity) n1=rhabdomyosarcome | n2=en:low-grade neuroendocrine carcinoma (submandibular glands, salivary glands, maxillary sinus, nasal cavity) | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:lung n1=rhabdomyosarcome | n2=en:lung | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:lymphoma (in some patients) n1=rhabdomyosarcome | n2=en:lymphoma (in some patients) | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:lymphosarcoma of lymph nodes of head, face and neck n1=rhabdomyosarcome | n2=en:lymphosarcoma of lymph nodes of head, face and neck | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:male germ cell tumors (gct), 2 subtypes - n1=rhabdomyosarcome | n2=en:male germ cell tumors (gct), 2 subtypes - | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:malignant cell n1=rhabdomyosarcome | n2=en:malignant cell | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:malignant granular cell tumor n1=rhabdomyosarcome | n2=en:malignant granular cell tumor | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:malignant joint neoplasm n1=rhabdomyosarcome | n2=en:malignant joint neoplasm | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:malignant melanoma in precancerous melanosis n1=rhabdomyosarcome | n2=en:malignant melanoma in precancerous melanosis | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:malignant muscle neoplasm n1=rhabdomyosarcome | n2=en:malignant muscle neoplasm | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:malignant neoplasm of bone, connective tissue, skin and breast n1=rhabdomyosarcome | n2=en:malignant neoplasm of bone, connective tissue, skin and breast | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:malignant neoplasm of genitourinary organ n1=rhabdomyosarcome | n2=en:malignant neoplasm of genitourinary organ | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:malignant neoplasm, overlapping lesion of digestive system n1=rhabdomyosarcome | n2=en:malignant neoplasm, overlapping lesion of digestive system | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:malignant odontogenic neoplasm n1=rhabdomyosarcome | n2=en:malignant odontogenic neoplasm | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:malignant peripheral nerve sheath tumor n1=rhabdomyosarcome | n2=en:malignant peripheral nerve sheath tumor | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:malignant soft tissue neoplasm n1=rhabdomyosarcome | n2=en:malignant soft tissue neoplasm | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:malignant squamous cell neoplasm n1=rhabdomyosarcome | n2=en:malignant squamous cell neoplasm | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:malignant type ab thymoma n1=rhabdomyosarcome | n2=en:malignant type ab thymoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:mesothelioma (malignant, clinical disorder) (disorder) n1=rhabdomyosarcome | n2=en:mesothelioma (malignant, clinical disorder) (disorder) | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:metastasis to lymph node from squamous cell carcinoma n1=rhabdomyosarcome | n2=en:metastasis to lymph node from squamous cell carcinoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:metastatic malignant neoplasm in the neck n1=rhabdomyosarcome | n2=en:metastatic malignant neoplasm in the neck | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:metastatic malignant neoplasm in the spine n1=rhabdomyosarcome | n2=en:metastatic malignant neoplasm in the spine | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:metastatic synovial sarcoma n1=rhabdomyosarcome | n2=en:metastatic synovial sarcoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:metastatic undifferentiated pleomorphic sarcoma n1=rhabdomyosarcome | n2=en:metastatic undifferentiated pleomorphic sarcoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:miscellaneous and site unspecified neoplasms benign n1=rhabdomyosarcome | n2=en:miscellaneous and site unspecified neoplasms benign | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:mixed type rhabdomyosarcoma n1=rhabdomyosarcome | n2=en:mixed type rhabdomyosarcoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:mucin-producing adenocarcinoma n1=rhabdomyosarcome | n2=en:mucin-producing adenocarcinoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:mucoepidermoid tumor n1=rhabdomyosarcome | n2=en:mucoepidermoid tumor | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:multiple tumors n1=rhabdomyosarcome | n2=en:multiple tumors | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:myxoma n1=rhabdomyosarcome | n2=en:myxoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:neoplasm of uncertain malignant potential n1=rhabdomyosarcome | n2=en:neoplasm of uncertain malignant potential | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:neuroblastoma n1=rhabdomyosarcome | n2=en:neuroblastoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:neuroblastoma (less common) n1=rhabdomyosarcome | n2=en:neuroblastoma (less common) | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:nonseminomatous germ cell tumor n1=rhabdomyosarcome | n2=en:nonseminomatous germ cell tumor | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:oligodendroglioma n1=rhabdomyosarcome | n2=en:oligodendroglioma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:pancreatic squamous cell carcinoma n1=rhabdomyosarcome | n2=en:pancreatic squamous cell carcinoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:parathyroid gland carcinoma n1=rhabdomyosarcome | n2=en:parathyroid gland carcinoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:pathological aspects n1=rhabdomyosarcome | n2=en:pathological aspects | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:pediatric terminology n1=rhabdomyosarcome | n2=en:pediatric terminology | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:peripheral primitive neuroectodermal tumor n1=rhabdomyosarcome | n2=en:peripheral primitive neuroectodermal tumor | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:plasma cell myeloma/plasmacytoma n1=rhabdomyosarcome | n2=en:plasma cell myeloma/plasmacytoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:plasma cell neoplasm n1=rhabdomyosarcome | n2=en:plasma cell neoplasm | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:poorly differentiated carcinoma n1=rhabdomyosarcome | n2=en:poorly differentiated carcinoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:possible increased risk of germ-cell tumors n1=rhabdomyosarcome | n2=en:possible increased risk of germ-cell tumors | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:precancerous condition n1=rhabdomyosarcome | n2=en:precancerous condition | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:primary malignant neoplasm of back n1=rhabdomyosarcome | n2=en:primary malignant neoplasm of back | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:primary malignant neoplasm of neck n1=rhabdomyosarcome | n2=en:primary malignant neoplasm of neck | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:primary malignant neoplasm of soft tissues n1=rhabdomyosarcome | n2=en:primary malignant neoplasm of soft tissues | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:recurrent epithelioid sarcoma n1=rhabdomyosarcome | n2=en:recurrent epithelioid sarcoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:reported colon and other abdominal cancer in relatives n1=rhabdomyosarcome | n2=en:reported colon and other abdominal cancer in relatives | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:reproductive and genitourinary neoplasms gender unspecified nec n1=rhabdomyosarcome | n2=en:reproductive and genitourinary neoplasms gender unspecified nec | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:rhabdomyosarcoma, embryonal, 2 n1=rhabdomyosarcome | n2=en:rhabdomyosarcoma, embryonal, 2 | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:signet ring cell carcinoma n1=rhabdomyosarcome | n2=en:signet ring cell carcinoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:skin basal cell carcinoma n1=rhabdomyosarcome | n2=en:skin basal cell carcinoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:small cell carcinoma carcinomatosis n1=rhabdomyosarcome | n2=en:small cell carcinoma carcinomatosis | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:smooth muscle neoplasm n1=rhabdomyosarcome | n2=en:smooth muscle neoplasm | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:soft tissue neoplasms malignant and unspecified n1=rhabdomyosarcome | n2=en:soft tissue neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:solid neoplasm n1=rhabdomyosarcome | n2=en:solid neoplasm | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:spindle cell melanoma n1=rhabdomyosarcome | n2=en:spindle cell melanoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:spindle cell rhabdomyosarcoma n1=rhabdomyosarcome | n2=en:spindle cell rhabdomyosarcoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:spongioneuroblastoma n1=rhabdomyosarcome | n2=en:spongioneuroblastoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:thymic carcinoma n1=rhabdomyosarcome | n2=en:thymic carcinoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:thyroid gland oncocytic neoplasm n1=rhabdomyosarcome | n2=en:thyroid gland oncocytic neoplasm | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:thyroid gland papillary carcinoma n1=rhabdomyosarcome | n2=en:thyroid gland papillary carcinoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:tssc4 gene n1=rhabdomyosarcome | n2=en:tssc4 gene | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:tumor in vein n1=rhabdomyosarcome | n2=en:tumor in vein | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:undifferentiated (embryonal) sarcoma n1=rhabdomyosarcome | n2=en:undifferentiated (embryonal) sarcoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:undifferentiated pleomorphic sarcoma n1=rhabdomyosarcome | n2=en:undifferentiated pleomorphic sarcoma | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:vestibular schwannoma (over 90% of patients) n1=rhabdomyosarcome | n2=en:vestibular schwannoma (over 90% of patients) | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> en:veterinary aspects n1=rhabdomyosarcome | n2=en:veterinary aspects | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> maladie n1=rhabdomyosarcome | n2=maladie | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> myosarcome n1=rhabdomyosarcome | n2=myosarcome | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> néoplasme malin n1=rhabdomyosarcome | n2=néoplasme malin | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 35 / 0.071 -> tumeur mésenchymateuse maligne n1=rhabdomyosarcome | n2=tumeur mésenchymateuse maligne | rel=r_associated | relid=0 | w=35 rhabdomyosarcome -- r_associated #0: 34 / 0.069 -> en:oncology n1=rhabdomyosarcome | n2=en:oncology | rel=r_associated | relid=0 | w=34 rhabdomyosarcome -- r_associated #0: 33 / 0.067 -> néoplasme malin non classé n1=rhabdomyosarcome | n2=néoplasme malin non classé | rel=r_associated | relid=0 | w=33 rhabdomyosarcome -- r_associated #0: 32 / 0.065 -> en:specialized branches of medicine n1=rhabdomyosarcome | n2=en:specialized branches of medicine | rel=r_associated | relid=0 | w=32 rhabdomyosarcome -- r_associated #0: 32 / 0.065 -> tumeur maligne de siège primitif inconnu n1=rhabdomyosarcome | n2=tumeur maligne de siège primitif inconnu | rel=r_associated | relid=0 | w=32 rhabdomyosarcome -- r_associated #0: 32 / 0.065 -> tumeur maligne sans précision de site n1=rhabdomyosarcome | n2=tumeur maligne sans précision de site | rel=r_associated | relid=0 | w=32 rhabdomyosarcome -- r_associated #0: 31 / 0.063 -> Spécialités médicales n1=rhabdomyosarcome | n2=Spécialités médicales | rel=r_associated | relid=0 | w=31 rhabdomyosarcome -- r_associated #0: 31 / 0.063 -> tumeur maligne non classée n1=rhabdomyosarcome | n2=tumeur maligne non classée | rel=r_associated | relid=0 | w=31 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:atypical medullary carcinoma n1=rhabdomyosarcome | n2=en:atypical medullary carcinoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:b-cell non-hodgkin lymphoma n1=rhabdomyosarcome | n2=en:b-cell non-hodgkin lymphoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:basocellular neoplasms develop after second decade n1=rhabdomyosarcome | n2=en:basocellular neoplasms develop after second decade | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:benign soft tissue neoplasm n1=rhabdomyosarcome | n2=en:benign soft tissue neoplasm | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:benign tumors of the eye, heart, and lungs n1=rhabdomyosarcome | n2=en:benign tumors of the eye, heart, and lungs | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:borderline ovarian epithelial tumor n1=rhabdomyosarcome | n2=en:borderline ovarian epithelial tumor | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:breast cancer, early-onset (in some patients) n1=rhabdomyosarcome | n2=en:breast cancer, early-onset (in some patients) | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:chondroblastic osteosarcoma n1=rhabdomyosarcome | n2=en:chondroblastic osteosarcoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:combined small cell lung carcinoma n1=rhabdomyosarcome | n2=en:combined small cell lung carcinoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:desmoid-type fibromatosis n1=rhabdomyosarcome | n2=en:desmoid-type fibromatosis | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:desmoplastic small cell tumor n1=rhabdomyosarcome | n2=en:desmoplastic small cell tumor | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:digestive system neoplasms n1=rhabdomyosarcome | n2=en:digestive system neoplasms | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:dysplasia with neoplasia n1=rhabdomyosarcome | n2=en:dysplasia with neoplasia | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:esthesioneurocytoma n1=rhabdomyosarcome | n2=en:esthesioneurocytoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:extraskeletal myxoid chondrosarcoma n1=rhabdomyosarcome | n2=en:extraskeletal myxoid chondrosarcoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:extraskeletal osteosarcoma n1=rhabdomyosarcome | n2=en:extraskeletal osteosarcoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:fibrohistiocytic neoplasm n1=rhabdomyosarcome | n2=en:fibrohistiocytic neoplasm | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:follicular dendritic cell sarcoma n1=rhabdomyosarcome | n2=en:follicular dendritic cell sarcoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:g antigen family d member 3 n1=rhabdomyosarcome | n2=en:g antigen family d member 3 | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:germ cell tumor n1=rhabdomyosarcome | n2=en:germ cell tumor | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:giant cell lesion of small bones n1=rhabdomyosarcome | n2=en:giant cell lesion of small bones | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:hepatoblastoma n1=rhabdomyosarcome | n2=en:hepatoblastoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:increased risk for embryonal tumors n1=rhabdomyosarcome | n2=en:increased risk for embryonal tumors | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:increased risk of testicular cancer n1=rhabdomyosarcome | n2=en:increased risk of testicular cancer | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:increased risk of tumor formation, especially of the head n1=rhabdomyosarcome | n2=en:increased risk of tumor formation, especially of the head | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:increased susceptibility to large granular lymphocytic t-cell leukemia n1=rhabdomyosarcome | n2=en:increased susceptibility to large granular lymphocytic t-cell leukemia | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:islet cell tumor n1=rhabdomyosarcome | n2=en:islet cell tumor | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:large cell lung carcinoma with rhabdoid phenotype n1=rhabdomyosarcome | n2=en:large cell lung carcinoma with rhabdoid phenotype | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:lentigo maligna melanoma n1=rhabdomyosarcome | n2=en:lentigo maligna melanoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:leukemia n1=rhabdomyosarcome | n2=en:leukemia | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:lymphoproliferative disorder n1=rhabdomyosarcome | n2=en:lymphoproliferative disorder | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:malignant bone marrow neoplasm n1=rhabdomyosarcome | n2=en:malignant bone marrow neoplasm | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:malignant genitourinary tract tumor n1=rhabdomyosarcome | n2=en:malignant genitourinary tract tumor | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:malignant melanoma in giant pigmented nevus n1=rhabdomyosarcome | n2=en:malignant melanoma in giant pigmented nevus | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:malignant pancreatic neoplasm n1=rhabdomyosarcome | n2=en:malignant pancreatic neoplasm | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:malignant trophoblastic teratoma n1=rhabdomyosarcome | n2=en:malignant trophoblastic teratoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:malignant type a thymoma n1=rhabdomyosarcome | n2=en:malignant type a thymoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:malignant type b2 thymoma n1=rhabdomyosarcome | n2=en:malignant type b2 thymoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:mast cell malignancy n1=rhabdomyosarcome | n2=en:mast cell malignancy | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:medulloblastoma n1=rhabdomyosarcome | n2=en:medulloblastoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:melanoma n1=rhabdomyosarcome | n2=en:melanoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:metastatic ewing sarcoma n1=rhabdomyosarcome | n2=en:metastatic ewing sarcoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:microcystic adnexal carcinoma n1=rhabdomyosarcome | n2=en:microcystic adnexal carcinoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:mir29c wt allele n1=rhabdomyosarcome | n2=en:mir29c wt allele | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:mixed germ cell tumor n1=rhabdomyosarcome | n2=en:mixed germ cell tumor | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:myomatous neoplasm n1=rhabdomyosarcome | n2=en:myomatous neoplasm | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:myosarcoma n1=rhabdomyosarcome | n2=en:myosarcoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:nci ctep simplified disease classification terminology n1=rhabdomyosarcome | n2=en:nci ctep simplified disease classification terminology | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:neoplasm by site n1=rhabdomyosarcome | n2=en:neoplasm by site | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:neoplasm related morbidities n1=rhabdomyosarcome | n2=en:neoplasm related morbidities | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:neoplasms by histologic type n1=rhabdomyosarcome | n2=en:neoplasms by histologic type | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:neoplasms of uncertain or unknown behaviour n1=rhabdomyosarcome | n2=en:neoplasms of uncertain or unknown behaviour | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:neoplastic skeletal muscle cell n1=rhabdomyosarcome | n2=en:neoplastic skeletal muscle cell | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:neuroepitheliomatous neoplasm n1=rhabdomyosarcome | n2=en:neuroepitheliomatous neoplasm | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:nevus and/or melanoma n1=rhabdomyosarcome | n2=en:nevus and/or melanoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:no progression to cancer n1=rhabdomyosarcome | n2=en:no progression to cancer | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:olfactory neurogenic tumor n1=rhabdomyosarcome | n2=en:olfactory neurogenic tumor | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:optic glioma (19%) n1=rhabdomyosarcome | n2=en:optic glioma (19%) | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:parathyroid disease rare n1=rhabdomyosarcome | n2=en:parathyroid disease rare | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:periampullary carcinoma nos n1=rhabdomyosarcome | n2=en:periampullary carcinoma nos | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:periosteal chondrosarcoma n1=rhabdomyosarcome | n2=en:periosteal chondrosarcoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:periosteal fibrosarcoma n1=rhabdomyosarcome | n2=en:periosteal fibrosarcoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:polycythemia vera n1=rhabdomyosarcome | n2=en:polycythemia vera | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:poorly differentiated sarcoma n1=rhabdomyosarcome | n2=en:poorly differentiated sarcoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:primary malignant neoplasm of bone n1=rhabdomyosarcome | n2=en:primary malignant neoplasm of bone | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:primary malignant neoplasm of paraganglion n1=rhabdomyosarcome | n2=en:primary malignant neoplasm of paraganglion | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:primary malignant neoplasm of sweat gland n1=rhabdomyosarcome | n2=en:primary malignant neoplasm of sweat gland | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:prolactin-producing pituitary gland adenoma n1=rhabdomyosarcome | n2=en:prolactin-producing pituitary gland adenoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:prolymphocytic lymphosarcoma n1=rhabdomyosarcome | n2=en:prolymphocytic lymphosarcoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:radiotherapeutic n1=rhabdomyosarcome | n2=en:radiotherapeutic | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:reactive immunoproliferative disease n1=rhabdomyosarcome | n2=en:reactive immunoproliferative disease | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:recurrent alveolar soft part sarcoma n1=rhabdomyosarcome | n2=en:recurrent alveolar soft part sarcoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:recurrent liposarcoma n1=rhabdomyosarcome | n2=en:recurrent liposarcoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:recurrent undifferentiated pleomorphic sarcoma n1=rhabdomyosarcome | n2=en:recurrent undifferentiated pleomorphic sarcoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:refractory anemia with excess blasts in transformation n1=rhabdomyosarcome | n2=en:refractory anemia with excess blasts in transformation | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:regressed germ cell tumor n1=rhabdomyosarcome | n2=en:regressed germ cell tumor | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:renal cell carcinoma, usually clear cell type n1=rhabdomyosarcome | n2=en:renal cell carcinoma, usually clear cell type | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:respiratory and mediastinal neoplasms benign (excl mesotheliomas) n1=rhabdomyosarcome | n2=en:respiratory and mediastinal neoplasms benign (excl mesotheliomas) | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:rhabdoid tumors, malignant (renal or extrarenal) n1=rhabdomyosarcome | n2=en:rhabdoid tumors, malignant (renal or extrarenal) | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:round cell liposarcoma n1=rhabdomyosarcome | n2=en:round cell liposarcoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:second primary malignant neoplasm n1=rhabdomyosarcome | n2=en:second primary malignant neoplasm | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:seromucinous carcinoma n1=rhabdomyosarcome | n2=en:seromucinous carcinoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:skeletal muscle neoplasm n1=rhabdomyosarcome | n2=en:skeletal muscle neoplasm | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:skeletal neoplasms malignant and unspecified n1=rhabdomyosarcome | n2=en:skeletal neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:skin appendage tumors may show malignant transformation n1=rhabdomyosarcome | n2=en:skin appendage tumors may show malignant transformation | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:small intestinal carcinoma n1=rhabdomyosarcome | n2=en:small intestinal carcinoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:soft tissue neoplasms malignant and unspecified nec (excl sarcomas) n1=rhabdomyosarcome | n2=en:soft tissue neoplasms malignant and unspecified nec (excl sarcomas) | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:squamous cell carcinoma n1=rhabdomyosarcome | n2=en:squamous cell carcinoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:squamous cell carcinoma (skin and tongue) n1=rhabdomyosarcome | n2=en:squamous cell carcinoma (skin and tongue) | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:storiform-pleomorphic malignant fibrous histiocytoma n1=rhabdomyosarcome | n2=en:storiform-pleomorphic malignant fibrous histiocytoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:susceptibility to malignant melanoma n1=rhabdomyosarcome | n2=en:susceptibility to malignant melanoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:synovial neoplasm n1=rhabdomyosarcome | n2=en:synovial neoplasm | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:t-cell non-hodgkin lymphoma n1=rhabdomyosarcome | n2=en:t-cell non-hodgkin lymphoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:testicular sex cord-stromal tumor n1=rhabdomyosarcome | n2=en:testicular sex cord-stromal tumor | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:thyroid gland oncocytic adenoma n1=rhabdomyosarcome | n2=en:thyroid gland oncocytic adenoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:thyroid gland spindle cell tumor with thymus-like differentiation n1=rhabdomyosarcome | n2=en:thyroid gland spindle cell tumor with thymus-like differentiation | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:trophoblastic tumor n1=rhabdomyosarcome | n2=en:trophoblastic tumor | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:tspan32 wt allele n1=rhabdomyosarcome | n2=en:tspan32 wt allele | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:tssc4 wt allele n1=rhabdomyosarcome | n2=en:tssc4 wt allele | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:tumors at multiple other sites including cns n1=rhabdomyosarcome | n2=en:tumors at multiple other sites including cns | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:use of ultrasonography n1=rhabdomyosarcome | n2=en:use of ultrasonography | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:vagus nerve paraganglioma n1=rhabdomyosarcome | n2=en:vagus nerve paraganglioma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> en:well differentiated liposarcoma n1=rhabdomyosarcome | n2=en:well differentiated liposarcoma | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 30 / 0.061 -> maladie (médecine) n1=rhabdomyosarcome | n2=maladie (médecine) | rel=r_associated | relid=0 | w=30 rhabdomyosarcome -- r_associated #0: 29 / 0.059 -> neo n1=rhabdomyosarcome | n2=neo | rel=r_associated | relid=0 | w=29 rhabdomyosarcome -- r_associated #0: 26 / 0.053 -> maladie néoplasique maligne n1=rhabdomyosarcome | n2=maladie néoplasique maligne | rel=r_associated | relid=0 | w=26 rhabdomyosarcome -- r_associated #0: 23 / 0.047 -> cancer des tissus mous n1=rhabdomyosarcome | n2=cancer des tissus mous | rel=r_associated | relid=0 | w=23 rhabdomyosarcome -- r_associated #0: 23 / 0.047 -> rhabdomyosarcome alvéolaire n1=rhabdomyosarcome | n2=rhabdomyosarcome alvéolaire | rel=r_associated | relid=0 | w=23 rhabdomyosarcome -- r_associated #0: 22 / 0.045 -> tumeur primitive n1=rhabdomyosarcome | n2=tumeur primitive | rel=r_associated | relid=0 | w=22 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> Cancer de la prostate n1=rhabdomyosarcome | n2=Cancer de la prostate | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> Cancer des tissus mous n1=rhabdomyosarcome | n2=Cancer des tissus mous | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> cancer prostate n1=rhabdomyosarcome | n2=cancer prostate | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> cancer prostatique n1=rhabdomyosarcome | n2=cancer prostatique | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> en:bladder sarcoma n1=rhabdomyosarcome | n2=en:bladder sarcoma | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> en:botryoid sarcoma n1=rhabdomyosarcome | n2=en:botryoid sarcoma | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> en:Costello's syndrome n1=rhabdomyosarcome | n2=en:Costello's syndrome | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> en:cutaneous myosarcoma n1=rhabdomyosarcome | n2=en:cutaneous myosarcoma | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> en:malignant neoplasm of prostate n1=rhabdomyosarcome | n2=en:malignant neoplasm of prostate | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> en:malignant prostate neoplasm n1=rhabdomyosarcome | n2=en:malignant prostate neoplasm | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> en:muscular sarcoma n1=rhabdomyosarcome | n2=en:muscular sarcoma | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> en:polymorphic rhabdomyosarcoma n1=rhabdomyosarcome | n2=en:polymorphic rhabdomyosarcoma | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> en:primary tumor n1=rhabdomyosarcome | n2=en:primary tumor | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> en:prostata n1=rhabdomyosarcome | n2=en:prostata | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> en:prostate n1=rhabdomyosarcome | n2=en:prostate | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> en:prostate cancer n1=rhabdomyosarcome | n2=en:prostate cancer | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> en:prostate gland n1=rhabdomyosarcome | n2=en:prostate gland | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> en:soft tissue cancer n1=rhabdomyosarcome | n2=en:soft tissue cancer | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> en:vincristine n1=rhabdomyosarcome | n2=en:vincristine | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> glande prostatique n1=rhabdomyosarcome | n2=glande prostatique | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> rhabdomyosarcome à cellules fusiformes n1=rhabdomyosarcome | n2=rhabdomyosarcome à cellules fusiformes | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> rhabdomyosarcome avec différenciation ganglionnaire n1=rhabdomyosarcome | n2=rhabdomyosarcome avec différenciation ganglionnaire | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> rhabdomyosarcome chez l'enfant n1=rhabdomyosarcome | n2=rhabdomyosarcome chez l'enfant | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> tumeur de la prostate n1=rhabdomyosarcome | n2=tumeur de la prostate | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> tumeur maligne de la prostate n1=rhabdomyosarcome | n2=tumeur maligne de la prostate | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> tumeur maligne prostatique n1=rhabdomyosarcome | n2=tumeur maligne prostatique | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 20 / 0.041 -> tumeur primaire n1=rhabdomyosarcome | n2=tumeur primaire | rel=r_associated | relid=0 | w=20 rhabdomyosarcome -- r_associated #0: 12 / 0.024 -> rhabdomyosarcome embryonnaire n1=rhabdomyosarcome | n2=rhabdomyosarcome embryonnaire | rel=r_associated | relid=0 | w=12 rhabdomyosarcome -- r_associated #0: 11 / 0.022 -> angiome n1=rhabdomyosarcome | n2=angiome | rel=r_associated | relid=0 | w=11 rhabdomyosarcome -- r_associated #0: 11 / 0.022 -> lipome n1=rhabdomyosarcome | n2=lipome | rel=r_associated | relid=0 | w=11 rhabdomyosarcome -- r_associated #0: 11 / 0.022 -> mélanome n1=rhabdomyosarcome | n2=mélanome | rel=r_associated | relid=0 | w=11 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> acral lentiginous melanoma n1=rhabdomyosarcome | n2=acral lentiginous melanoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> adenocarcinoma n1=rhabdomyosarcome | n2=adenocarcinoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> adénocarcinome n1=rhabdomyosarcome | n2=adénocarcinome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> Adénocarcinome n1=rhabdomyosarcome | n2=Adénocarcinome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> adénocarcinome du côlon n1=rhabdomyosarcome | n2=adénocarcinome du côlon | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> adénocarcinome sudoripare n1=rhabdomyosarcome | n2=adénocarcinome sudoripare | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> adénome à cellules oncocytaires n1=rhabdomyosarcome | n2=adénome à cellules oncocytaires | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> adénome malin n1=rhabdomyosarcome | n2=adénome malin | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> adénome oncocytaire n1=rhabdomyosarcome | n2=adénome oncocytaire | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> adénosarcome sébacé n1=rhabdomyosarcome | n2=adénosarcome sébacé | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> androblastome malin n1=rhabdomyosarcome | n2=androblastome malin | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> anémie réfractaire n1=rhabdomyosarcome | n2=anémie réfractaire | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> angio-endothéliome malin n1=rhabdomyosarcome | n2=angio-endothéliome malin | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> angioléiomyome n1=rhabdomyosarcome | n2=angioléiomyome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> arrhénoblastome malin n1=rhabdomyosarcome | n2=arrhénoblastome malin | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> balloon cell melanoma n1=rhabdomyosarcome | n2=balloon cell melanoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> blastome n1=rhabdomyosarcome | n2=blastome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> cancer à cellules claires du rein n1=rhabdomyosarcome | n2=cancer à cellules claires du rein | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> cancer colo-rectal n1=rhabdomyosarcome | n2=cancer colo-rectal | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> cancer colorectal n1=rhabdomyosarcome | n2=cancer colorectal | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> cancer cutané n1=rhabdomyosarcome | n2=cancer cutané | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> cancer de l'endomètre n1=rhabdomyosarcome | n2=cancer de l'endomètre | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> cancer de l'oesophage n1=rhabdomyosarcome | n2=cancer de l'oesophage | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> cancer de la peau n1=rhabdomyosarcome | n2=cancer de la peau | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> Cancer de la peau n1=rhabdomyosarcome | n2=Cancer de la peau | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> cancer des os n1=rhabdomyosarcome | n2=cancer des os | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> cancer du côlon n1=rhabdomyosarcome | n2=cancer du côlon | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> cancer du duodénum n1=rhabdomyosarcome | n2=cancer du duodénum | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> Cancer du pancréas n1=rhabdomyosarcome | n2=Cancer du pancréas | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> cancer du pancréas n1=rhabdomyosarcome | n2=cancer du pancréas | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> cancer du sang n1=rhabdomyosarcome | n2=cancer du sang | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> cancer duodénal n1=rhabdomyosarcome | n2=cancer duodénal | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> cancer embryonnaire n1=rhabdomyosarcome | n2=cancer embryonnaire | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> cancer endométrial n1=rhabdomyosarcome | n2=cancer endométrial | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> cancer épithélial n1=rhabdomyosarcome | n2=cancer épithélial | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> cancer glandulaire n1=rhabdomyosarcome | n2=cancer glandulaire | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> cancer oesophagien n1=rhabdomyosarcome | n2=cancer oesophagien | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> cancer osseux n1=rhabdomyosarcome | n2=cancer osseux | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> Cancer osseux n1=rhabdomyosarcome | n2=Cancer osseux | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> cancer pancréatique n1=rhabdomyosarcome | n2=cancer pancréatique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> cancer sébacé n1=rhabdomyosarcome | n2=cancer sébacé | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> carcinoma n1=rhabdomyosarcome | n2=carcinoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> carcinome n1=rhabdomyosarcome | n2=carcinome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> carcinôme n1=rhabdomyosarcome | n2=carcinôme | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> carcinome annexiel microkystique n1=rhabdomyosarcome | n2=carcinome annexiel microkystique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> carcinome colo-rectal n1=rhabdomyosarcome | n2=carcinome colo-rectal | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> carcinome colorectal n1=rhabdomyosarcome | n2=carcinome colorectal | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> carcinome de l'endomètre n1=rhabdomyosarcome | n2=carcinome de l'endomètre | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> carcinome du gros intestin n1=rhabdomyosarcome | n2=carcinome du gros intestin | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> carcinome du pancréas n1=rhabdomyosarcome | n2=carcinome du pancréas | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> carcinome du pancreas n1=rhabdomyosarcome | n2=carcinome du pancreas | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> carcinome duodénal n1=rhabdomyosarcome | n2=carcinome duodénal | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> carcinome endométrial n1=rhabdomyosarcome | n2=carcinome endométrial | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> carcinome glandulaire n1=rhabdomyosarcome | n2=carcinome glandulaire | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> carcinome pancréatique n1=rhabdomyosarcome | n2=carcinome pancréatique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> carcinome recto-colique n1=rhabdomyosarcome | n2=carcinome recto-colique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> carcinome rectocolique n1=rhabdomyosarcome | n2=carcinome rectocolique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> carcinome rénal à cellules claires n1=rhabdomyosarcome | n2=carcinome rénal à cellules claires | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> carcinome sébacé n1=rhabdomyosarcome | n2=carcinome sébacé | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> carcinosarcome n1=rhabdomyosarcome | n2=carcinosarcome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> cellule épithéliale n1=rhabdomyosarcome | n2=cellule épithéliale | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> cellule tumorale n1=rhabdomyosarcome | n2=cellule tumorale | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> chondrosarcome n1=rhabdomyosarcome | n2=chondrosarcome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> chordome n1=rhabdomyosarcome | n2=chordome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> dermatofibrosarcoma protuberans n1=rhabdomyosarcome | n2=dermatofibrosarcoma protuberans | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> dysgerminome n1=rhabdomyosarcome | n2=dysgerminome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:« osteogenic » sarcoma n1=rhabdomyosarcome | n2=en:« osteogenic » sarcoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:acute myeloblastic leukaemia n1=rhabdomyosarcome | n2=en:acute myeloblastic leukaemia | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:acute myeloblastic leukemia n1=rhabdomyosarcome | n2=en:acute myeloblastic leukemia | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:adenocarcinoma of colon n1=rhabdomyosarcome | n2=en:adenocarcinoma of colon | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:angiomatous meningioma n1=rhabdomyosarcome | n2=en:angiomatous meningioma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:astrocytoma, increased risk of n1=rhabdomyosarcome | n2=en:astrocytoma, increased risk of | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:b-cell acute lymphoblastic leukemia (in some patients) n1=rhabdomyosarcome | n2=en:b-cell acute lymphoblastic leukemia (in some patients) | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:benign growth n1=rhabdomyosarcome | n2=en:benign growth | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:benign tumor n1=rhabdomyosarcome | n2=en:benign tumor | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:benign tumour n1=rhabdomyosarcome | n2=en:benign tumour | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:bone metastases from squamous cell carcinoma n1=rhabdomyosarcome | n2=en:bone metastases from squamous cell carcinoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:classic hodgkin lymphoma n1=rhabdomyosarcome | n2=en:classic hodgkin lymphoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:classic hodgkin lymphoma (in some patients) n1=rhabdomyosarcome | n2=en:classic hodgkin lymphoma (in some patients) | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:colloid tumor n1=rhabdomyosarcome | n2=en:colloid tumor | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:colorectal cancer n1=rhabdomyosarcome | n2=en:colorectal cancer | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:comedocarcinoma, no international classification of diseases for oncology subtype n1=rhabdomyosarcome | n2=en:comedocarcinoma, no international classification of diseases for oncology subtype | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:duodenal cancer n1=rhabdomyosarcome | n2=en:duodenal cancer | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:enchondrosarcoma n1=rhabdomyosarcome | n2=en:enchondrosarcoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:endometrial cancer n1=rhabdomyosarcome | n2=en:endometrial cancer | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:fibrocellular tumor n1=rhabdomyosarcome | n2=en:fibrocellular tumor | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:fibroid tumor n1=rhabdomyosarcome | n2=en:fibroid tumor | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:gangliocytoneuroma n1=rhabdomyosarcome | n2=en:gangliocytoneuroma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:glioma, increased risk of n1=rhabdomyosarcome | n2=en:glioma, increased risk of | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:heavy chains disease n1=rhabdomyosarcome | n2=en:heavy chains disease | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:hemangioma n1=rhabdomyosarcome | n2=en:hemangioma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:hepatocellular carcinoma, childhood onset (reported in 2 patients) n1=rhabdomyosarcome | n2=en:hepatocellular carcinoma, childhood onset (reported in 2 patients) | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:high grade lesion n1=rhabdomyosarcome | n2=en:high grade lesion | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:Hodgkin lymphoma n1=rhabdomyosarcome | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:increased risk of endometrial cancer n1=rhabdomyosarcome | n2=en:increased risk of endometrial cancer | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:increased risk of giant cell tumor of bone n1=rhabdomyosarcome | n2=en:increased risk of giant cell tumor of bone | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:increased risk of other cancers (e.g., kidney cancer, lung cancer, and leukemia) n1=rhabdomyosarcome | n2=en:increased risk of other cancers (e.g., kidney cancer, lung cancer, and leukemia) | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:increased susceptibility to juvenile myelomonocytic leukemia n1=rhabdomyosarcome | n2=en:increased susceptibility to juvenile myelomonocytic leukemia | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:increased susceptibility to malignancy n1=rhabdomyosarcome | n2=en:increased susceptibility to malignancy | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:increased susceptibility to multiple carcinomas n1=rhabdomyosarcome | n2=en:increased susceptibility to multiple carcinomas | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:innocent tumor n1=rhabdomyosarcome | n2=en:innocent tumor | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:Kaposi sarcoma n1=rhabdomyosarcome | n2=en:Kaposi sarcoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:lelomyosarcoma n1=rhabdomyosarcome | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:leucemia n1=rhabdomyosarcome | n2=en:leucemia | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:leukaemia n1=rhabdomyosarcome | n2=en:leukaemia | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:leukocythemia n1=rhabdomyosarcome | n2=en:leukocythemia | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:malignant colon neoplasm n1=rhabdomyosarcome | n2=en:malignant colon neoplasm | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:malignant fibrous histiocytoma n1=rhabdomyosarcome | n2=en:malignant fibrous histiocytoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:malignant histiocytoma n1=rhabdomyosarcome | n2=en:malignant histiocytoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:malignant neoplasm of skin n1=rhabdomyosarcome | n2=en:malignant neoplasm of skin | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:malignant transformation of choroid plexus papilloma n1=rhabdomyosarcome | n2=en:malignant transformation of choroid plexus papilloma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:malignant tumor of colon n1=rhabdomyosarcome | n2=en:malignant tumor of colon | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:malignant tumors (smq) n1=rhabdomyosarcome | n2=en:malignant tumors (smq) | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:meduloepithelioma n1=rhabdomyosarcome | n2=en:meduloepithelioma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:mu chain disease n1=rhabdomyosarcome | n2=en:mu chain disease | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:mucinous cystic neoplasm with invasive carcinoma n1=rhabdomyosarcome | n2=en:mucinous cystic neoplasm with invasive carcinoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:mucous tumor n1=rhabdomyosarcome | n2=en:mucous tumor | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:muscular tissue n1=rhabdomyosarcome | n2=en:muscular tissue | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:myelogeneous leukemia, chronic n1=rhabdomyosarcome | n2=en:myelogeneous leukemia, chronic | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:myxoblastoma n1=rhabdomyosarcome | n2=en:myxoblastoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:neoplasms of unspecified nature or uncertain behavior n1=rhabdomyosarcome | n2=en:neoplasms of unspecified nature or uncertain behavior | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:neurilemmoma n1=rhabdomyosarcome | n2=en:neurilemmoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:neurinoma n1=rhabdomyosarcome | n2=en:neurinoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:neuroma n1=rhabdomyosarcome | n2=en:neuroma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:non-hematological malignant tumors (smq) n1=rhabdomyosarcome | n2=en:non-hematological malignant tumors (smq) | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:nonmedullary thyroid carcinoma (papillary and follicular) n1=rhabdomyosarcome | n2=en:nonmedullary thyroid carcinoma (papillary and follicular) | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:orbital leiomyoma n1=rhabdomyosarcome | n2=en:orbital leiomyoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:pancreas cancer n1=rhabdomyosarcome | n2=en:pancreas cancer | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:pancreatic cancer n1=rhabdomyosarcome | n2=en:pancreatic cancer | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:pancreatic neoplasm n1=rhabdomyosarcome | n2=en:pancreatic neoplasm | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:papillary renal cell adenoma n1=rhabdomyosarcome | n2=en:papillary renal cell adenoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:pleomorphic benign salivary gland adenoma (psa) n1=rhabdomyosarcome | n2=en:pleomorphic benign salivary gland adenoma (psa) | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:pleomorphic leiomyosarcoma n1=rhabdomyosarcome | n2=en:pleomorphic leiomyosarcoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:primary liposarcoma of retroperitoneum n1=rhabdomyosarcome | n2=en:primary liposarcoma of retroperitoneum | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:primary malignant mesenchymal neoplasm of stomach n1=rhabdomyosarcome | n2=en:primary malignant mesenchymal neoplasm of stomach | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:primary malignant neoplasm of placenta n1=rhabdomyosarcome | n2=en:primary malignant neoplasm of placenta | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:primary myxofibrosarcoma n1=rhabdomyosarcome | n2=en:primary myxofibrosarcoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:primary rhabdomyosarcoma of intrathoracic organ n1=rhabdomyosarcome | n2=en:primary rhabdomyosarcoma of intrathoracic organ | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:primary rhabdomyosarcoma of oral cavity n1=rhabdomyosarcome | n2=en:primary rhabdomyosarcoma of oral cavity | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:primary rhabdomyosarcoma of pharynx n1=rhabdomyosarcome | n2=en:primary rhabdomyosarcoma of pharynx | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:primary rhabdomyosarcoma of respiratory organ n1=rhabdomyosarcome | n2=en:primary rhabdomyosarcoma of respiratory organ | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:primary sarcoma n1=rhabdomyosarcome | n2=en:primary sarcoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:primary sarcoma of left lower limb n1=rhabdomyosarcome | n2=en:primary sarcoma of left lower limb | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:primary sarcoma of retroperitoneum n1=rhabdomyosarcome | n2=en:primary sarcoma of retroperitoneum | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:primary sarcoma of right lower limb n1=rhabdomyosarcome | n2=en:primary sarcoma of right lower limb | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:primary synovial sarcoma of intrathoracic organ n1=rhabdomyosarcome | n2=en:primary synovial sarcoma of intrathoracic organ | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:primary synovial sarcoma of respiratory organ n1=rhabdomyosarcome | n2=en:primary synovial sarcoma of respiratory organ | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:resectable sarcoma n1=rhabdomyosarcome | n2=en:resectable sarcoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:skeletal muscle tissue n1=rhabdomyosarcome | n2=en:skeletal muscle tissue | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:skin cancer n1=rhabdomyosarcome | n2=en:skin cancer | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:skin carcinoma n1=rhabdomyosarcome | n2=en:skin carcinoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:stim1 protein, human n1=rhabdomyosarcome | n2=en:stim1 protein, human | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:systemic epstein-barr virus positive t-cell lymphoproliferative disease of childhood n1=rhabdomyosarcome | n2=en:systemic epstein-barr virus positive t-cell lymphoproliferative disease of childhood | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:thyroid cancer, follicular variant papillary n1=rhabdomyosarcome | n2=en:thyroid cancer, follicular variant papillary | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:tumor cell n1=rhabdomyosarcome | n2=en:tumor cell | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:ulcerating basal cell carcinoma n1=rhabdomyosarcome | n2=en:ulcerating basal cell carcinoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:ulcus exedens n1=rhabdomyosarcome | n2=en:ulcus exedens | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:Vaquez' disease n1=rhabdomyosarcome | n2=en:Vaquez' disease | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> en:von Recklinghausen's disease n1=rhabdomyosarcome | n2=en:von Recklinghausen's disease | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> enzymologie n1=rhabdomyosarcome | n2=enzymologie | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> enzymology n1=rhabdomyosarcome | n2=enzymology | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> épidémiologique n1=rhabdomyosarcome | n2=épidémiologique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> épithélioma malin n1=rhabdomyosarcome | n2=épithélioma malin | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> épithélioma sébacé n1=rhabdomyosarcome | n2=épithélioma sébacé | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> état prénéoplasique n1=rhabdomyosarcome | n2=état prénéoplasique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> ethnologique n1=rhabdomyosarcome | n2=ethnologique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> fibrome n1=rhabdomyosarcome | n2=fibrome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> fibrosarcome n1=rhabdomyosarcome | n2=fibrosarcome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> fibrosarcome améloblastique n1=rhabdomyosarcome | n2=fibrosarcome améloblastique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> fibroxanthome malin n1=rhabdomyosarcome | n2=fibroxanthome malin | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> ganglioneurome n1=rhabdomyosarcome | n2=ganglioneurome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> germinome n1=rhabdomyosarcome | n2=germinome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> gliome périphérique n1=rhabdomyosarcome | n2=gliome périphérique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> hémangio-sarcome osseux n1=rhabdomyosarcome | n2=hémangio-sarcome osseux | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> hémangiome n1=rhabdomyosarcome | n2=hémangiome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> histiocytes bleu de mer (maladie des) n1=rhabdomyosarcome | n2=histiocytes bleu de mer (maladie des) | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> histiocytofibrome malin n1=rhabdomyosarcome | n2=histiocytofibrome malin | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> histiocytome fibreux malin n1=rhabdomyosarcome | n2=histiocytome fibreux malin | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> histiocytome fibreux malin stade non spécifié n1=rhabdomyosarcome | n2=histiocytome fibreux malin stade non spécifié | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> histiocytome malin n1=rhabdomyosarcome | n2=histiocytome malin | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> la à granulocytes n1=rhabdomyosarcome | n2=la à granulocytes | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> LA à granulocytes n1=rhabdomyosarcome | n2=LA à granulocytes | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> lam n1=rhabdomyosarcome | n2=lam | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> lanl n1=rhabdomyosarcome | n2=lanl | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leiomyosarcome n1=rhabdomyosarcome | n2=leiomyosarcome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> léiomyosarcome n1=rhabdomyosarcome | n2=léiomyosarcome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> lemmome n1=rhabdomyosarcome | n2=lemmome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leucémie n1=rhabdomyosarcome | n2=leucémie | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leucémie aiguë granulocytaire n1=rhabdomyosarcome | n2=leucémie aiguë granulocytaire | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leucémie aiguë myéloblastique n1=rhabdomyosarcome | n2=leucémie aiguë myéloblastique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leucémie aigüe myéloblastique n1=rhabdomyosarcome | n2=leucémie aigüe myéloblastique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leucémie aiguë myélocytaire n1=rhabdomyosarcome | n2=leucémie aiguë myélocytaire | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leucémie aiguë myéloïde n1=rhabdomyosarcome | n2=leucémie aiguë myéloïde | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leucémie aigüe myéloïde n1=rhabdomyosarcome | n2=leucémie aigüe myéloïde | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leucémie aiguë non lymphoblastique n1=rhabdomyosarcome | n2=leucémie aiguë non lymphoblastique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leucémie aigüe non lymphoblastique n1=rhabdomyosarcome | n2=leucémie aigüe non lymphoblastique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leucémie aiguë non lymphocytaire n1=rhabdomyosarcome | n2=leucémie aiguë non lymphocytaire | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leucémie blastique granulocytaire n1=rhabdomyosarcome | n2=leucémie blastique granulocytaire | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leucémie granuleuse aiguë n1=rhabdomyosarcome | n2=leucémie granuleuse aiguë | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leucémie granulocytaire aiguë n1=rhabdomyosarcome | n2=leucémie granulocytaire aiguë | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leucémie lymphoïde aiguë n1=rhabdomyosarcome | n2=leucémie lymphoïde aiguë | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leucémie lymphoïde chronique n1=rhabdomyosarcome | n2=leucémie lymphoïde chronique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leucémie myéloblastique aigüe n1=rhabdomyosarcome | n2=leucémie myéloblastique aigüe | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leucémie myéloblastique aiguë n1=rhabdomyosarcome | n2=leucémie myéloblastique aiguë | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leucémie myélocytaire aiguë n1=rhabdomyosarcome | n2=leucémie myélocytaire aiguë | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leucémie myélogène aigüe n1=rhabdomyosarcome | n2=leucémie myélogène aigüe | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leucémie myélogène aiguë n1=rhabdomyosarcome | n2=leucémie myélogène aiguë | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leucémie myéloïde aiguë n1=rhabdomyosarcome | n2=leucémie myéloïde aiguë | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leucémie myéloïde aigüe n1=rhabdomyosarcome | n2=leucémie myéloïde aigüe | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leucémie non lymphoblastique aiguë n1=rhabdomyosarcome | n2=leucémie non lymphoblastique aiguë | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> leucémies myéloïdes aiguës n1=rhabdomyosarcome | n2=leucémies myéloïdes aiguës | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> lipomyxosarcome n1=rhabdomyosarcome | n2=lipomyxosarcome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> liposarcome n1=rhabdomyosarcome | n2=liposarcome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> liposarcome pléomorphe n1=rhabdomyosarcome | n2=liposarcome pléomorphe | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> lung n1=rhabdomyosarcome | n2=lung | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> lymphangio-sarcome n1=rhabdomyosarcome | n2=lymphangio-sarcome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> lymphome folliculaire n1=rhabdomyosarcome | n2=lymphome folliculaire | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> maladie clinique de recklinghausen n1=rhabdomyosarcome | n2=maladie clinique de recklinghausen | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> maladie de Recklinghausen n1=rhabdomyosarcome | n2=maladie de Recklinghausen | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> maladie de Vaquez n1=rhabdomyosarcome | n2=maladie de Vaquez | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> maladie de von Recklinghausen n1=rhabdomyosarcome | n2=maladie de von Recklinghausen | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> maladie des chaînes lourdes n1=rhabdomyosarcome | n2=maladie des chaînes lourdes | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> médulloépithéliome n1=rhabdomyosarcome | n2=médulloépithéliome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> médulloépithéliome tératoïde n1=rhabdomyosarcome | n2=médulloépithéliome tératoïde | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> melanoma n1=rhabdomyosarcome | n2=melanoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> melanomalignom n1=rhabdomyosarcome | n2=melanomalignom | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> mélanome à cellules ballonnisantes n1=rhabdomyosarcome | n2=mélanome à cellules ballonnisantes | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> mélanome à cellules fusiformes n1=rhabdomyosarcome | n2=mélanome à cellules fusiformes | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> mélanome à cellules fusiformes de type b n1=rhabdomyosarcome | n2=mélanome à cellules fusiformes de type b | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> mélanome achromique n1=rhabdomyosarcome | n2=mélanome achromique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> mélanome desmoplastique n1=rhabdomyosarcome | n2=mélanome desmoplastique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> mélanome lentigineux acral n1=rhabdomyosarcome | n2=mélanome lentigineux acral | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> mélanome superficiel extensif n1=rhabdomyosarcome | n2=mélanome superficiel extensif | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> méningiome n1=rhabdomyosarcome | n2=méningiome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> méningiome angiomateux n1=rhabdomyosarcome | n2=méningiome angiomateux | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> méningiomes n1=rhabdomyosarcome | n2=méningiomes | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> mésothéliome n1=rhabdomyosarcome | n2=mésothéliome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> microbiologique n1=rhabdomyosarcome | n2=microbiologique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> myélofibrose primaire n1=rhabdomyosarcome | n2=myélofibrose primaire | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> myélofibrose primitive n1=rhabdomyosarcome | n2=myélofibrose primitive | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> myélome plasmocytaire n1=rhabdomyosarcome | n2=myélome plasmocytaire | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> myxoma n1=rhabdomyosarcome | n2=myxoma | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> myxome n1=rhabdomyosarcome | n2=myxome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> myxomes cardiaques et cutanés, lentiginose faciale et syndrome de Cushing n1=rhabdomyosarcome | n2=myxomes cardiaques et cutanés, lentiginose faciale et syndrome de Cushing | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> myxosarcome n1=rhabdomyosarcome | n2=myxosarcome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> naevocarcinome à cellules fusiformes n1=rhabdomyosarcome | n2=naevocarcinome à cellules fusiformes | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> naevocarcinome à cellules fusiformes de type b n1=rhabdomyosarcome | n2=naevocarcinome à cellules fusiformes de type b | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> néoplasme bénin n1=rhabdomyosarcome | n2=néoplasme bénin | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> neurilemmome n1=rhabdomyosarcome | n2=neurilemmome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> neurinome n1=rhabdomyosarcome | n2=neurinome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> neurinome acoustique n1=rhabdomyosarcome | n2=neurinome acoustique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> neurinome de l'acoustique n1=rhabdomyosarcome | n2=neurinome de l'acoustique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> Neurinome de l'acoustique n1=rhabdomyosarcome | n2=Neurinome de l'acoustique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> neurinome malin n1=rhabdomyosarcome | n2=neurinome malin | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> neuro-épithéliome n1=rhabdomyosarcome | n2=neuro-épithéliome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> neuroépithéliome n1=rhabdomyosarcome | n2=neuroépithéliome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> neurofibromatose de type 1 n1=rhabdomyosarcome | n2=neurofibromatose de type 1 | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> névrome n1=rhabdomyosarcome | n2=névrome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> névrome cutané n1=rhabdomyosarcome | n2=névrome cutané | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> névrome palissadique encapsulé n1=rhabdomyosarcome | n2=névrome palissadique encapsulé | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> névrome, sai n1=rhabdomyosarcome | n2=névrome, sai | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> odontosarcome améloblastique n1=rhabdomyosarcome | n2=odontosarcome améloblastique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> oligodendrogliome n1=rhabdomyosarcome | n2=oligodendrogliome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> ostéoporose-pseudogliome (syndrome) n1=rhabdomyosarcome | n2=ostéoporose-pseudogliome (syndrome) | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> ostéosarcome n1=rhabdomyosarcome | n2=ostéosarcome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> ostéosarcome juxta-cortical n1=rhabdomyosarcome | n2=ostéosarcome juxta-cortical | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> ostéosarcome juxtacortical n1=rhabdomyosarcome | n2=ostéosarcome juxtacortical | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> ostéosarcome périosté n1=rhabdomyosarcome | n2=ostéosarcome périosté | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> ostéosarcome télangiectasique n1=rhabdomyosarcome | n2=ostéosarcome télangiectasique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> pancréas (cancer du) n1=rhabdomyosarcome | n2=pancréas (cancer du) | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> parasitologie n1=rhabdomyosarcome | n2=parasitologie | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> partie non précisée tumeur maligne du pancréas n1=rhabdomyosarcome | n2=partie non précisée tumeur maligne du pancréas | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> polycythemia vera n1=rhabdomyosarcome | n2=polycythemia vera | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> polyembryome n1=rhabdomyosarcome | n2=polyembryome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> polyglobulie essentielle n1=rhabdomyosarcome | n2=polyglobulie essentielle | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> polyglobulie vraie n1=rhabdomyosarcome | n2=polyglobulie vraie | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> porocarcinome n1=rhabdomyosarcome | n2=porocarcinome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> poumon n1=rhabdomyosarcome | n2=poumon | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> poumon vert n1=rhabdomyosarcome | n2=poumon vert | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> radiographique n1=rhabdomyosarcome | n2=radiographique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> rétinoblastome n1=rhabdomyosarcome | n2=rétinoblastome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> rhabomyosarcome alvéolaire n1=rhabdomyosarcome | n2=rhabomyosarcome alvéolaire | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> sarcome à petites cellules n1=rhabdomyosarcome | n2=sarcome à petites cellules | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> sarcome a petites cellules n1=rhabdomyosarcome | n2=sarcome a petites cellules | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> sarcome de la vulve n1=rhabdomyosarcome | n2=sarcome de la vulve | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> sarcome épithélioïde n1=rhabdomyosarcome | n2=sarcome épithélioïde | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> sarcome granulocytaire n1=rhabdomyosarcome | n2=sarcome granulocytaire | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> schwannogliome n1=rhabdomyosarcome | n2=schwannogliome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> schwannome n1=rhabdomyosarcome | n2=schwannome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> schwannome ancien n1=rhabdomyosarcome | n2=schwannome ancien | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> schwannome bénin n1=rhabdomyosarcome | n2=schwannome bénin | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> schwannome cellulaire n1=rhabdomyosarcome | n2=schwannome cellulaire | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> schwannome dégénéré n1=rhabdomyosarcome | n2=schwannome dégénéré | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> schwannome malin n1=rhabdomyosarcome | n2=schwannome malin | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> schwannome mélanocytaire n1=rhabdomyosarcome | n2=schwannome mélanocytaire | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> schwannome pigmenté n1=rhabdomyosarcome | n2=schwannome pigmenté | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> schwannome plexiforme n1=rhabdomyosarcome | n2=schwannome plexiforme | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> schwannome psammomateux n1=rhabdomyosarcome | n2=schwannome psammomateux | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> séminome n1=rhabdomyosarcome | n2=séminome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> syringo-cystadénome papillifère n1=rhabdomyosarcome | n2=syringo-cystadénome papillifère | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> syringocystadénome papillaire n1=rhabdomyosarcome | n2=syringocystadénome papillaire | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> syringocystadénome papillifère n1=rhabdomyosarcome | n2=syringocystadénome papillifère | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tératome à prédominance médulloépithéliale n1=rhabdomyosarcome | n2=tératome à prédominance médulloépithéliale | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tissu épithélial n1=rhabdomyosarcome | n2=tissu épithélial | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tissu musculaire n1=rhabdomyosarcome | n2=tissu musculaire | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> Tumeur bénigne n1=rhabdomyosarcome | n2=Tumeur bénigne | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur bénigne n1=rhabdomyosarcome | n2=tumeur bénigne | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur cancéreuse n1=rhabdomyosarcome | n2=tumeur cancéreuse | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur colo-rectale n1=rhabdomyosarcome | n2=tumeur colo-rectale | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur colorectale n1=rhabdomyosarcome | n2=tumeur colorectale | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur cutanée maligne n1=rhabdomyosarcome | n2=tumeur cutanée maligne | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur d'autres sièges précisés à évolution imprévisible ou inconnue n1=rhabdomyosarcome | n2=tumeur d'autres sièges précisés à évolution imprévisible ou inconnue | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur d'autres sites non précisés à évolution imprévisible n1=rhabdomyosarcome | n2=tumeur d'autres sites non précisés à évolution imprévisible | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur d'autres sites précisés à évolution imprévisible ou inconnue n1=rhabdomyosarcome | n2=tumeur d'autres sites précisés à évolution imprévisible ou inconnue | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur de bénignité ou de malignité non assurée n1=rhabdomyosarcome | n2=tumeur de bénignité ou de malignité non assurée | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur de Grawitz n1=rhabdomyosarcome | n2=tumeur de Grawitz | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur du côlon n1=rhabdomyosarcome | n2=tumeur du côlon | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur du pancréas n1=rhabdomyosarcome | n2=tumeur du pancréas | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur maligne d'Abrikossof n1=rhabdomyosarcome | n2=tumeur maligne d'Abrikossof | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur maligne de gaine nerveuse périphérique n1=rhabdomyosarcome | n2=tumeur maligne de gaine nerveuse périphérique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur maligne de l'oesophage n1=rhabdomyosarcome | n2=tumeur maligne de l'oesophage | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur maligne de la peau n1=rhabdomyosarcome | n2=tumeur maligne de la peau | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur maligne de siège non précisé n1=rhabdomyosarcome | n2=tumeur maligne de siège non précisé | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur maligne des os n1=rhabdomyosarcome | n2=tumeur maligne des os | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur maligne du côlon n1=rhabdomyosarcome | n2=tumeur maligne du côlon | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur maligne du duodénum n1=rhabdomyosarcome | n2=tumeur maligne du duodénum | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur maligne du muscle n1=rhabdomyosarcome | n2=tumeur maligne du muscle | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur maligne du pancréas n1=rhabdomyosarcome | n2=tumeur maligne du pancréas | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur maligne duodénale n1=rhabdomyosarcome | n2=tumeur maligne duodénale | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur maligne oesophagienne n1=rhabdomyosarcome | n2=tumeur maligne oesophagienne | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur maligne osseuse n1=rhabdomyosarcome | n2=tumeur maligne osseuse | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur maligne pancréatique n1=rhabdomyosarcome | n2=tumeur maligne pancréatique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur neuro-ectodermique primitive n1=rhabdomyosarcome | n2=tumeur neuro-ectodermique primitive | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur neuroectodermique périphérique primitive n1=rhabdomyosarcome | n2=tumeur neuroectodermique périphérique primitive | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur neuroectodermique primitive n1=rhabdomyosarcome | n2=tumeur neuroectodermique primitive | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur non classée de bénignité ou de malignité incertaine n1=rhabdomyosarcome | n2=tumeur non classée de bénignité ou de malignité incertaine | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur odontogène maligne n1=rhabdomyosarcome | n2=tumeur odontogène maligne | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur pancréatique maligne n1=rhabdomyosarcome | n2=tumeur pancréatique maligne | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur primitive neuroectodermique n1=rhabdomyosarcome | n2=tumeur primitive neuroectodermique | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur tubulopapillaire du rein n1=rhabdomyosarcome | n2=tumeur tubulopapillaire du rein | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeur vasculaire n1=rhabdomyosarcome | n2=tumeur vasculaire | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeurs du pancréas n1=rhabdomyosarcome | n2=tumeurs du pancréas | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeurs du pancreas n1=rhabdomyosarcome | n2=tumeurs du pancreas | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeurs hématopoïétiques n1=rhabdomyosarcome | n2=tumeurs hématopoïétiques | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeurs neuroectodermiques périphériques primitives n1=rhabdomyosarcome | n2=tumeurs neuroectodermiques périphériques primitives | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> tumeurs pancréatiques n1=rhabdomyosarcome | n2=tumeurs pancréatiques | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 10 / 0.02 -> ulcus rodens n1=rhabdomyosarcome | n2=ulcus rodens | rel=r_associated | relid=0 | w=10 rhabdomyosarcome -- r_associated #0: 5 / 0.01 -> en:cancer research n1=rhabdomyosarcome | n2=en:cancer research | rel=r_associated | relid=0 | w=5 rhabdomyosarcome -- r_associated #0: 5 / 0.01 -> en:cancrology n1=rhabdomyosarcome | n2=en:cancrology | rel=r_associated | relid=0 | w=5 rhabdomyosarcome -- r_associated #0: 5 / 0.01 -> en:carcinology n1=rhabdomyosarcome | n2=en:carcinology | rel=r_associated | relid=0 | w=5 rhabdomyosarcome -- r_associated #0: 3 / 0.006 -> processus n1=rhabdomyosarcome | n2=processus | rel=r_associated | relid=0 | w=3 rhabdomyosarcome -- r_associated #0: 3 / 0.006 -> rhabdomyosarcome polymorphe n1=rhabdomyosarcome | n2=rhabdomyosarcome polymorphe | rel=r_associated | relid=0 | w=3 rhabdomyosarcome -- r_associated #0: 2 / 0.004 -> en:neoplastic process n1=rhabdomyosarcome | n2=en:neoplastic process | rel=r_associated | relid=0 | w=2 rhabdomyosarcome -- r_associated #0: 1 / 0.002 -> cancer (maladie) n1=rhabdomyosarcome | n2=cancer (maladie) | rel=r_associated | relid=0 | w=1 rhabdomyosarcome -- r_associated #0: 1 / 0.002 -> en:new growth n1=rhabdomyosarcome | n2=en:new growth | rel=r_associated | relid=0 | w=1 rhabdomyosarcome -- r_associated #0: 1 / 0.002 -> maladie tumorale n1=rhabdomyosarcome | n2=maladie tumorale | rel=r_associated | relid=0 | w=1 rhabdomyosarcome -- r_associated #0: 1 / 0.002 -> néoplasme n1=rhabdomyosarcome | n2=néoplasme | rel=r_associated | relid=0 | w=1 rhabdomyosarcome -- r_associated #0: 1 / 0.002 -> processus néoplasique n1=rhabdomyosarcome | n2=processus néoplasique | rel=r_associated | relid=0 | w=1 rhabdomyosarcome -- r_associated #0: 1 / 0.002 -> tumorisation n1=rhabdomyosarcome | n2=tumorisation | rel=r_associated | relid=0 | w=1

≈ 1359 relations entrantes néoplasme malin --- r_associated #0: 576 --> rhabdomyosarcome n1=néoplasme malin | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=576 en:malignant neoplasm --- r_associated #0: 575 --> rhabdomyosarcome n1=en:malignant neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=575 maladie néoplasique maligne --- r_associated #0: 400 --> rhabdomyosarcome n1=maladie néoplasique maligne | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=400 médecine --- r_associated #0: 395 --> rhabdomyosarcome n1=médecine | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=395 néoplasme malin non classé --- r_associated #0: 310 --> rhabdomyosarcome n1=néoplasme malin non classé | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=310 tumeur maligne de siège primitif inconnu --- r_associated #0: 310 --> rhabdomyosarcome n1=tumeur maligne de siège primitif inconnu | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=310 tumeur maligne non classée --- r_associated #0: 310 --> rhabdomyosarcome n1=tumeur maligne non classée | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=310 tumeur maligne sans précision de site --- r_associated #0: 310 --> rhabdomyosarcome n1=tumeur maligne sans précision de site | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=310 maladies --- r_associated #0: 266 --> rhabdomyosarcome n1=maladies | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=266 en:sarcoma --- r_associated #0: 260 --> rhabdomyosarcome n1=en:sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=260 sarcome --- r_associated #0: 260 --> rhabdomyosarcome n1=sarcome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=260 cancer des tissus mous --- r_associated #0: 221 --> rhabdomyosarcome n1=cancer des tissus mous | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=221 Cancer des tissus mous --- r_associated #0: 220 --> rhabdomyosarcome n1=Cancer des tissus mous | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=220 en:soft tissue cancer --- r_associated #0: 195 --> rhabdomyosarcome n1=en:soft tissue cancer | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=195 Spécialités médicales --- r_associated #0: 165 --> rhabdomyosarcome n1=Spécialités médicales | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=165 spécialités médicales --- r_associated #0: 161 --> rhabdomyosarcome n1=spécialités médicales | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=161 cancers --- r_associated #0: 118 --> rhabdomyosarcome n1=cancers | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=118 neo --- r_associated #0: 115 --> rhabdomyosarcome n1=neo | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=115 Cancer de la prostate --- r_associated #0: 85 --> rhabdomyosarcome n1=Cancer de la prostate | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=85 cancer de la prostate --- r_associated #0: 85 --> rhabdomyosarcome n1=cancer de la prostate | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=85 cancer prostate --- r_associated #0: 85 --> rhabdomyosarcome n1=cancer prostate | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=85 cancer prostatique --- r_associated #0: 85 --> rhabdomyosarcome n1=cancer prostatique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=85 en:malignant neoplasm of prostate --- r_associated #0: 85 --> rhabdomyosarcome n1=en:malignant neoplasm of prostate | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=85 en:malignant prostate neoplasm --- r_associated #0: 85 --> rhabdomyosarcome n1=en:malignant prostate neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=85 en:prostate cancer --- r_associated #0: 85 --> rhabdomyosarcome n1=en:prostate cancer | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=85 tumeur de la prostate --- r_associated #0: 85 --> rhabdomyosarcome n1=tumeur de la prostate | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=85 tumeur maligne de la prostate --- r_associated #0: 85 --> rhabdomyosarcome n1=tumeur maligne de la prostate | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=85 tumeur maligne prostatique --- r_associated #0: 85 --> rhabdomyosarcome n1=tumeur maligne prostatique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=85 oncologie --- r_associated #0: 83 --> rhabdomyosarcome n1=oncologie | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=83 tumeur primitive --- r_associated #0: 81 --> rhabdomyosarcome n1=tumeur primitive | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=81 cancérologie --- r_associated #0: 80 --> rhabdomyosarcome n1=cancérologie | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=80 en:primary tumor --- r_associated #0: 80 --> rhabdomyosarcome n1=en:primary tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=80 carcinologie (oncologie) --- r_associated #0: 79 --> rhabdomyosarcome n1=carcinologie (oncologie) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=79 tumeur maligne de siège non précisé --- r_associated #0: 75 --> rhabdomyosarcome n1=tumeur maligne de siège non précisé | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=75 en:oncology --- r_associated #0: 68 --> rhabdomyosarcome n1=en:oncology | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=68 en:prostate --- r_associated #0: 65 --> rhabdomyosarcome n1=en:prostate | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=65 glande prostatique --- r_associated #0: 65 --> rhabdomyosarcome n1=glande prostatique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=65 prostate --- r_associated #0: 61 --> rhabdomyosarcome n1=prostate | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=61 rhabdomyosarcome embryonnaire --- r_associated #0: 60 --> rhabdomyosarcome n1=rhabdomyosarcome embryonnaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=60 rhabdomyosarcome polymorphe --- r_associated #0: 59 --> rhabdomyosarcome n1=rhabdomyosarcome polymorphe | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=59 en:prostate gland --- r_associated #0: 55 --> rhabdomyosarcome n1=en:prostate gland | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=55 rhabdomyosarcome alvéolaire --- r_associated #0: 51 --> rhabdomyosarcome n1=rhabdomyosarcome alvéolaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=51 tumeur mésenchymateuse maligne --- r_associated #0: 51 --> rhabdomyosarcome n1=tumeur mésenchymateuse maligne | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=51 rhabdomyosarcome chez l'enfant --- r_associated #0: 49 --> rhabdomyosarcome n1=rhabdomyosarcome chez l'enfant | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=49 en:polymorphic rhabdomyosarcoma --- r_associated #0: 46 --> rhabdomyosarcome n1=en:polymorphic rhabdomyosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=46 en:vincristine --- r_associated #0: 45 --> rhabdomyosarcome n1=en:vincristine | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=45 vincristine --- r_associated #0: 45 --> rhabdomyosarcome n1=vincristine | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=45 en:embryonal rhabdomyosarcoma --- r_associated #0: 44 --> rhabdomyosarcome n1=en:embryonal rhabdomyosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=44 Médecine --- r_associated #0: 41 --> rhabdomyosarcome n1=Médecine | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=41 IGF2 gene --- r_associated #0: 40 --> rhabdomyosarcome n1=IGF2 gene | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=40 sarcome de la vessie --- r_associated #0: 40 --> rhabdomyosarcome n1=sarcome de la vessie | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=40 syndrome de Costello --- r_associated #0: 40 --> rhabdomyosarcome n1=syndrome de Costello | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=40 en:bladder sarcoma --- r_associated #0: 39 --> rhabdomyosarcome n1=en:bladder sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=39 médecine spécialisée --- r_associated #0: 39 --> rhabdomyosarcome n1=médecine spécialisée | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=39 médecine (science) --- r_associated #0: 39 --> rhabdomyosarcome n1=médecine (science) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=39 maladie --- r_associated #0: 38 --> rhabdomyosarcome n1=maladie | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=38 en:specialized branches of medicine --- r_associated #0: 37 --> rhabdomyosarcome n1=en:specialized branches of medicine | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=37 tumeur primaire --- r_associated #0: 36 --> rhabdomyosarcome n1=tumeur primaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=36 en:botryoid sarcoma --- r_associated #0: 35 --> rhabdomyosarcome n1=en:botryoid sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=35 en:muscular sarcoma --- r_associated #0: 35 --> rhabdomyosarcome n1=en:muscular sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=35 myosarcome cutané --- r_associated #0: 35 --> rhabdomyosarcome n1=myosarcome cutané | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=35 rhabdomyome embryonnaire --- r_associated #0: 35 --> rhabdomyosarcome n1=rhabdomyome embryonnaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=35 sarcome botryoïde --- r_associated #0: 35 --> rhabdomyosarcome n1=sarcome botryoïde | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=35 sarcome musculaire --- r_associated #0: 35 --> rhabdomyosarcome n1=sarcome musculaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=35 en:rhabdomyosarcoma --- r_associated #0: 34 --> rhabdomyosarcome n1=en:rhabdomyosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=34 rhabdomyosarcomes --- r_associated #0: 34 --> rhabdomyosarcome n1=rhabdomyosarcomes | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=34 en:cutaneous myosarcoma --- r_associated #0: 32 --> rhabdomyosarcome n1=en:cutaneous myosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=32 carcinologie --- r_associated #0: 31 --> rhabdomyosarcome n1=carcinologie | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=31 cancer --- r_associated #0: 30 --> rhabdomyosarcome n1=cancer | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=30 en:cancer research --- r_associated #0: 30 --> rhabdomyosarcome n1=en:cancer research | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=30 en:cancrology --- r_associated #0: 30 --> rhabdomyosarcome n1=en:cancrology | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=30 en:carcinology --- r_associated #0: 30 --> rhabdomyosarcome n1=en:carcinology | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=30 maladie tumorale de l'appareil locomoteur --- r_associated #0: 30 --> rhabdomyosarcome n1=maladie tumorale de l'appareil locomoteur | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=30 muscle strié --- r_associated #0: 30 --> rhabdomyosarcome n1=muscle strié | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=30 en:Costello's syndrome --- r_associated #0: 29 --> rhabdomyosarcome n1=en:Costello's syndrome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=29 tumeurs --- r_associated #0: 29 --> rhabdomyosarcome n1=tumeurs | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=29 sarcomes --- r_associated #0: 28 --> rhabdomyosarcome n1=sarcomes | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=28 en:prostata --- r_associated #0: 27 --> rhabdomyosarcome n1=en:prostata | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=27 rhabdomyosarcome avec différenciation ganglionnaire --- r_associated #0: 26 --> rhabdomyosarcome n1=rhabdomyosarcome avec différenciation ganglionnaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=26 rhabdomyosarcome à cellules fusiformes --- r_associated #0: 26 --> rhabdomyosarcome n1=rhabdomyosarcome à cellules fusiformes | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=26 cancer utérin --- r_associated #0: 25 --> rhabdomyosarcome n1=cancer utérin | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=25 en:cancerology --- r_associated #0: 25 --> rhabdomyosarcome n1=en:cancerology | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=25 méningiomes --- r_associated #0: 25 --> rhabdomyosarcome n1=méningiomes | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=25 processus pathologique --- r_associated #0: 25 --> rhabdomyosarcome n1=processus pathologique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=25 rhabdomyosarcome embryonnaire, sai --- r_associated #0: 25 --> rhabdomyosarcome n1=rhabdomyosarcome embryonnaire, sai | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=25 myosarcome --- r_associated #0: 24 --> rhabdomyosarcome n1=myosarcome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=24 prostatique --- r_associated #0: 24 --> rhabdomyosarcome n1=prostatique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=24 tumeurs maligne --- r_associated #0: 23 --> rhabdomyosarcome n1=tumeurs maligne | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=23 Maladies --- r_associated #0: 21 --> rhabdomyosarcome n1=Maladies | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=21 en:prostatic cancer --- r_associated #0: 21 --> rhabdomyosarcome n1=en:prostatic cancer | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=21 adénome malin --- r_associated #0: 20 --> rhabdomyosarcome n1=adénome malin | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:abdominal tumors (immunodeficiency-associated form) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:abdominal tumors (immunodeficiency-associated form) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:accelerated neoplasm growth --- r_associated #0: 20 --> rhabdomyosarcome n1=en:accelerated neoplasm growth | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:acinar cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:acinar cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:acinar cell neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:acinar cell neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:acoustic schwannoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:acoustic schwannoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:acral lentiginous melanoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:acral lentiginous melanoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:acute leukemia --- r_associated #0: 20 --> rhabdomyosarcome n1=en:acute leukemia | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:acute lymphoblastic leukemia --- r_associated #0: 20 --> rhabdomyosarcome n1=en:acute lymphoblastic leukemia | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:acute lymphoblastic leukemia (in 1 patient) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:acute lymphoblastic leukemia (in 1 patient) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:acute megakaryoblastic leukemia --- r_associated #0: 20 --> rhabdomyosarcome n1=en:acute megakaryoblastic leukemia | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:acute monocytic leukemia --- r_associated #0: 20 --> rhabdomyosarcome n1=en:acute monocytic leukemia | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:acute myeloid leukemia --- r_associated #0: 20 --> rhabdomyosarcome n1=en:acute myeloid leukemia | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:adamantinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:adamantinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:adenocarcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:adenocarcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:adenocarcinoma (some) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:adenocarcinoma (some) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:adenocarcinoma in adenomatous polyp --- r_associated #0: 20 --> rhabdomyosarcome n1=en:adenocarcinoma in adenomatous polyp | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:adenocarcinoma in villous adenoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:adenocarcinoma in villous adenoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:adenoid cystic carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:adenoid cystic carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:adenomyoepithelioma with carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:adenomyoepithelioma with carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:adenosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:adenosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:adenosquamous carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:adenosquamous carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:adnexal and/or skin appendage neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:adnexal and/or skin appendage neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:adnexal carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:adnexal carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:adrenal cortex carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:adrenal cortex carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:adrenal gland pheochromocytoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:adrenal gland pheochromocytoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:adrenal glands are most common site --- r_associated #0: 20 --> rhabdomyosarcome n1=en:adrenal glands are most common site | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:adult pleomorphic rhabdomyosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:adult pleomorphic rhabdomyosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:adult rhabdomyoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:adult rhabdomyoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:alpha heavy chain disease --- r_associated #0: 20 --> rhabdomyosarcome n1=en:alpha heavy chain disease | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:alveolar cell carcinoma (some) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:alveolar cell carcinoma (some) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:alveolar rhabdomyosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:alveolar rhabdomyosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:alveolar soft part sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:alveolar soft part sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:amelanotic melanoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:amelanotic melanoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:ameloblastic fibrosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:ameloblastic fibrosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:ameloblastic odontosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:ameloblastic odontosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:ampulla of vater adenocarcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:ampulla of vater adenocarcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:anal canal cloacogenic carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:anal canal cloacogenic carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:anaplastic (malignant) meningioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:anaplastic (malignant) meningioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:anaplastic ganglioglioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:anaplastic ganglioglioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:angioleiomyoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:angioleiomyoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:angiolipoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:angiolipoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:angiomatous meningioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:angiomatous meningioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:angiomyoliposarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:angiomyoliposarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:angiomyosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:angiomyosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:angiosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:angiosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:angiosarcoma nci grade 3 --- r_associated #0: 20 --> rhabdomyosarcome n1=en:angiosarcoma nci grade 3 | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:aplastic anemia --- r_associated #0: 20 --> rhabdomyosarcome n1=en:aplastic anemia | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:approximately 10% of cases are paraneoplastic --- r_associated #0: 20 --> rhabdomyosarcome n1=en:approximately 10% of cases are paraneoplastic | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:askin tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:askin tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:aspects of mortality statistics --- r_associated #0: 20 --> rhabdomyosarcome n1=en:aspects of mortality statistics | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:aspects of radionuclide imaging --- r_associated #0: 20 --> rhabdomyosarcome n1=en:aspects of radionuclide imaging | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:associated with other malignancies --- r_associated #0: 20 --> rhabdomyosarcome n1=en:associated with other malignancies | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:astrocytoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:astrocytoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:atypical medullary carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:atypical medullary carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:atypical teratoid/rhabdoid tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:atypical teratoid/rhabdoid tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:avian leukosis/sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:avian leukosis/sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:b-cell lymphomas --- r_associated #0: 20 --> rhabdomyosarcome n1=en:b-cell lymphomas | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:b-cell non-hodgkin lymphoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:b-cell non-hodgkin lymphoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:balloon cell melanoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:balloon cell melanoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:basal cell nevus --- r_associated #0: 20 --> rhabdomyosarcome n1=en:basal cell nevus | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:basaloid carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:basaloid carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:basocellular neoplasms --- r_associated #0: 20 --> rhabdomyosarcome n1=en:basocellular neoplasms | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:basocellular neoplasms develop after second decade --- r_associated #0: 20 --> rhabdomyosarcome n1=en:basocellular neoplasms develop after second decade | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:beckwith-wiedemann syndrome --- r_associated #0: 20 --> rhabdomyosarcome n1=en:beckwith-wiedemann syndrome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:benign digestive system neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:benign digestive system neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:benign endocrine neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:benign endocrine neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:benign female reproductive system neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:benign female reproductive system neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:benign genitourinary tract neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:benign genitourinary tract neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:benign male reproductive system neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:benign male reproductive system neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:benign muscle neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:benign muscle neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:benign myomatous tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:benign myomatous tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:benign neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:benign neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:benign nervous system neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:benign nervous system neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:benign skeletal muscle neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:benign skeletal muscle neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:benign skin neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:benign skin neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:benign soft tissue neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:benign soft tissue neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:benign teratoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:benign teratoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:benign tumors of the eye, heart, and lungs --- r_associated #0: 20 --> rhabdomyosarcome n1=en:benign tumors of the eye, heart, and lungs | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:biphasic mesothelioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:biphasic mesothelioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:bizarre leiomyoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:bizarre leiomyoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:bladder carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:bladder carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:bladder neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:bladder neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:bladder urothelial carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:bladder urothelial carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:blood supply aspects --- r_associated #0: 20 --> rhabdomyosarcome n1=en:blood supply aspects | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:blood vessel neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:blood vessel neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:bone neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:bone neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:bone sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:bone sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:bone-forming neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:bone-forming neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:borderline ovarian epithelial tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:borderline ovarian epithelial tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:brain neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:brain neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:breast cancer (rare) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:breast cancer (rare) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:breast cancer, early-onset (in some patients) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:breast cancer, early-onset (in some patients) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:breast cancer, lobular --- r_associated #0: 20 --> rhabdomyosarcome n1=en:breast cancer, lobular | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:breast carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:breast carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:breast neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:breast neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:breast neoplasms benign (incl nipple) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:breast neoplasms benign (incl nipple) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:breast neoplasms malignant and unspecified (incl nipple) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:breast neoplasms malignant and unspecified (incl nipple) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:breast sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:breast sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:bronchogenic carcinoma (some) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:bronchogenic carcinoma (some) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:burkitt leukemia --- r_associated #0: 20 --> rhabdomyosarcome n1=en:burkitt leukemia | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:burkitt lymphoma (b-cell lymphoma) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:burkitt lymphoma (b-cell lymphoma) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:carcinofibroma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:carcinofibroma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:carcinoid tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:carcinoid tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:carcinoma ex pleomorphic adenoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:carcinoma ex pleomorphic adenoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:carcinoma in situ --- r_associated #0: 20 --> rhabdomyosarcome n1=en:carcinoma in situ | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:carcinoma in situ of sphincter of oddi --- r_associated #0: 20 --> rhabdomyosarcome n1=en:carcinoma in situ of sphincter of oddi | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:carcinoma of bone, connective tissue, skin and breast --- r_associated #0: 20 --> rhabdomyosarcome n1=en:carcinoma of bone, connective tissue, skin and breast | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:carcinoma of lip, oral cavity and pharynx --- r_associated #0: 20 --> rhabdomyosarcome n1=en:carcinoma of lip, oral cavity and pharynx | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:carcinoma of unknown primary origin --- r_associated #0: 20 --> rhabdomyosarcome n1=en:carcinoma of unknown primary origin | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:carcinoma with osteoclast-like giant cells --- r_associated #0: 20 --> rhabdomyosarcome n1=en:carcinoma with osteoclast-like giant cells | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:carcinoma with pleomorphic, sarcomatoid or sarcomatous elements --- r_associated #0: 20 --> rhabdomyosarcome n1=en:carcinoma with pleomorphic, sarcomatoid or sarcomatous elements | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:carcinosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:carcinosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:carcinosarcoma, embryonal --- r_associated #0: 20 --> rhabdomyosarcome n1=en:carcinosarcoma, embryonal | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:carotid body paraganglioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:carotid body paraganglioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:carotid body tumors (most common location) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:carotid body tumors (most common location) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:carotid body tumors (most common) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:carotid body tumors (most common) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:cartilage-forming neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:cartilage-forming neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:cdisc send terminology --- r_associated #0: 20 --> rhabdomyosarcome n1=en:cdisc send terminology | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:cdisc send tumor findings results terminology --- r_associated #0: 20 --> rhabdomyosarcome n1=en:cdisc send tumor findings results terminology | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:cellular leiomyoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:cellular leiomyoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:cellular secretion --- r_associated #0: 20 --> rhabdomyosarcome n1=en:cellular secretion | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:cervical cancer (rare) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:cervical cancer (rare) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:cervical carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:cervical carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:chemical aspects --- r_associated #0: 20 --> rhabdomyosarcome n1=en:chemical aspects | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:chemically induced --- r_associated #0: 20 --> rhabdomyosarcome n1=en:chemically induced | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:chief cell adenocarcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:chief cell adenocarcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:childhood malignant liver neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:childhood malignant liver neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:chondroblastic osteosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:chondroblastic osteosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:chondroblastoma, malignant --- r_associated #0: 20 --> rhabdomyosarcome n1=en:chondroblastoma, malignant | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:chondroid chordoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:chondroid chordoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:chondrosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:chondrosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:chordoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:chordoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:choriocarcinoma combined with other germ cell elements --- r_associated #0: 20 --> rhabdomyosarcome n1=en:choriocarcinoma combined with other germ cell elements | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:choroid plexus carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:choroid plexus carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:chromaffin cell neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:chromaffin cell neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:chronic lymphocytic leukemia --- r_associated #0: 20 --> rhabdomyosarcome n1=en:chronic lymphocytic leukemia | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:chronic lymphocytic leukemia, b-cell, susceptibility to --- r_associated #0: 20 --> rhabdomyosarcome n1=en:chronic lymphocytic leukemia, b-cell, susceptibility to | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:chronic myelomonocytic leukemia --- r_associated #0: 20 --> rhabdomyosarcome n1=en:chronic myelomonocytic leukemia | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:classic kaposi sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:classic kaposi sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:clear cell acanthoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:clear cell acanthoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:clear cell chondrosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:clear cell chondrosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:clear cell neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:clear cell neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:clear cell renal cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:clear cell renal cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:clear cell sarcoma of soft tissue --- r_associated #0: 20 --> rhabdomyosarcome n1=en:clear cell sarcoma of soft tissue | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:clear cell sarcoma of the kidney --- r_associated #0: 20 --> rhabdomyosarcome n1=en:clear cell sarcoma of the kidney | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:clinical data interchange standards consortium terminology --- r_associated #0: 20 --> rhabdomyosarcome n1=en:clinical data interchange standards consortium terminology | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:colon adenocarcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:colon adenocarcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:colon carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:colon carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:colorectal cancer (in some patients) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:colorectal cancer (in some patients) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:colorectal cancer, early onset --- r_associated #0: 20 --> rhabdomyosarcome n1=en:colorectal cancer, early onset | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:colorectal carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:colorectal carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:combined small cell lung carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:combined small cell lung carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:complex mixed and/or stromal neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:complex mixed and/or stromal neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:complication aspects --- r_associated #0: 20 --> rhabdomyosarcome n1=en:complication aspects | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:composite hodgkin and non-hodgkin lymphoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:composite hodgkin and non-hodgkin lymphoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:congenital mesh qualifier --- r_associated #0: 20 --> rhabdomyosarcome n1=en:congenital mesh qualifier | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:congenital rhabdomyoma of heart --- r_associated #0: 20 --> rhabdomyosarcome n1=en:congenital rhabdomyoma of heart | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:connective and soft tissue --- r_associated #0: 20 --> rhabdomyosarcome n1=en:connective and soft tissue | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:connective and soft tissue cell --- r_associated #0: 20 --> rhabdomyosarcome n1=en:connective and soft tissue cell | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:conventional osteosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:conventional osteosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:costello syndrome --- r_associated #0: 20 --> rhabdomyosarcome n1=en:costello syndrome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:craniopharyngioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:craniopharyngioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:cutaneous leiomyosarcoma (less common) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:cutaneous leiomyosarcoma (less common) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:cutaneous melanoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:cutaneous melanoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:cylindromas may show malignant transformation --- r_associated #0: 20 --> rhabdomyosarcome n1=en:cylindromas may show malignant transformation | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:cyst --- r_associated #0: 20 --> rhabdomyosarcome n1=en:cyst | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:cystadenoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:cystadenoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:cystic partially differentiated nephroblastoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:cystic partially differentiated nephroblastoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:cystic, mucinous and/or serous neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:cystic, mucinous and/or serous neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:dedifferentiated chondrosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:dedifferentiated chondrosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:dedifferentiated chordoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:dedifferentiated chordoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:dedifferentiated liposarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:dedifferentiated liposarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:dermatofibrosarcoma protuberans --- r_associated #0: 20 --> rhabdomyosarcome n1=en:dermatofibrosarcoma protuberans | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:desmoid-type fibromatosis --- r_associated #0: 20 --> rhabdomyosarcome n1=en:desmoid-type fibromatosis | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:desmoplastic melanoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:desmoplastic melanoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:desmoplastic mesothelioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:desmoplastic mesothelioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:desmoplastic small cell tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:desmoplastic small cell tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:desmoplastic small round cell tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:desmoplastic small round cell tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:development of tumors in adulthood --- r_associated #0: 20 --> rhabdomyosarcome n1=en:development of tumors in adulthood | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:diagnosis aspect --- r_associated #0: 20 --> rhabdomyosarcome n1=en:diagnosis aspect | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:diffuse embryoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:diffuse embryoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:digestive system carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:digestive system carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:digestive system neoplasms --- r_associated #0: 20 --> rhabdomyosarcome n1=en:digestive system neoplasms | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:digital papillary eccrine carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:digital papillary eccrine carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:duct carcinoma, desmoplastic type --- r_associated #0: 20 --> rhabdomyosarcome n1=en:duct carcinoma, desmoplastic type | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:ductal breast carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:ductal breast carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:ductal carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:ductal carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:ductal, lobular and/or medullary neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:ductal, lobular and/or medullary neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:duodenal carcinoid --- r_associated #0: 20 --> rhabdomyosarcome n1=en:duodenal carcinoid | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:duodenal carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:duodenal carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:dysgerminoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:dysgerminoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:dysplasia with neoplasia --- r_associated #0: 20 --> rhabdomyosarcome n1=en:dysplasia with neoplasia | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:ear carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:ear carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:early-onset hepatocellular carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:early-onset hepatocellular carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:ebv-induced b-cell lymphoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:ebv-induced b-cell lymphoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:eccrine adenocarcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:eccrine adenocarcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:eccrine porocarcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:eccrine porocarcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:ectomesenchymoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:ectomesenchymoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:embryologic --- r_associated #0: 20 --> rhabdomyosarcome n1=en:embryologic | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:embryonal carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:embryonal carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:embryonal neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:embryonal neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:embryonal rhabdomyosarcoma of the mouse pharynx --- r_associated #0: 20 --> rhabdomyosarcome n1=en:embryonal rhabdomyosarcoma of the mouse pharynx | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:embryonal tumor with multilayered rosettes, c19mc-altered --- r_associated #0: 20 --> rhabdomyosarcome n1=en:embryonal tumor with multilayered rosettes, c19mc-altered | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:encapsulated papillary carcinoma with invasion --- r_associated #0: 20 --> rhabdomyosarcome n1=en:encapsulated papillary carcinoma with invasion | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:endocrine neoplasms malignant and unspecified --- r_associated #0: 20 --> rhabdomyosarcome n1=en:endocrine neoplasms malignant and unspecified | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:endolymphatic sac tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:endolymphatic sac tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:endometrial adenocarcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:endometrial adenocarcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:endometrial carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:endometrial carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:endometrial stromal sarcoma - category --- r_associated #0: 20 --> rhabdomyosarcome n1=en:endometrial stromal sarcoma - category | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:endometrial stromal tumors --- r_associated #0: 20 --> rhabdomyosarcome n1=en:endometrial stromal tumors | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:enteropathy-associated t-cell lymphoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:enteropathy-associated t-cell lymphoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:enzymology --- r_associated #0: 20 --> rhabdomyosarcome n1=en:enzymology | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:ependymoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:ependymoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:epidemiologic --- r_associated #0: 20 --> rhabdomyosarcome n1=en:epidemiologic | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:epithelial cell --- r_associated #0: 20 --> rhabdomyosarcome n1=en:epithelial cell | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:epithelial neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:epithelial neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:epithelial tissue --- r_associated #0: 20 --> rhabdomyosarcome n1=en:epithelial tissue | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:epithelial-myoepithelial carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:epithelial-myoepithelial carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:epithelioid cell melanoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:epithelioid cell melanoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:epithelioid cell type gastrointestinal stromal tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:epithelioid cell type gastrointestinal stromal tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:epithelioid leiomyosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:epithelioid leiomyosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:epithelioid malignant peripheral nerve sheath tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:epithelioid malignant peripheral nerve sheath tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:epithelioid mesothelioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:epithelioid mesothelioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:epithelioid sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:epithelioid sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:epithelioid sarcoma nci grade 3 --- r_associated #0: 20 --> rhabdomyosarcome n1=en:epithelioid sarcoma nci grade 3 | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:epithelioid trophoblastic tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:epithelioid trophoblastic tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:esophageal carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:esophageal carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:essential thrombocythemia --- r_associated #0: 20 --> rhabdomyosarcome n1=en:essential thrombocythemia | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:esthesioneurocytoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:esthesioneurocytoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:ethnologic --- r_associated #0: 20 --> rhabdomyosarcome n1=en:ethnologic | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:etiology aspects --- r_associated #0: 20 --> rhabdomyosarcome n1=en:etiology aspects | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:ewing sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:ewing sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:ewing sarcoma/peripheral primitive neuroectodermal tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:ewing sarcoma/peripheral primitive neuroectodermal tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:exposure as collected domain --- r_associated #0: 20 --> rhabdomyosarcome n1=en:exposure as collected domain | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:extra-adrenal paraganglioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:extra-adrenal paraganglioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:extra-adrenal sympathetic paraganglioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:extra-adrenal sympathetic paraganglioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:extramammary paget disease --- r_associated #0: 20 --> rhabdomyosarcome n1=en:extramammary paget disease | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:extrarenal rhabdoid tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:extrarenal rhabdoid tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:extraskeletal chondrosarcoma metastatic --- r_associated #0: 20 --> rhabdomyosarcome n1=en:extraskeletal chondrosarcoma metastatic | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:extraskeletal chondrosarcoma recurrent --- r_associated #0: 20 --> rhabdomyosarcome n1=en:extraskeletal chondrosarcoma recurrent | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:extraskeletal ewing sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:extraskeletal ewing sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:extraskeletal myxoid chondrosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:extraskeletal myxoid chondrosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:extraskeletal osteosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:extraskeletal osteosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:eye neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:eye neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:fallopian tube carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:fallopian tube carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:familial letterer-siwe disease --- r_associated #0: 20 --> rhabdomyosarcome n1=en:familial letterer-siwe disease | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:fascial fibrosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:fascial fibrosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:fetal rhabdomyoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:fetal rhabdomyoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:fibroblastic liposarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:fibroblastic liposarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:fibroblastic osteosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:fibroblastic osteosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:fibroelastoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:fibroelastoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:fibroepithelial neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:fibroepithelial neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:fibrohistiocytic neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:fibrohistiocytic neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:fibroma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:fibroma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:fibrosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:fibrosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:fibrosarcoma of connective tissue --- r_associated #0: 20 --> rhabdomyosarcome n1=en:fibrosarcoma of connective tissue | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:fibrosarcoma of spleen --- r_associated #0: 20 --> rhabdomyosarcome n1=en:fibrosarcoma of spleen | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:fibrous connective tissue neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:fibrous connective tissue neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:fibrous dysplasia of bone with intramuscular myxoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:fibrous dysplasia of bone with intramuscular myxoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:follicular dendritic cell sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:follicular dendritic cell sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:follicular dendritic sarcoma of intraabdominal lymph node --- r_associated #0: 20 --> rhabdomyosarcome n1=en:follicular dendritic sarcoma of intraabdominal lymph node | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:follicular dendritic sarcoma of lymph nodes of multiple sites --- r_associated #0: 20 --> rhabdomyosarcome n1=en:follicular dendritic sarcoma of lymph nodes of multiple sites | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:follicular lymphoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:follicular lymphoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:follicular neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:follicular neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:frequent skin cancer --- r_associated #0: 20 --> rhabdomyosarcome n1=en:frequent skin cancer | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:g antigen family d member 3 --- r_associated #0: 20 --> rhabdomyosarcome n1=en:g antigen family d member 3 | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:gallbladder carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:gallbladder carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:ganglioneuroblastoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:ganglioneuroblastoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:ganglioneuroma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:ganglioneuroma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:gastric adenocarcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:gastric adenocarcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:gastric cancer, diffuse type, poorly differentiated, high-grade submucosal lesions --- r_associated #0: 20 --> rhabdomyosarcome n1=en:gastric cancer, diffuse type, poorly differentiated, high-grade submucosal lesions | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:gastrointestinal neoplasms malignant and unspecified --- r_associated #0: 20 --> rhabdomyosarcome n1=en:gastrointestinal neoplasms malignant and unspecified | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:gastrointestinal stromal tumors (less common) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:gastrointestinal stromal tumors (less common) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:genetic aspects --- r_associated #0: 20 --> rhabdomyosarcome n1=en:genetic aspects | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:genital rhabdomyoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:genital rhabdomyoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:germ cell tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:germ cell tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:germinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:germinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:gestational trophoblastic tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:gestational trophoblastic tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:giant cell astrocytoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:giant cell astrocytoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:giant cell lesion of small bones --- r_associated #0: 20 --> rhabdomyosarcome n1=en:giant cell lesion of small bones | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:giant cell sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:giant cell sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:giant cell sarcoma (except of bone, m-92503) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:giant cell sarcoma (except of bone, m-92503) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:giant cell tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:giant cell tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:glassy cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:glassy cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:glioblastoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:glioblastoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:glioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:glioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:glomus tympanicum paraganglioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:glomus tympanicum paraganglioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:gonadoblastoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:gonadoblastoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:grade 3 --- r_associated #0: 20 --> rhabdomyosarcome n1=en:grade 3 | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:granular cell tumor and/or alveolar soft part sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:granular cell tumor and/or alveolar soft part sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:granulocytic sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:granulocytic sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:growth hormone-producing pituitary gland neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:growth hormone-producing pituitary gland neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:haematopoietic neoplasms (excl leukaemias and lymphomas) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:haematopoietic neoplasms (excl leukaemias and lymphomas) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:hamartoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:hamartoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:head and neck paraganglioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:head and neck paraganglioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:heavy chain disease --- r_associated #0: 20 --> rhabdomyosarcome n1=en:heavy chain disease | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:hemangioblastoma, sporadic cerebellar (e.g., 193300.0007) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:hemangioblastoma, sporadic cerebellar (e.g., 193300.0007) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:hematopoietic and lymphoid cell neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:hematopoietic and lymphoid cell neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:hemophagocytic lymphohistiocytosis --- r_associated #0: 20 --> rhabdomyosarcome n1=en:hemophagocytic lymphohistiocytosis | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:hemophagocytic lymphohistiocytosis (in some patients) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:hemophagocytic lymphohistiocytosis (in some patients) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:hepatic and biliary neoplasms benign --- r_associated #0: 20 --> rhabdomyosarcome n1=en:hepatic and biliary neoplasms benign | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:hepatobiliary neoplasms malignant and unspecified --- r_associated #0: 20 --> rhabdomyosarcome n1=en:hepatobiliary neoplasms malignant and unspecified | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:hepatoblastoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:hepatoblastoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:hepatoid adenocarcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:hepatoid adenocarcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:hereditary neoplastic syndrome --- r_associated #0: 20 --> rhabdomyosarcome n1=en:hereditary neoplastic syndrome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:high grade serous carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:high grade serous carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:high grade surface osteosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:high grade surface osteosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:high risk gastrointestinal stromal tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:high risk gastrointestinal stromal tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:histiocytic and dendritic cell neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:histiocytic and dendritic cell neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:histiocytic sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:histiocytic sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:historical aspects qualifier --- r_associated #0: 20 --> rhabdomyosarcome n1=en:historical aspects qualifier | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:history of rhabdomyosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:history of rhabdomyosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:hodgkin lymphoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:hodgkin lymphoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:hypereosinophilic syndrome --- r_associated #0: 20 --> rhabdomyosarcome n1=en:hypereosinophilic syndrome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:hypersensitivity to chemotherapy --- r_associated #0: 20 --> rhabdomyosarcome n1=en:hypersensitivity to chemotherapy | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:hypothalamic neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:hypothalamic neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:idiopathic hypereosinophilic syndrome --- r_associated #0: 20 --> rhabdomyosarcome n1=en:idiopathic hypereosinophilic syndrome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:ileal, cecal, ovarian, and breast tumors, occasionally (endemic form) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:ileal, cecal, ovarian, and breast tumors, occasionally (endemic form) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:immunology aspects --- r_associated #0: 20 --> rhabdomyosarcome n1=en:immunology aspects | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:in blood --- r_associated #0: 20 --> rhabdomyosarcome n1=en:in blood | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:in cerebrospinal fluid --- r_associated #0: 20 --> rhabdomyosarcome n1=en:in cerebrospinal fluid | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:in situ neoplasm (morphology) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:in situ neoplasm (morphology) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:in urine --- r_associated #0: 20 --> rhabdomyosarcome n1=en:in urine | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased hepatocellular carcinoma risk --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased hepatocellular carcinoma risk | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased incidence of hepatocellular carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased incidence of hepatocellular carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased incidence of rectosigmoid cancer --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased incidence of rectosigmoid cancer | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased malignancy risk, especially lymphoma and skin neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased malignancy risk, especially lymphoma and skin neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased risk for cancer --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased risk for cancer | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased risk for embryonal tumors --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased risk for embryonal tumors | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased risk for hematologic cancer, particularly acute myeloid leukemia --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased risk for hematologic cancer, particularly acute myeloid leukemia | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased risk for lymphoma hodgkin disease --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased risk for lymphoma hodgkin disease | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased risk for monoclonal gammopathy --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased risk for monoclonal gammopathy | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased risk for multiple myeloma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased risk for multiple myeloma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased risk for wilms tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased risk for wilms tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased risk in heterozygotes --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased risk in heterozygotes | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased risk of breast cancer in women --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased risk of breast cancer in women | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased risk of chondrosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased risk of chondrosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased risk of chondrosarcoma (mean age of onset 31 years) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased risk of chondrosarcoma (mean age of onset 31 years) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased risk of gastrointestinal cancer --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased risk of gastrointestinal cancer | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased risk of hematologic malignancy (1 patient) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased risk of hematologic malignancy (1 patient) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased risk of leukemia --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased risk of leukemia | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased risk of malignancy --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased risk of malignancy | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased risk of malignancy (classic feature) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased risk of malignancy (classic feature) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased risk of malignant lymphoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased risk of malignant lymphoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased risk of medulloblastoma (rare) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased risk of medulloblastoma (rare) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased risk of meningioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased risk of meningioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased risk of myelodysplastic syndrome or leukemia (in some patients) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased risk of myelodysplastic syndrome or leukemia (in some patients) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased risk of myelodysplastic syndromes --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased risk of myelodysplastic syndromes | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased risk of pancreatic cancer --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased risk of pancreatic cancer | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased risk of testicular cancer --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased risk of testicular cancer | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased risk of tumor formation, especially of the head --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased risk of tumor formation, especially of the head | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased susceptibility to b-cell lymphoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased susceptibility to b-cell lymphoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased susceptibility to cancer --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased susceptibility to cancer | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased susceptibility to carcinomas, especially cancers related to cutaneous viral infections --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased susceptibility to carcinomas, especially cancers related to cutaneous viral infections | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased susceptibility to hematologic malignancies --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased susceptibility to hematologic malignancies | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:increased susceptibility to large granular lymphocytic t-cell leukemia --- r_associated #0: 20 --> rhabdomyosarcome n1=en:increased susceptibility to large granular lymphocytic t-cell leukemia | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:index tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:index tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:indolent clinical course --- r_associated #0: 20 --> rhabdomyosarcome n1=en:indolent clinical course | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:indolent systemic mastocytosis --- r_associated #0: 20 --> rhabdomyosarcome n1=en:indolent systemic mastocytosis | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:infantile fibrosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:infantile fibrosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:infiltrating carcinoma with ductal and lobular features --- r_associated #0: 20 --> rhabdomyosarcome n1=en:infiltrating carcinoma with ductal and lobular features | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:infiltrating duct mixed with other types of carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:infiltrating duct mixed with other types of carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:infiltrating lobular mixed with other types of carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:infiltrating lobular mixed with other types of carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:interdigitating dendritic cell sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:interdigitating dendritic cell sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:intermediate filaments present --- r_associated #0: 20 --> rhabdomyosarcome n1=en:intermediate filaments present | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:intracytoplasmic eosinophilic inclusion --- r_associated #0: 20 --> rhabdomyosarcome n1=en:intracytoplasmic eosinophilic inclusion | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:intraductal papillary adenocarcinoma with invasion --- r_associated #0: 20 --> rhabdomyosarcome n1=en:intraductal papillary adenocarcinoma with invasion | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:invasive ductal and lobular carcinoma in situ --- r_associated #0: 20 --> rhabdomyosarcome n1=en:invasive ductal and lobular carcinoma in situ | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:invasive ductal carcinoma, not otherwise specified --- r_associated #0: 20 --> rhabdomyosarcome n1=en:invasive ductal carcinoma, not otherwise specified | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:invasive micropapillary breast carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:invasive micropapillary breast carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:islet cell tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:islet cell tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:jaw and kidney tumor (endemic form) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:jaw and kidney tumor (endemic form) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:jugulotympanic paraganglioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:jugulotympanic paraganglioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:juvenile ovarian granulosa cell tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:juvenile ovarian granulosa cell tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:kaposi sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:kaposi sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:kaposi sarcoma (1 patient) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:kaposi sarcoma (1 patient) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:kaposi sarcoma nci grade 3 --- r_associated #0: 20 --> rhabdomyosarcome n1=en:kaposi sarcoma nci grade 3 | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:kidney sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:kidney sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:kidney wilms tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:kidney wilms tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:langerhans cell histiocytosis --- r_associated #0: 20 --> rhabdomyosarcome n1=en:langerhans cell histiocytosis | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:langerhans cell sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:langerhans cell sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:large cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:large cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:large cell lung carcinoma with rhabdoid phenotype --- r_associated #0: 20 --> rhabdomyosarcome n1=en:large cell lung carcinoma with rhabdoid phenotype | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:large cell neuroendocrine carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:large cell neuroendocrine carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:laryngeal carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:laryngeal carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:leiomyoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:leiomyoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:leiomyomatosis --- r_associated #0: 20 --> rhabdomyosarcome n1=en:leiomyomatosis | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:leiomyomatous neoplasm - category --- r_associated #0: 20 --> rhabdomyosarcome n1=en:leiomyomatous neoplasm - category | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:leiomyosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:leiomyosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:leiomyosarcoma nci grade 3 --- r_associated #0: 20 --> rhabdomyosarcome n1=en:leiomyosarcoma nci grade 3 | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:lentigo maligna melanoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:lentigo maligna melanoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:leukemia --- r_associated #0: 20 --> rhabdomyosarcome n1=en:leukemia | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:leukemia (both all and aml) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:leukemia (both all and aml) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:leukemia (category) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:leukemia (category) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:lipoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:lipoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:lipomatous neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:lipomatous neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:liposarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:liposarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:liposarcoma of connective tissue --- r_associated #0: 20 --> rhabdomyosarcome n1=en:liposarcoma of connective tissue | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:liver carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:liver carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:liver sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:liver sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:lobular breast carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:lobular breast carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:low grade central osteosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:low grade central osteosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:low grade myofibroblastic sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:low grade myofibroblastic sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:low grade serous carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:low grade serous carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:low incidence of plexiform neurofibromas --- r_associated #0: 20 --> rhabdomyosarcome n1=en:low incidence of plexiform neurofibromas | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:low-grade neuroendocrine carcinoma (submandibular glands, salivary glands, maxillary sinus, nasal cavity) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:low-grade neuroendocrine carcinoma (submandibular glands, salivary glands, maxillary sinus, nasal cavity) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:lung --- r_associated #0: 20 --> rhabdomyosarcome n1=en:lung | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:lung adenocarcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:lung adenocarcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:lymphangiosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:lymphangiosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:lymphatic vessel neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:lymphatic vessel neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:lymphoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:lymphoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:lymphoma (in some patients) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:lymphoma (in some patients) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:lymphomas nec --- r_associated #0: 20 --> rhabdomyosarcome n1=en:lymphomas nec | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:lymphoproliferative disorder --- r_associated #0: 20 --> rhabdomyosarcome n1=en:lymphoproliferative disorder | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:lymphoproliferative disorder (in some patients) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:lymphoproliferative disorder (in some patients) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:lymphosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:lymphosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:lymphosarcoma of lymph nodes of head, face and neck --- r_associated #0: 20 --> rhabdomyosarcome n1=en:lymphosarcoma of lymph nodes of head, face and neck | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:lymphosarcoma of lymph nodes of multiple sites --- r_associated #0: 20 --> rhabdomyosarcome n1=en:lymphosarcoma of lymph nodes of multiple sites | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:male germ cell tumors (gct), 2 subtypes - --- r_associated #0: 20 --> rhabdomyosarcome n1=en:male germ cell tumors (gct), 2 subtypes - | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignancy (34%) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignancy (34%) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignancy in approximately 10% --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignancy in approximately 10% | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignancy in giant cell tumor of bone --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignancy in giant cell tumor of bone | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant adrenal gland pheochromocytoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant adrenal gland pheochromocytoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant aortic body tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant aortic body tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant blood vessel neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant blood vessel neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant bone marrow neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant bone marrow neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant bone neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant bone neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant breast neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant breast neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant carotid body paraganglioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant carotid body paraganglioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant cell --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant cell | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant central nervous system neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant central nervous system neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant digestive system neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant digestive system neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant epithelioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant epithelioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant esophageal neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant esophageal neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant extra-adrenal paraganglioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant extra-adrenal paraganglioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant fibrous histiocytoma (in about 35% of patients) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant fibrous histiocytoma (in about 35% of patients) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant genitourinary tract tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant genitourinary tract tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant giant cell neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant giant cell neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant glioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant glioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant glomus tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant glomus tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant granular cell tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant granular cell tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant granulosa cell tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant granulosa cell tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant histiocytosis --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant histiocytosis | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant immunoproliferative disease (clinical) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant immunoproliferative disease (clinical) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant immunoproliferative neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant immunoproliferative neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant joint neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant joint neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant leydig cell tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant leydig cell tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant mast cell neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant mast cell neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant melanoma in giant pigmented nevus --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant melanoma in giant pigmented nevus | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant melanoma in precancerous melanosis --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant melanoma in precancerous melanosis | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant mesenchymoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant mesenchymoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant mesenchymoma metastatic --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant mesenchymoma metastatic | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant mesenchymoma recurrent --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant mesenchymoma recurrent | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant mesothelioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant mesothelioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant mixed neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant mixed neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant mixed tumor, carcinomatous type --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant mixed tumor, carcinomatous type | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant mixed tumor, chondrosarcomatous type --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant mixed tumor, chondrosarcomatous type | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant mixed tumor, osteosarcomatous type --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant mixed tumor, osteosarcomatous type | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant muscle neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant muscle neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant musculoskeletal and connective tissue neoplasms --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant musculoskeletal and connective tissue neoplasms | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant myoepithelioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant myoepithelioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant myomatous tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant myomatous tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant neoplasm (morphology) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant neoplasm (morphology) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant neoplasm musculoskeletal --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant neoplasm musculoskeletal | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant neoplasm of bone, connective tissue, skin and breast --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant neoplasm of bone, connective tissue, skin and breast | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant neoplasm of connective tissue --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant neoplasm of connective tissue | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant neoplasm of digestive organs and peritoneum --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant neoplasm of digestive organs and peritoneum | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant neoplasm of genitourinary organ --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant neoplasm of genitourinary organ | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant neoplasm of lip, oral cavity and pharynx --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant neoplasm of lip, oral cavity and pharynx | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant neoplasm of nail apparatus --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant neoplasm of nail apparatus | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant neoplasm of other and unspecified sites --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant neoplasm of other and unspecified sites | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant neoplasm, overlapping lesion of digestive system --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant neoplasm, overlapping lesion of digestive system | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant neoplasm, uncertain whether primary or metastatic --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant neoplasm, uncertain whether primary or metastatic | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant neoplasms of respiratory and intrathoracic organs --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant neoplasms of respiratory and intrathoracic organs | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant neuroendocrine neoplasm, epithelial --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant neuroendocrine neoplasm, epithelial | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant neuroendocrine neoplasm, neural --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant neuroendocrine neoplasm, neural | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant neuroendocrine tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant neuroendocrine tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant odontogenic ghost cell tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant odontogenic ghost cell tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant odontogenic neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant odontogenic neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant ossifying fibromyxoid tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant ossifying fibromyxoid tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant ovarian brenner tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant ovarian brenner tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant ovarian neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant ovarian neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant ovarian thecoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant ovarian thecoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant pancreatic neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant pancreatic neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant pecoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant pecoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant peripheral nerve sheath tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant peripheral nerve sheath tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant peripheral nerve sheath tumor with perineurial differentiation --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant peripheral nerve sheath tumor with perineurial differentiation | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant peripheral nerve sheath tumors (21%) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant peripheral nerve sheath tumors (21%) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant pharyngeal neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant pharyngeal neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant phyllodes tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant phyllodes tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant rhabdomyoblast --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant rhabdomyoblast | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant sebaceous neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant sebaceous neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant sertoli cell tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant sertoli cell tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant sex cord-stromal tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant sex cord-stromal tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant skeletal muscle cell --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant skeletal muscle cell | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant skeletal muscle neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant skeletal muscle neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant skin neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant skin neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant soft tissue neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant soft tissue neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant solitary fibrous tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant solitary fibrous tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant spindle cell neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant spindle cell neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant squamous cell neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant squamous cell neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant struma ovarii --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant struma ovarii | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant tenosynovial giant cell tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant tenosynovial giant cell tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant thymoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant thymoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant thyroid gland neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant thyroid gland neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant triton tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant triton tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant trophoblastic teratoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant trophoblastic teratoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant tumor of lymphoid hemopoietic and related tissue --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant tumor of lymphoid hemopoietic and related tissue | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant tumor, clear cell type --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant tumor, clear cell type | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant tumor, small cell type --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant tumor, small cell type | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant type a thymoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant type a thymoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant type ab thymoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant type ab thymoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant type b1 thymoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant type b1 thymoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant type b2 thymoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant type b2 thymoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:malignant uterine neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:malignant uterine neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mammary ductal fibroadenoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mammary ductal fibroadenoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mast cell malignancy --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mast cell malignancy | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mast cell neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mast cell neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mast cell sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mast cell sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:medullary carcinoma with lymphoid stroma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:medullary carcinoma with lymphoid stroma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:medulloblastoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:medulloblastoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:medulloepithelioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:medulloepithelioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:melanocytic neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:melanocytic neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:melanoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:melanoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:melanoma arising from blue nevus --- r_associated #0: 20 --> rhabdomyosarcome n1=en:melanoma arising from blue nevus | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:melanoma in junctional nevus --- r_associated #0: 20 --> rhabdomyosarcome n1=en:melanoma in junctional nevus | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:meningeal melanomatosis --- r_associated #0: 20 --> rhabdomyosarcome n1=en:meningeal melanomatosis | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:meningeal sarcomatosis --- r_associated #0: 20 --> rhabdomyosarcome n1=en:meningeal sarcomatosis | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:meningioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:meningioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:merkel cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:merkel cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mesenchymal chondrosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mesenchymal chondrosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mesonephric adenocarcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mesonephric adenocarcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mesonephric neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mesonephric neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mesothelial neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mesothelial neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mesothelioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mesothelioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mesothelioma (malignant, clinical disorder) (disorder) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mesothelioma (malignant, clinical disorder) (disorder) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mesothelioma, malignant, after asbestos exposure --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mesothelioma, malignant, after asbestos exposure | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metabolic aspects --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metabolic aspects | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metaplastic carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metaplastic carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastases to muscle --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastases to muscle | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastases to perineum --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastases to perineum | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastasis to lymph node from adenocarcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastasis to lymph node from adenocarcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastasis to lymph node from squamous cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastasis to lymph node from squamous cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastasizing ameloblastoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastasizing ameloblastoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastasizing leiomyoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastasizing leiomyoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastatic alveolar soft part sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastatic alveolar soft part sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastatic angiosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastatic angiosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastatic chondrosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastatic chondrosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastatic epithelioid sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastatic epithelioid sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastatic ewing sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastatic ewing sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastatic extraskeletal ewing sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastatic extraskeletal ewing sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastatic extraskeletal osteosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastatic extraskeletal osteosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastatic fibrosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastatic fibrosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastatic leiomyosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastatic leiomyosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastatic liposarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastatic liposarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastatic malignant neoplasm in the bone --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastatic malignant neoplasm in the bone | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastatic malignant neoplasm in the chest wall --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastatic malignant neoplasm in the chest wall | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastatic malignant neoplasm in the neck --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastatic malignant neoplasm in the neck | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastatic malignant neoplasm in the spine --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastatic malignant neoplasm in the spine | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastatic malignant peripheral nerve sheath tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastatic malignant peripheral nerve sheath tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastatic neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastatic neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastatic osteosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastatic osteosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastatic peripheral primitive neuroectodermal tumor of bone --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastatic peripheral primitive neuroectodermal tumor of bone | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastatic qualifier --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastatic qualifier | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastatic synovial sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastatic synovial sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:metastatic undifferentiated pleomorphic sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:metastatic undifferentiated pleomorphic sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:microbiological --- r_associated #0: 20 --> rhabdomyosarcome n1=en:microbiological | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:microcystic adnexal carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:microcystic adnexal carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:micropapillary transitional cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:micropapillary transitional cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:minimal deviation malignant melanoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:minimal deviation malignant melanoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mir29b2 gene --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mir29b2 gene | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mir29b2 wt allele --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mir29b2 wt allele | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mir29c gene --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mir29c gene | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mir29c wt allele --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mir29c wt allele | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:miscellaneous and site unspecified neoplasms benign --- r_associated #0: 20 --> rhabdomyosarcome n1=en:miscellaneous and site unspecified neoplasms benign | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:miscellaneous and site unspecified neoplasms malignant and unspecified --- r_associated #0: 20 --> rhabdomyosarcome n1=en:miscellaneous and site unspecified neoplasms malignant and unspecified | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mixed acinar-ductal carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mixed acinar-ductal carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mixed epithelioid and spindle cell melanoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mixed epithelioid and spindle cell melanoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mixed germ cell tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mixed germ cell tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mixed glioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mixed glioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mixed liposarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mixed liposarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mixed mesodermal (mullerian) tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mixed mesodermal (mullerian) tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mixed tumor, mesodermal --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mixed tumor, mesodermal | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mixed type rhabdomyosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mixed type rhabdomyosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:monomorphic cells, medium-sized, with round nuclei, multiple nucleoli, and moderate amount of cytoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:monomorphic cells, medium-sized, with round nuclei, multiple nucleoli, and moderate amount of cytoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mosaic variegated aneuploidy syndrome --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mosaic variegated aneuploidy syndrome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mouse cardiac rhabdomyosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mouse cardiac rhabdomyosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mouse rhabdomyosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mouse rhabdomyosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mucin-producing adenocarcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mucin-producing adenocarcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mucoepidermoid carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mucoepidermoid carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mucoepidermoid tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mucoepidermoid tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mucosal lentiginous melanoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mucosal lentiginous melanoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:mucosal neuromas --- r_associated #0: 20 --> rhabdomyosarcome n1=en:mucosal neuromas | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:multiple bilateral renal angiomyolipoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:multiple bilateral renal angiomyolipoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:multiple giant cell granulomas (bones, joints, soft tissues) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:multiple giant cell granulomas (bones, joints, soft tissues) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:multiple schwannomas --- r_associated #0: 20 --> rhabdomyosarcome n1=en:multiple schwannomas | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:multiple tumors --- r_associated #0: 20 --> rhabdomyosarcome n1=en:multiple tumors | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:multiple tumors in 28% of patients --- r_associated #0: 20 --> rhabdomyosarcome n1=en:multiple tumors in 28% of patients | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:multiple tumors in 74% of patients --- r_associated #0: 20 --> rhabdomyosarcome n1=en:multiple tumors in 74% of patients | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:muscle cell --- r_associated #0: 20 --> rhabdomyosarcome n1=en:muscle cell | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:muscle tissue --- r_associated #0: 20 --> rhabdomyosarcome n1=en:muscle tissue | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:muscle tumor, special type --- r_associated #0: 20 --> rhabdomyosarcome n1=en:muscle tumor, special type | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:muscle tumors (all subtypes) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:muscle tumors (all subtypes) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:myelodysplastic syndrome --- r_associated #0: 20 --> rhabdomyosarcome n1=en:myelodysplastic syndrome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:myelodysplastic syndrome with isolated del(5q) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:myelodysplastic syndrome with isolated del(5q) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:myelodysplastic syndrome, no icd-o subtype --- r_associated #0: 20 --> rhabdomyosarcome n1=en:myelodysplastic syndrome, no icd-o subtype | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:myeloid sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:myeloid sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:myeloliposarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:myeloliposarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:myeloproliferative neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:myeloproliferative neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:myocardial rhabdomyoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:myocardial rhabdomyoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:myogenic sarcoma, nos --- r_associated #0: 20 --> rhabdomyosarcome n1=en:myogenic sarcoma, nos | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:myomatous neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:myomatous neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:myosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:myosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:myxofibrosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:myxofibrosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:myxoid chondrosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:myxoid chondrosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:myxoid leiomyosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:myxoid leiomyosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:myxoid liposarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:myxoid liposarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:myxoid subcutaneous tumors --- r_associated #0: 20 --> rhabdomyosarcome n1=en:myxoid subcutaneous tumors | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:myxoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:myxoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:myxomatous neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:myxomatous neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:myxosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:myxosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:nci ctep sdc rhabdomyosarcoma sub-category terminology --- r_associated #0: 20 --> rhabdomyosarcome n1=en:nci ctep sdc rhabdomyosarcoma sub-category terminology | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:nci ctep simplified disease classification terminology --- r_associated #0: 20 --> rhabdomyosarcome n1=en:nci ctep simplified disease classification terminology | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:ncit neoplasm core terminology --- r_associated #0: 20 --> rhabdomyosarcome n1=en:ncit neoplasm core terminology | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:ncoa1 gene --- r_associated #0: 20 --> rhabdomyosarcome n1=en:ncoa1 gene | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:ncoa1 wt allele --- r_associated #0: 20 --> rhabdomyosarcome n1=en:ncoa1 wt allele | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neonatal research network terminology --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neonatal research network terminology | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasm by morphology --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasm by morphology | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasm by site --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasm by site | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasm by special category --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasm by special category | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasm of muscle of head --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasm of muscle of head | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasm of muscle of lower limb --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasm of muscle of lower limb | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasm of muscle of neck --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasm of muscle of neck | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasm of muscle of trunk --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasm of muscle of trunk | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasm of muscle of upper limb --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasm of muscle of upper limb | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasm of perivascular myoid type - category --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasm of perivascular myoid type - category | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasm of uncertain behavior of endocrine glands and nervous system --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasm of uncertain behavior of endocrine glands and nervous system | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasm of uncertain behavior of muscle --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasm of uncertain behavior of muscle | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasm of uncertain behavior of other and unspecified sites and tissues --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasm of uncertain behavior of other and unspecified sites and tissues | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasm of uncertain behavior of other specified sites --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasm of uncertain behavior of other specified sites | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasm of uncertain behavior, site unspecified --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasm of uncertain behavior, site unspecified | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasm of uncertain malignant potential --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasm of uncertain malignant potential | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasm of unspecified nature of bone, soft tissue, and skin --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasm of unspecified nature of bone, soft tissue, and skin | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasm of unspecified nature of endocrine glands and other parts of nervous system --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasm of unspecified nature of endocrine glands and other parts of nervous system | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasm of unspecified nature of other genitourinary organs --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasm of unspecified nature of other genitourinary organs | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasm of unspecified nature of other specified sites --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasm of unspecified nature of other specified sites | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasm of unspecified nature of respiratory system --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasm of unspecified nature of respiratory system | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasm related morbidities --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasm related morbidities | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasm, uncertain whether benign or malignant --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasm, uncertain whether benign or malignant | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasm/cancer invasiveness --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasm/cancer invasiveness | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasms by histologic type --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasms by histologic type | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasms of uncertain or unknown behaviour --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasms of uncertain or unknown behaviour | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasms, experimental --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasms, experimental | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasms, hormone-dependent --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasms, hormone-dependent | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasms, multiple primary --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasms, multiple primary | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasms, post-traumatic --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasms, post-traumatic | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplasms, second primary --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplasms, second primary | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplastic cell --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplastic cell | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplastic connective and soft tissue cell --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplastic connective and soft tissue cell | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplastic muscle cell --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplastic muscle cell | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplastic processes --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplastic processes | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neoplastic skeletal muscle cell --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neoplastic skeletal muscle cell | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:nervous system neoplasms malignant and unspecified nec --- r_associated #0: 20 --> rhabdomyosarcome n1=en:nervous system neoplasms malignant and unspecified nec | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:nervous system tumor morphology --- r_associated #0: 20 --> rhabdomyosarcome n1=en:nervous system tumor morphology | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neural tissue tumors --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neural tissue tumors | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neuroblastoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neuroblastoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neuroblastoma (less common) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neuroblastoma (less common) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neuroblastoma, arises anywhere along the sympathetic chain (including intracranially) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neuroblastoma, arises anywhere along the sympathetic chain (including intracranially) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neuroendocrine neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neuroendocrine neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neuroepithelioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neuroepithelioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neuroepitheliomatous neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neuroepitheliomatous neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neurofibroma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neurofibroma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neurofibromatosis type 1 --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neurofibromatosis type 1 | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neuron, neuroepithelial cell, and supporting cell of the nervous system --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neuron, neuroepithelial cell, and supporting cell of the nervous system | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:neuronal or mixed neuronal-glial neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:neuronal or mixed neuronal-glial neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:nevus and/or melanoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:nevus and/or melanoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:nijmegen breakage syndrome --- r_associated #0: 20 --> rhabdomyosarcome n1=en:nijmegen breakage syndrome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:no cancer despite harboring complete deletions of the tp53 gene --- r_associated #0: 20 --> rhabdomyosarcome n1=en:no cancer despite harboring complete deletions of the tp53 gene | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:no progression to cancer --- r_associated #0: 20 --> rhabdomyosarcome n1=en:no progression to cancer | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:nodular melanoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:nodular melanoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:non-hodgkin lymphoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:non-hodgkin lymphoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:non-keratinizing sinonasal squamous cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:non-keratinizing sinonasal squamous cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:non-small cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:non-small cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:nonmelanoma skin cancer (in some patients) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:nonmelanoma skin cancer (in some patients) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:nonseminoma (embryonal carcinoma, teratoma, choriocarcinoma, endodermal sinus tumor) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:nonseminoma (embryonal carcinoma, teratoma, choriocarcinoma, endodermal sinus tumor) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:nonseminomatous germ cell tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:nonseminomatous germ cell tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:nursing therapy --- r_associated #0: 20 --> rhabdomyosarcome n1=en:nursing therapy | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:nutritional management --- r_associated #0: 20 --> rhabdomyosarcome n1=en:nutritional management | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:odontogenic neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:odontogenic neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:olfactory neurogenic tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:olfactory neurogenic tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:oligodendroglioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:oligodendroglioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:oncocytic adenoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:oncocytic adenoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:optic glioma (19%) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:optic glioma (19%) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:optic nerve glioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:optic nerve glioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:oropharyngeal carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:oropharyngeal carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:oropharyngeal squamous cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:oropharyngeal squamous cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:osseous and/or chondromatous neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:osseous and/or chondromatous neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:osteosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:osteosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:osteosarcoma and meningioma especially --- r_associated #0: 20 --> rhabdomyosarcome n1=en:osteosarcoma and meningioma especially | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:ovarian carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:ovarian carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:ovarian cystadenoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:ovarian cystadenoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:ovarian sex cord-stromal tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:ovarian sex cord-stromal tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:overlapping malignant melanoma of skin --- r_associated #0: 20 --> rhabdomyosarcome n1=en:overlapping malignant melanoma of skin | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:overlapping malignant neoplasm of gastrointestinal tract --- r_associated #0: 20 --> rhabdomyosarcome n1=en:overlapping malignant neoplasm of gastrointestinal tract | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:overlapping malignant neoplasm of ill-defined site --- r_associated #0: 20 --> rhabdomyosarcome n1=en:overlapping malignant neoplasm of ill-defined site | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:overlapping malignant neoplasm of lip, oral cavity and pharynx --- r_associated #0: 20 --> rhabdomyosarcome n1=en:overlapping malignant neoplasm of lip, oral cavity and pharynx | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:oxyphilic adenocarcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:oxyphilic adenocarcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:paget disease and intraductal carcinoma of the breast --- r_associated #0: 20 --> rhabdomyosarcome n1=en:paget disease and intraductal carcinoma of the breast | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:paget's disease and infiltrating duct carcinoma of breast --- r_associated #0: 20 --> rhabdomyosarcome n1=en:paget's disease and infiltrating duct carcinoma of breast | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:paired box protein pax-3 --- r_associated #0: 20 --> rhabdomyosarcome n1=en:paired box protein pax-3 | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:pancreatic acinar cell cystadenocarcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:pancreatic acinar cell cystadenocarcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:pancreatic adenocarcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:pancreatic adenocarcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:pancreatic carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:pancreatic carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:pancreatic squamous cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:pancreatic squamous cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:pancreatoblastoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:pancreatoblastoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:papillary meningioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:papillary meningioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:papillary neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:papillary neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:papillary renal cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:papillary renal cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:papillary thyroid carcinoma (rare) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:papillary thyroid carcinoma (rare) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:papillary transitional cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:papillary transitional cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:paraganglioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:paraganglioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:paraganglioma, catecholamine-secreting --- r_associated #0: 20 --> rhabdomyosarcome n1=en:paraganglioma, catecholamine-secreting | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:paragangliomas, head and neck (31%) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:paragangliomas, head and neck (31%) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:paragangliomas, head and neck (79%) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:paragangliomas, head and neck (79%) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:paraneoplastic sps is associated with autoantibodies to amphiphysin (amph, 600418) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:paraneoplastic sps is associated with autoantibodies to amphiphysin (amph, 600418) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:paraneoplastic sps is associated with breast cancer and other malignancies --- r_associated #0: 20 --> rhabdomyosarcome n1=en:paraneoplastic sps is associated with breast cancer and other malignancies | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:paraneoplastic syndrome --- r_associated #0: 20 --> rhabdomyosarcome n1=en:paraneoplastic syndrome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:parasitology --- r_associated #0: 20 --> rhabdomyosarcome n1=en:parasitology | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:parathyroid disease rare --- r_associated #0: 20 --> rhabdomyosarcome n1=en:parathyroid disease rare | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:parathyroid gland adenoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:parathyroid gland adenoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:parathyroid gland carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:parathyroid gland carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:parosteal osteosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:parosteal osteosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:parotid gland adenoma and adenocarcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:parotid gland adenoma and adenocarcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:parotid gland monomorphic adenoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:parotid gland monomorphic adenoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:parotid oncocytomas --- r_associated #0: 20 --> rhabdomyosarcome n1=en:parotid oncocytomas | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:pathological aspects --- r_associated #0: 20 --> rhabdomyosarcome n1=en:pathological aspects | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:pediatric adverse events terminology --- r_associated #0: 20 --> rhabdomyosarcome n1=en:pediatric adverse events terminology | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:pediatric terminology --- r_associated #0: 20 --> rhabdomyosarcome n1=en:pediatric terminology | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:periampullary carcinoma nos --- r_associated #0: 20 --> rhabdomyosarcome n1=en:periampullary carcinoma nos | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:periosteal chondrosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:periosteal chondrosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:periosteal fibrosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:periosteal fibrosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:periosteal osteosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:periosteal osteosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:peripheral primitive neuroectodermal tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:peripheral primitive neuroectodermal tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:peripheral primitive neuroectodermal tumor of bone --- r_associated #0: 20 --> rhabdomyosarcome n1=en:peripheral primitive neuroectodermal tumor of bone | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:peripheral primitive neuroectodermal tumor of soft tissues --- r_associated #0: 20 --> rhabdomyosarcome n1=en:peripheral primitive neuroectodermal tumor of soft tissues | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:pharmacotherapeutic --- r_associated #0: 20 --> rhabdomyosarcome n1=en:pharmacotherapeutic | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:pheochromocytoma, adrenal (53%) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:pheochromocytoma, adrenal (53%) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:pheochromocytoma, extraadrenal (21%) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:pheochromocytoma, extraadrenal (21%) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:pheochromocytomas, adrenal (28%) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:pheochromocytomas, adrenal (28%) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:pheochromocytomas, extraadrenal (48%) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:pheochromocytomas, extraadrenal (48%) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:phyllodes tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:phyllodes tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:physiopathological --- r_associated #0: 20 --> rhabdomyosarcome n1=en:physiopathological | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:pilocytic astrocytoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:pilocytic astrocytoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:pilomatrical carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:pilomatrical carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:pinealoma (trilateral retinoblastoma) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:pinealoma (trilateral retinoblastoma) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:pituitary gland adenoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:pituitary gland adenoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:pituitary gland carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:pituitary gland carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:plasma cell myeloma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:plasma cell myeloma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:plasma cell myeloma/plasmacytoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:plasma cell myeloma/plasmacytoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:plasma cell neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:plasma cell neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:pleomorphic liposarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:pleomorphic liposarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:pleomorphic rhabdomyosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:pleomorphic rhabdomyosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:pleuropulmonary blastoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:pleuropulmonary blastoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:polycythemia vera --- r_associated #0: 20 --> rhabdomyosarcome n1=en:polycythemia vera | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:polyembryoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:polyembryoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:polygonal cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:polygonal cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:polymorphous low grade adenocarcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:polymorphous low grade adenocarcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:poorly differentiated carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:poorly differentiated carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:poorly differentiated fibrosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:poorly differentiated fibrosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:poorly differentiated sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:poorly differentiated sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:possible increased risk of germ-cell tumors --- r_associated #0: 20 --> rhabdomyosarcome n1=en:possible increased risk of germ-cell tumors | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:possibly increased risk for other cancers --- r_associated #0: 20 --> rhabdomyosarcome n1=en:possibly increased risk for other cancers | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:possibly increased risk of cancer --- r_associated #0: 20 --> rhabdomyosarcome n1=en:possibly increased risk of cancer | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:precancerous condition --- r_associated #0: 20 --> rhabdomyosarcome n1=en:precancerous condition | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:precursor b-lymphoblastic leukemia/lymphoblastic lymphoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:precursor b-lymphoblastic leukemia/lymphoblastic lymphoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:predisposition to uv-induced malignancies --- r_associated #0: 20 --> rhabdomyosarcome n1=en:predisposition to uv-induced malignancies | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:pregnancy complications, neoplastic --- r_associated #0: 20 --> rhabdomyosarcome n1=en:pregnancy complications, neoplastic | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary adrenocortical nodular hyperplasia --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary adrenocortical nodular hyperplasia | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary malignant adenomatous neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary malignant adenomatous neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary malignant liver neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary malignant liver neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary malignant neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary malignant neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary malignant neoplasm of articular cartilage --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary malignant neoplasm of articular cartilage | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary malignant neoplasm of back --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary malignant neoplasm of back | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary malignant neoplasm of bone --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary malignant neoplasm of bone | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary malignant neoplasm of ear, nose and/or throat --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary malignant neoplasm of ear, nose and/or throat | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary malignant neoplasm of endocrine gland --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary malignant neoplasm of endocrine gland | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary malignant neoplasm of gastrointestinal tract --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary malignant neoplasm of gastrointestinal tract | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary malignant neoplasm of head --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary malignant neoplasm of head | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary malignant neoplasm of ill-defined site --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary malignant neoplasm of ill-defined site | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary malignant neoplasm of independent multiple sites --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary malignant neoplasm of independent multiple sites | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary malignant neoplasm of lower limb --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary malignant neoplasm of lower limb | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary malignant neoplasm of muscle --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary malignant neoplasm of muscle | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary malignant neoplasm of neck --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary malignant neoplasm of neck | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary malignant neoplasm of nervous system --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary malignant neoplasm of nervous system | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary malignant neoplasm of paraganglion --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary malignant neoplasm of paraganglion | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary malignant neoplasm of respiratory tract --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary malignant neoplasm of respiratory tract | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary malignant neoplasm of soft tissues --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary malignant neoplasm of soft tissues | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary malignant neoplasm of sweat gland --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary malignant neoplasm of sweat gland | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary malignant neoplasm of trunk --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary malignant neoplasm of trunk | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary malignant neoplasm of unknown site --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary malignant neoplasm of unknown site | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary malignant neoplasm of unspecified site (clinical) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary malignant neoplasm of unspecified site (clinical) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary malignant neoplasm of upper limb (disorder) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary malignant neoplasm of upper limb (disorder) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary myelofibrosis --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary myelofibrosis | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primary undifferentiated large cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primary undifferentiated large cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:primitive neuroectodermal tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:primitive neuroectodermal tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:prolactin-producing pituitary gland adenoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:prolactin-producing pituitary gland adenoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:prolymphocytic lymphosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:prolymphocytic lymphosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:propensity to tumor development --- r_associated #0: 20 --> rhabdomyosarcome n1=en:propensity to tumor development | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:prostate carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:prostate carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:psammomatous melanotic schwannomas --- r_associated #0: 20 --> rhabdomyosarcome n1=en:psammomatous melanotic schwannomas | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:pseudoglandular squamous cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:pseudoglandular squamous cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:psychology qualifier --- r_associated #0: 20 --> rhabdomyosarcome n1=en:psychology qualifier | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:radiation-related neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:radiation-related neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:radiation-related sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:radiation-related sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:radiotherapeutic --- r_associated #0: 20 --> rhabdomyosarcome n1=en:radiotherapeutic | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:rarely malignant --- r_associated #0: 20 --> rhabdomyosarcome n1=en:rarely malignant | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:reactive immunoproliferative disease --- r_associated #0: 20 --> rhabdomyosarcome n1=en:reactive immunoproliferative disease | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:recurrent alveolar soft part sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:recurrent alveolar soft part sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:recurrent chondrosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:recurrent chondrosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:recurrent epithelioid sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:recurrent epithelioid sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:recurrent ewing sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:recurrent ewing sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:recurrent extraskeletal ewing sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:recurrent extraskeletal ewing sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:recurrent extraskeletal osteosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:recurrent extraskeletal osteosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:recurrent leiomyosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:recurrent leiomyosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:recurrent liposarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:recurrent liposarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:recurrent malignant mesothelioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:recurrent malignant mesothelioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:recurrent malignant peripheral nerve sheath tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:recurrent malignant peripheral nerve sheath tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:recurrent osteosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:recurrent osteosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:recurrent peripheral primitive neuroectodermal tumor of bone --- r_associated #0: 20 --> rhabdomyosarcome n1=en:recurrent peripheral primitive neuroectodermal tumor of bone | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:recurrent rhabdomyosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:recurrent rhabdomyosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:recurrent synovial sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:recurrent synovial sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:recurrent undifferentiated pleomorphic sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:recurrent undifferentiated pleomorphic sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:refractory anemia --- r_associated #0: 20 --> rhabdomyosarcome n1=en:refractory anemia | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:refractory anemia with excess blasts --- r_associated #0: 20 --> rhabdomyosarcome n1=en:refractory anemia with excess blasts | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:refractory anemia with excess blasts in transformation --- r_associated #0: 20 --> rhabdomyosarcome n1=en:refractory anemia with excess blasts in transformation | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:refractory anemia with ring sideroblasts --- r_associated #0: 20 --> rhabdomyosarcome n1=en:refractory anemia with ring sideroblasts | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:refractory cytopenia with multilineage dysplasia --- r_associated #0: 20 --> rhabdomyosarcome n1=en:refractory cytopenia with multilineage dysplasia | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:refractory cytopenia with multilineage dysplasia and ring sideroblasts --- r_associated #0: 20 --> rhabdomyosarcome n1=en:refractory cytopenia with multilineage dysplasia and ring sideroblasts | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:regressed germ cell tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:regressed germ cell tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:regressing melanoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:regressing melanoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:rehabilitation aspects --- r_associated #0: 20 --> rhabdomyosarcome n1=en:rehabilitation aspects | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:renal and urinary tract neoplasms benign --- r_associated #0: 20 --> rhabdomyosarcome n1=en:renal and urinary tract neoplasms benign | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:renal and urinary tract neoplasms malignant and unspecified --- r_associated #0: 20 --> rhabdomyosarcome n1=en:renal and urinary tract neoplasms malignant and unspecified | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:renal cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:renal cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:renal cell carcinoma (less common) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:renal cell carcinoma (less common) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:renal cell carcinoma, solitary papillary type 2 (about 20% of patients) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:renal cell carcinoma, solitary papillary type 2 (about 20% of patients) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:renal cell carcinoma, usually clear cell type --- r_associated #0: 20 --> rhabdomyosarcome n1=en:renal cell carcinoma, usually clear cell type | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:renal cortical adenoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:renal cortical adenoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:reported colon and other abdominal cancer in relatives --- r_associated #0: 20 --> rhabdomyosarcome n1=en:reported colon and other abdominal cancer in relatives | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:reproductive and genitourinary neoplasms gender unspecified nec --- r_associated #0: 20 --> rhabdomyosarcome n1=en:reproductive and genitourinary neoplasms gender unspecified nec | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:reproductive neoplasms female malignant and unspecified --- r_associated #0: 20 --> rhabdomyosarcome n1=en:reproductive neoplasms female malignant and unspecified | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:reproductive neoplasms male malignant and unspecified --- r_associated #0: 20 --> rhabdomyosarcome n1=en:reproductive neoplasms male malignant and unspecified | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:respiratory and mediastinal neoplasms benign (excl mesotheliomas) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:respiratory and mediastinal neoplasms benign (excl mesotheliomas) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:respiratory and mediastinal neoplasms malignant and unspecified --- r_associated #0: 20 --> rhabdomyosarcome n1=en:respiratory and mediastinal neoplasms malignant and unspecified | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:retinoblastoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:retinoblastoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:retroperitoneal sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:retroperitoneal sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:rhabdoid tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:rhabdoid tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:rhabdoid tumors, malignant (renal or extrarenal) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:rhabdoid tumors, malignant (renal or extrarenal) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:rhabdomyoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:rhabdomyoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:rhabdomyomatous neoplasm - category --- r_associated #0: 20 --> rhabdomyosarcome n1=en:rhabdomyomatous neoplasm - category | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:rhabdomyosarcoma - category --- r_associated #0: 20 --> rhabdomyosarcome n1=en:rhabdomyosarcoma - category | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:rhabdomyosarcoma 1 --- r_associated #0: 20 --> rhabdomyosarcome n1=en:rhabdomyosarcoma 1 | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:rhabdomyosarcoma of the mouse prostate gland --- r_associated #0: 20 --> rhabdomyosarcome n1=en:rhabdomyosarcoma of the mouse prostate gland | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:rhabdomyosarcoma of the mouse skin --- r_associated #0: 20 --> rhabdomyosarcome n1=en:rhabdomyosarcoma of the mouse skin | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:rhabdomyosarcoma previously treated --- r_associated #0: 20 --> rhabdomyosarcome n1=en:rhabdomyosarcoma previously treated | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:rhabdomyosarcoma previously untreated --- r_associated #0: 20 --> rhabdomyosarcome n1=en:rhabdomyosarcoma previously untreated | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:rhabdomyosarcoma, embryonal, 2 --- r_associated #0: 20 --> rhabdomyosarcome n1=en:rhabdomyosarcoma, embryonal, 2 | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:roentgenographic --- r_associated #0: 20 --> rhabdomyosarcome n1=en:roentgenographic | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:round cell liposarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:round cell liposarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sacrococcygeal teratoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sacrococcygeal teratoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sarcoma by ajcc grade --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sarcoma by ajcc grade | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sarcoma by fnclcc grade --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sarcoma by fnclcc grade | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sarcoma by nci grade --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sarcoma by nci grade | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sarcoma of back --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sarcoma of back | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sarcoma of head and neck --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sarcoma of head and neck | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sarcoma of pelvis --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sarcoma of pelvis | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sarcoma of posterior mediastinum --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sarcoma of posterior mediastinum | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sarcoma, experimental --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sarcoma, experimental | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sarcoma, metastatic --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sarcoma, metastatic | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sarcomatoid carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sarcomatoid carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sarcomatoid mesothelioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sarcomatoid mesothelioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sarcomatoid squamous cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sarcomatoid squamous cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sarcomatoid transitional cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sarcomatoid transitional cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sarcomatosis --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sarcomatosis | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:schwannoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:schwannoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sebaceous adenoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sebaceous adenoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sebaceous carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sebaceous carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sebaceous epithelioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sebaceous epithelioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:second primary malignant neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:second primary malignant neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:secondary malignant neoplasm of soft tissues --- r_associated #0: 20 --> rhabdomyosarcome n1=en:secondary malignant neoplasm of soft tissues | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:secondary osteosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:secondary osteosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:secretory breast carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:secretory breast carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:seminoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:seminoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sensitivity to genotoxic agents --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sensitivity to genotoxic agents | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:seromucinous carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:seromucinous carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sertoli cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sertoli cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sertoli cell tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sertoli cell tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sertoli-leydig cell ovarian tumors may occur --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sertoli-leydig cell ovarian tumors may occur | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sertoli-leydig cell tumor, poorly differentiated --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sertoli-leydig cell tumor, poorly differentiated | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sertoli-leydig cell tumor, poorly differentiated, with heterologous elements --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sertoli-leydig cell tumor, poorly differentiated, with heterologous elements | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sex cord-stromal tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sex cord-stromal tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:signet ring cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:signet ring cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sinonasal undifferentiated carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sinonasal undifferentiated carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:skeletal muscle cell --- r_associated #0: 20 --> rhabdomyosarcome n1=en:skeletal muscle cell | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:skeletal muscle neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:skeletal muscle neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:skeletal neoplasms benign --- r_associated #0: 20 --> rhabdomyosarcome n1=en:skeletal neoplasms benign | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:skeletal neoplasms malignant and unspecified --- r_associated #0: 20 --> rhabdomyosarcome n1=en:skeletal neoplasms malignant and unspecified | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:skin adenoid basal cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:skin adenoid basal cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:skin appendage tumors may show malignant transformation --- r_associated #0: 20 --> rhabdomyosarcome n1=en:skin appendage tumors may show malignant transformation | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:skin basal cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:skin basal cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:skin basosquamous cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:skin basosquamous cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:skin cancer susceptibility --- r_associated #0: 20 --> rhabdomyosarcome n1=en:skin cancer susceptibility | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:skin fibroepithelial basal cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:skin fibroepithelial basal cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:skin infiltrating basal cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:skin infiltrating basal cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:skin metatypical carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:skin metatypical carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:skin nodular basal cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:skin nodular basal cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:skin sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:skin sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:skin squamous cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:skin squamous cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:slc22a18 gene --- r_associated #0: 20 --> rhabdomyosarcome n1=en:slc22a18 gene | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:slc22a18 wt allele --- r_associated #0: 20 --> rhabdomyosarcome n1=en:slc22a18 wt allele | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:small cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:small cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:small cell carcinoma carcinomatosis --- r_associated #0: 20 --> rhabdomyosarcome n1=en:small cell carcinoma carcinomatosis | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:small cell carcinoma of the ovary, hypercalcemic type --- r_associated #0: 20 --> rhabdomyosarcome n1=en:small cell carcinoma of the ovary, hypercalcemic type | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:small cell carcinoma, fusiform cell type --- r_associated #0: 20 --> rhabdomyosarcome n1=en:small cell carcinoma, fusiform cell type | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:small cell intermediate cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:small cell intermediate cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:small cell osteosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:small cell osteosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:small cell sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:small cell sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:small intestinal carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:small intestinal carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:small intestine carcinoid --- r_associated #0: 20 --> rhabdomyosarcome n1=en:small intestine carcinoid | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:smooth muscle neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:smooth muscle neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:smooth muscle tumor of uncertain malignant potential --- r_associated #0: 20 --> rhabdomyosarcome n1=en:smooth muscle tumor of uncertain malignant potential | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:soft tissue neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:soft tissue neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:soft tissue neoplasms malignant and unspecified --- r_associated #0: 20 --> rhabdomyosarcome n1=en:soft tissue neoplasms malignant and unspecified | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:soft tissue neoplasms malignant and unspecified nec (excl sarcomas) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:soft tissue neoplasms malignant and unspecified nec (excl sarcomas) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:soft tissue sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:soft tissue sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:soft tissue sarcomas histology unspecified --- r_associated #0: 20 --> rhabdomyosarcome n1=en:soft tissue sarcomas histology unspecified | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:soft tissue tumor and/or sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:soft tissue tumor and/or sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:solid neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:solid neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:solid papillary carcinoma with invasion --- r_associated #0: 20 --> rhabdomyosarcome n1=en:solid papillary carcinoma with invasion | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:solid pseudopapillary carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:solid pseudopapillary carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:somatostatin-producing neuroendocrine tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:somatostatin-producing neuroendocrine tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:spindle cell melanoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:spindle cell melanoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:spindle cell rhabdomyosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:spindle cell rhabdomyosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:spindle cell sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:spindle cell sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:spiradenocarcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:spiradenocarcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:spongioneuroblastoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:spongioneuroblastoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:squamous cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:squamous cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:squamous cell carcinoma (1 patient) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:squamous cell carcinoma (1 patient) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:squamous cell carcinoma (skin and tongue) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:squamous cell carcinoma (skin and tongue) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:squamous cell carcinoma (skin or mucosa) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:squamous cell carcinoma (skin or mucosa) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:squamous cell carcinoma in area of palmoplantar keratoderma (rare) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:squamous cell carcinoma in area of palmoplantar keratoderma (rare) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:squamous epitheliomas, multiple --- r_associated #0: 20 --> rhabdomyosarcome n1=en:squamous epitheliomas, multiple | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:starry sky pattern --- r_associated #0: 20 --> rhabdomyosarcome n1=en:starry sky pattern | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:statistical association of extensive metabolism (em, wildtype) and malignancy, especially smoking-induced lung cancer --- r_associated #0: 20 --> rhabdomyosarcome n1=en:statistical association of extensive metabolism (em, wildtype) and malignancy, especially smoking-induced lung cancer | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:steroid cell tumor, malignant --- r_associated #0: 20 --> rhabdomyosarcome n1=en:steroid cell tumor, malignant | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:stim1 gene --- r_associated #0: 20 --> rhabdomyosarcome n1=en:stim1 gene | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:stim1 wt allele --- r_associated #0: 20 --> rhabdomyosarcome n1=en:stim1 wt allele | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:storiform-pleomorphic malignant fibrous histiocytoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:storiform-pleomorphic malignant fibrous histiocytoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:stromal interaction molecule 1 --- r_associated #0: 20 --> rhabdomyosarcome n1=en:stromal interaction molecule 1 | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:stromal sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:stromal sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:subependymoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:subependymoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:superficial multifocal basal cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:superficial multifocal basal cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:superficial spreading melanoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:superficial spreading melanoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:surgical aspects --- r_associated #0: 20 --> rhabdomyosarcome n1=en:surgical aspects | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:susceptibility to malignant melanoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:susceptibility to malignant melanoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:susceptibility to myelodysplasia --- r_associated #0: 20 --> rhabdomyosarcome n1=en:susceptibility to myelodysplasia | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:susceptibility to myeloid leukemia --- r_associated #0: 20 --> rhabdomyosarcome n1=en:susceptibility to myeloid leukemia | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:sweat gland adenocarcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:sweat gland adenocarcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:synovial neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:synovial neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:synovial sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:synovial sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:synovial sarcoma - category --- r_associated #0: 20 --> rhabdomyosarcome n1=en:synovial sarcoma - category | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:synovial-like neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:synovial-like neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:syringocystadenoma papilliferum --- r_associated #0: 20 --> rhabdomyosarcome n1=en:syringocystadenoma papilliferum | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:t lymphoblastic leukemia/lymphoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:t lymphoblastic leukemia/lymphoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:t-cell non-hodgkin lymphoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:t-cell non-hodgkin lymphoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:taxonomic --- r_associated #0: 20 --> rhabdomyosarcome n1=en:taxonomic | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:telangiectatic osteosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:telangiectatic osteosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:teratoid medulloepithelioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:teratoid medulloepithelioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:teratoid tumor, atypical --- r_associated #0: 20 --> rhabdomyosarcome n1=en:teratoid tumor, atypical | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:testicular sertoli cell tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:testicular sertoli cell tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:testicular sertoli cell tumor, calcified --- r_associated #0: 20 --> rhabdomyosarcome n1=en:testicular sertoli cell tumor, calcified | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:testicular sex cord-stromal tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:testicular sex cord-stromal tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:testicular spermatocytic seminoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:testicular spermatocytic seminoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:tetraspanin-32 --- r_associated #0: 20 --> rhabdomyosarcome n1=en:tetraspanin-32 | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:therapeutic aspects --- r_associated #0: 20 --> rhabdomyosarcome n1=en:therapeutic aspects | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:therapy-related myelodysplastic syndrome --- r_associated #0: 20 --> rhabdomyosarcome n1=en:therapy-related myelodysplastic syndrome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:thymic carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:thymic carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:thymoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:thymoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:thymoma type b3 --- r_associated #0: 20 --> rhabdomyosarcome n1=en:thymoma type b3 | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:thyroid cancer (follicular cell) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:thyroid cancer (follicular cell) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:thyroid follicular cell tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:thyroid follicular cell tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:thyroid gland carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:thyroid gland carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:thyroid gland carcinoma showing thymus-like differentiation --- r_associated #0: 20 --> rhabdomyosarcome n1=en:thyroid gland carcinoma showing thymus-like differentiation | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:thyroid gland diffuse sclerosing papillary carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:thyroid gland diffuse sclerosing papillary carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:thyroid gland medullary carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:thyroid gland medullary carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:thyroid gland oncocytic adenoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:thyroid gland oncocytic adenoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:thyroid gland oncocytic neoplasm --- r_associated #0: 20 --> rhabdomyosarcome n1=en:thyroid gland oncocytic neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:thyroid gland papillary carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:thyroid gland papillary carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:thyroid gland spindle cell tumor with thymus-like differentiation --- r_associated #0: 20 --> rhabdomyosarcome n1=en:thyroid gland spindle cell tumor with thymus-like differentiation | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:tracheal carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:tracheal carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:transitional cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:transitional cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:trichilemmocarcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:trichilemmocarcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:trichoblastoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:trichoblastoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:trichoepitheliomas may rarely show malignant transformation to basal cell carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:trichoepitheliomas may rarely show malignant transformation to basal cell carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:trophoblastic tumor --- r_associated #0: 20 --> rhabdomyosarcome n1=en:trophoblastic tumor | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:tspan32 gene --- r_associated #0: 20 --> rhabdomyosarcome n1=en:tspan32 gene | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:tspan32 wt allele --- r_associated #0: 20 --> rhabdomyosarcome n1=en:tspan32 wt allele | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:tssc4 gene --- r_associated #0: 20 --> rhabdomyosarcome n1=en:tssc4 gene | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:tssc4 protein --- r_associated #0: 20 --> rhabdomyosarcome n1=en:tssc4 protein | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:tssc4 wt allele --- r_associated #0: 20 --> rhabdomyosarcome n1=en:tssc4 wt allele | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:tumor cells, benign --- r_associated #0: 20 --> rhabdomyosarcome n1=en:tumor cells, benign | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:tumor in vein --- r_associated #0: 20 --> rhabdomyosarcome n1=en:tumor in vein | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:tumors at multiple other sites including cns --- r_associated #0: 20 --> rhabdomyosarcome n1=en:tumors at multiple other sites including cns | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:tumors of the sympathetic nervous system (5 to 10%) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:tumors of the sympathetic nervous system (5 to 10%) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:turcot syndrome --- r_associated #0: 20 --> rhabdomyosarcome n1=en:turcot syndrome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:type a spindle cell melanoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:type a spindle cell melanoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:type b spindle cell melanoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:type b spindle cell melanoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:ultrastructure --- r_associated #0: 20 --> rhabdomyosarcome n1=en:ultrastructure | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:undifferentiated (embryonal) sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:undifferentiated (embryonal) sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:undifferentiated carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:undifferentiated carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:undifferentiated high grade pleomorphic sarcoma of bone --- r_associated #0: 20 --> rhabdomyosarcome n1=en:undifferentiated high grade pleomorphic sarcoma of bone | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:undifferentiated pleomorphic sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:undifferentiated pleomorphic sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:undifferentiated pleomorphic sarcoma with osteoclast-like giant cells --- r_associated #0: 20 --> rhabdomyosarcome n1=en:undifferentiated pleomorphic sarcoma with osteoclast-like giant cells | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:undifferentiated pleomorphic sarcoma, inflammatory variant --- r_associated #0: 20 --> rhabdomyosarcome n1=en:undifferentiated pleomorphic sarcoma, inflammatory variant | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:undifferentiated sarcoma, not otherwise specified --- r_associated #0: 20 --> rhabdomyosarcome n1=en:undifferentiated sarcoma, not otherwise specified | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:unilateral vestibular schwannoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:unilateral vestibular schwannoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:urethral carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:urethral carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:use of ultrasonography --- r_associated #0: 20 --> rhabdomyosarcome n1=en:use of ultrasonography | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:uterine cancer --- r_associated #0: 20 --> rhabdomyosarcome n1=en:uterine cancer | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:uterine leiomyosarcoma (less common) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:uterine leiomyosarcoma (less common) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:uveal melanoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:uveal melanoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:vaccine-induced fibrosarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:vaccine-induced fibrosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:vagus nerve paraganglioma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:vagus nerve paraganglioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:verrucous carcinoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:verrucous carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:vestibular schwannoma (over 90% of patients) --- r_associated #0: 20 --> rhabdomyosarcome n1=en:vestibular schwannoma (over 90% of patients) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:veterinary aspects --- r_associated #0: 20 --> rhabdomyosarcome n1=en:veterinary aspects | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:viruses --- r_associated #0: 20 --> rhabdomyosarcome n1=en:viruses | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:vulvar sarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:vulvar sarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 en:well differentiated liposarcoma --- r_associated #0: 20 --> rhabdomyosarcome n1=en:well differentiated liposarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 muscle --- r_associated #0: 20 --> rhabdomyosarcome n1=muscle | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 pathologie --- r_associated #0: 20 --> rhabdomyosarcome n1=pathologie | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 pathologie du muscle strié --- r_associated #0: 20 --> rhabdomyosarcome n1=pathologie du muscle strié | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 tissu musculaire strié squelettique --- r_associated #0: 20 --> rhabdomyosarcome n1=tissu musculaire strié squelettique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20 maladie (médecine) --- r_associated #0: 19 --> rhabdomyosarcome n1=maladie (médecine) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=19 tumeur maligne --- r_associated #0: 18 --> rhabdomyosarcome n1=tumeur maligne | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=18 Adénocarcinome --- r_associated #0: 15 --> rhabdomyosarcome n1=Adénocarcinome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 Cancer osseux --- r_associated #0: 15 --> rhabdomyosarcome n1=Cancer osseux | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 Igbo Ora (virus) --- r_associated #0: 15 --> rhabdomyosarcome n1=Igbo Ora (virus) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 Prostate --- r_associated #0: 15 --> rhabdomyosarcome n1=Prostate | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 adénocarcinome --- r_associated #0: 15 --> rhabdomyosarcome n1=adénocarcinome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 adénome à cellules oncocytaires --- r_associated #0: 15 --> rhabdomyosarcome n1=adénome à cellules oncocytaires | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 anémie médullaire --- r_associated #0: 15 --> rhabdomyosarcome n1=anémie médullaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 cancer pancréatique --- r_associated #0: 15 --> rhabdomyosarcome n1=cancer pancréatique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 cancer épidermoïde --- r_associated #0: 15 --> rhabdomyosarcome n1=cancer épidermoïde | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 carcinome acineux --- r_associated #0: 15 --> rhabdomyosarcome n1=carcinome acineux | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 carcinome du pancreas --- r_associated #0: 15 --> rhabdomyosarcome n1=carcinome du pancreas | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 carcinome glandulaire et malpighien --- r_associated #0: 15 --> rhabdomyosarcome n1=carcinome glandulaire et malpighien | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 carcinome malpighien --- r_associated #0: 15 --> rhabdomyosarcome n1=carcinome malpighien | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 carcinome mixte glandulaire et spinocellulaire --- r_associated #0: 15 --> rhabdomyosarcome n1=carcinome mixte glandulaire et spinocellulaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 carcinome médullaire de la thyroïde --- r_associated #0: 15 --> rhabdomyosarcome n1=carcinome médullaire de la thyroïde | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 carcinome spino-cellulaire --- r_associated #0: 15 --> rhabdomyosarcome n1=carcinome spino-cellulaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 en:rhabdosarcoma --- r_associated #0: 15 --> rhabdomyosarcome n1=en:rhabdosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 fibroxanthome malin --- r_associated #0: 15 --> rhabdomyosarcome n1=fibroxanthome malin | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 histiocytome fibreux malin stade non spécifié --- r_associated #0: 15 --> rhabdomyosarcome n1=histiocytome fibreux malin stade non spécifié | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 lam --- r_associated #0: 15 --> rhabdomyosarcome n1=lam | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 lanl --- r_associated #0: 15 --> rhabdomyosarcome n1=lanl | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 leucémie aiguë myélocytaire --- r_associated #0: 15 --> rhabdomyosarcome n1=leucémie aiguë myélocytaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 leucémie aiguë non lymphocytaire --- r_associated #0: 15 --> rhabdomyosarcome n1=leucémie aiguë non lymphocytaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 leucémie aigüe non lymphoblastique --- r_associated #0: 15 --> rhabdomyosarcome n1=leucémie aigüe non lymphoblastique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 leucémie blastique granulocytaire --- r_associated #0: 15 --> rhabdomyosarcome n1=leucémie blastique granulocytaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 leucémie granuleuse aiguë --- r_associated #0: 15 --> rhabdomyosarcome n1=leucémie granuleuse aiguë | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 leucémie myéloblastique aiguë --- r_associated #0: 15 --> rhabdomyosarcome n1=leucémie myéloblastique aiguë | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 leucémie myélogène aiguë --- r_associated #0: 15 --> rhabdomyosarcome n1=leucémie myélogène aiguë | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 leucémie myélogène aigüe --- r_associated #0: 15 --> rhabdomyosarcome n1=leucémie myélogène aigüe | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 leucémie myéloïde aiguë --- r_associated #0: 15 --> rhabdomyosarcome n1=leucémie myéloïde aiguë | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 leucémie non lymphoblastique aiguë --- r_associated #0: 15 --> rhabdomyosarcome n1=leucémie non lymphoblastique aiguë | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 lymphome malin diffus --- r_associated #0: 15 --> rhabdomyosarcome n1=lymphome malin diffus | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 lymphome à cellules b --- r_associated #0: 15 --> rhabdomyosarcome n1=lymphome à cellules b | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 non précisée, anémie aplasique --- r_associated #0: 15 --> rhabdomyosarcome n1=non précisée, anémie aplasique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 tumeur d'autres sites précisés à évolution imprévisible ou inconnue --- r_associated #0: 15 --> rhabdomyosarcome n1=tumeur d'autres sites précisés à évolution imprévisible ou inconnue | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 tumeur d'autres sièges précisés à évolution imprévisible ou inconnue --- r_associated #0: 15 --> rhabdomyosarcome n1=tumeur d'autres sièges précisés à évolution imprévisible ou inconnue | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 tumeur de bénignité ou de malignité non assurée --- r_associated #0: 15 --> rhabdomyosarcome n1=tumeur de bénignité ou de malignité non assurée | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 tumeur maligne pancréatique --- r_associated #0: 15 --> rhabdomyosarcome n1=tumeur maligne pancréatique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 tumeur neuroectodermique périphérique primitive --- r_associated #0: 15 --> rhabdomyosarcome n1=tumeur neuroectodermique périphérique primitive | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 tumeur primitive neuroectodermique --- r_associated #0: 15 --> rhabdomyosarcome n1=tumeur primitive neuroectodermique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=15 sarcome des tissus mous --- r_associated #0: 11 --> rhabdomyosarcome n1=sarcome des tissus mous | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=11 Cancers --- r_associated #0: 10 --> rhabdomyosarcome n1=Cancers | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 Cancérologie --- r_associated #0: 10 --> rhabdomyosarcome n1=Cancérologie | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 Costello (syndrome de) --- r_associated #0: 10 --> rhabdomyosarcome n1=Costello (syndrome de) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 Oncologie --- r_associated #0: 10 --> rhabdomyosarcome n1=Oncologie | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 Sarcome --- r_associated #0: 10 --> rhabdomyosarcome n1=Sarcome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 Syndrome de Costello --- r_associated #0: 10 --> rhabdomyosarcome n1=Syndrome de Costello | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 Tumeurs --- r_associated #0: 10 --> rhabdomyosarcome n1=Tumeurs | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 Vincent (signe de) --- r_associated #0: 10 --> rhabdomyosarcome n1=Vincent (signe de) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 Vincristine --- r_associated #0: 10 --> rhabdomyosarcome n1=Vincristine | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 acral lentiginous melanoma --- r_associated #0: 10 --> rhabdomyosarcome n1=acral lentiginous melanoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 anémie aplasique --- r_associated #0: 10 --> rhabdomyosarcome n1=anémie aplasique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 anémie aplasique non précisée --- r_associated #0: 10 --> rhabdomyosarcome n1=anémie aplasique non précisée | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 aplasie médullaire --- r_associated #0: 10 --> rhabdomyosarcome n1=aplasie médullaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 aplasie érythrocytaire --- r_associated #0: 10 --> rhabdomyosarcome n1=aplasie érythrocytaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 balloon cell melanoma --- r_associated #0: 10 --> rhabdomyosarcome n1=balloon cell melanoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 cancer de l'oeil --- r_associated #0: 10 --> rhabdomyosarcome n1=cancer de l'oeil | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 cancer de l'ovaire --- r_associated #0: 10 --> rhabdomyosarcome n1=cancer de l'ovaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 cancer de l'utérus --- r_associated #0: 10 --> rhabdomyosarcome n1=cancer de l'utérus | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 cancer des os --- r_associated #0: 10 --> rhabdomyosarcome n1=cancer des os | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 cancer du pancréas --- r_associated #0: 10 --> rhabdomyosarcome n1=cancer du pancréas | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 cancer endométrial --- r_associated #0: 10 --> rhabdomyosarcome n1=cancer endométrial | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 carcinome adéno-squameux --- r_associated #0: 10 --> rhabdomyosarcome n1=carcinome adéno-squameux | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 carcinome du pancréas --- r_associated #0: 10 --> rhabdomyosarcome n1=carcinome du pancréas | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 carcinome endométrial --- r_associated #0: 10 --> rhabdomyosarcome n1=carcinome endométrial | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 carcinome glandulaire --- r_associated #0: 10 --> rhabdomyosarcome n1=carcinome glandulaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 carcinome mixte glandulaire et épidermoïde --- r_associated #0: 10 --> rhabdomyosarcome n1=carcinome mixte glandulaire et épidermoïde | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 carcinome pancréatique --- r_associated #0: 10 --> rhabdomyosarcome n1=carcinome pancréatique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 carcinome spinocellulaire --- r_associated #0: 10 --> rhabdomyosarcome n1=carcinome spinocellulaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 carcinome squameux --- r_associated #0: 10 --> rhabdomyosarcome n1=carcinome squameux | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 cellule tumorale --- r_associated #0: 10 --> rhabdomyosarcome n1=cellule tumorale | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 en:adenocarcinoma of colon --- r_associated #0: 10 --> rhabdomyosarcome n1=en:adenocarcinoma of colon | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 en:histiocytosis, langerhans-cell --- r_associated #0: 10 --> rhabdomyosarcome n1=en:histiocytosis, langerhans-cell | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 en:in situ cancer --- r_associated #0: 10 --> rhabdomyosarcome n1=en:in situ cancer | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 gliome --- r_associated #0: 10 --> rhabdomyosarcome n1=gliome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 hamartoma --- r_associated #0: 10 --> rhabdomyosarcome n1=hamartoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 histiocytofibrome malin --- r_associated #0: 10 --> rhabdomyosarcome n1=histiocytofibrome malin | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 histiocytome malin --- r_associated #0: 10 --> rhabdomyosarcome n1=histiocytome malin | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 histiocytose à cellules de langerhans --- r_associated #0: 10 --> rhabdomyosarcome n1=histiocytose à cellules de langerhans | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 la recherche contre le cancer --- r_associated #0: 10 --> rhabdomyosarcome n1=la recherche contre le cancer | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 la recherche sur le cancer --- r_associated #0: 10 --> rhabdomyosarcome n1=la recherche sur le cancer | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 la à granulocytes --- r_associated #0: 10 --> rhabdomyosarcome n1=la à granulocytes | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 leucose --- r_associated #0: 10 --> rhabdomyosarcome n1=leucose | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 leucémie aiguë granulocytaire --- r_associated #0: 10 --> rhabdomyosarcome n1=leucémie aiguë granulocytaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 leucémie aiguë myéloïde --- r_associated #0: 10 --> rhabdomyosarcome n1=leucémie aiguë myéloïde | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 leucémie aiguë non lymphoblastique --- r_associated #0: 10 --> rhabdomyosarcome n1=leucémie aiguë non lymphoblastique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 leucémie aigüe myéloblastique --- r_associated #0: 10 --> rhabdomyosarcome n1=leucémie aigüe myéloblastique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 leucémie aigüe myéloïde --- r_associated #0: 10 --> rhabdomyosarcome n1=leucémie aigüe myéloïde | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 leucémie granulocytaire aiguë --- r_associated #0: 10 --> rhabdomyosarcome n1=leucémie granulocytaire aiguë | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 leucémie myélocytaire aiguë --- r_associated #0: 10 --> rhabdomyosarcome n1=leucémie myélocytaire aiguë | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 leucémies myéloïdes aiguës --- r_associated #0: 10 --> rhabdomyosarcome n1=leucémies myéloïdes aiguës | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 lymphome --- r_associated #0: 10 --> rhabdomyosarcome n1=lymphome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 lymphome malin non hodgkinien --- r_associated #0: 10 --> rhabdomyosarcome n1=lymphome malin non hodgkinien | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 lymphome malin à cellules à noyaux non encochés --- r_associated #0: 10 --> rhabdomyosarcome n1=lymphome malin à cellules à noyaux non encochés | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 lymphome non hodgkinien --- r_associated #0: 10 --> rhabdomyosarcome n1=lymphome non hodgkinien | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 lymphomes non hodgkiniens --- r_associated #0: 10 --> rhabdomyosarcome n1=lymphomes non hodgkiniens | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 léiomyosarcome --- r_associated #0: 10 --> rhabdomyosarcome n1=léiomyosarcome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 muscle jambier antérieur --- r_associated #0: 10 --> rhabdomyosarcome n1=muscle jambier antérieur | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 myopie forte (génétique) --- r_associated #0: 10 --> rhabdomyosarcome n1=myopie forte (génétique) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 myélofibrose primaire --- r_associated #0: 10 --> rhabdomyosarcome n1=myélofibrose primaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 myélofibrose primitive --- r_associated #0: 10 --> rhabdomyosarcome n1=myélofibrose primitive | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 mélanome --- r_associated #0: 10 --> rhabdomyosarcome n1=mélanome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 mélanome à cellules fusiformes --- r_associated #0: 10 --> rhabdomyosarcome n1=mélanome à cellules fusiformes | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 mélanome à cellules fusiformes de type b --- r_associated #0: 10 --> rhabdomyosarcome n1=mélanome à cellules fusiformes de type b | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 méningiome --- r_associated #0: 10 --> rhabdomyosarcome n1=méningiome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 naevocarcinome à cellules fusiformes --- r_associated #0: 10 --> rhabdomyosarcome n1=naevocarcinome à cellules fusiformes | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 naevocarcinome à cellules fusiformes de type b --- r_associated #0: 10 --> rhabdomyosarcome n1=naevocarcinome à cellules fusiformes de type b | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 neuro-épithéliome --- r_associated #0: 10 --> rhabdomyosarcome n1=neuro-épithéliome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 neuroépithéliome --- r_associated #0: 10 --> rhabdomyosarcome n1=neuroépithéliome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 néoplasme bénin --- r_associated #0: 10 --> rhabdomyosarcome n1=néoplasme bénin | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 parasitologie --- r_associated #0: 10 --> rhabdomyosarcome n1=parasitologie | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 partie non précisée tumeur maligne du pancréas --- r_associated #0: 10 --> rhabdomyosarcome n1=partie non précisée tumeur maligne du pancréas | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 polycythemia vera --- r_associated #0: 10 --> rhabdomyosarcome n1=polycythemia vera | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 processus néoplasiques --- r_associated #0: 10 --> rhabdomyosarcome n1=processus néoplasiques | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 prospective (étude) --- r_associated #0: 10 --> rhabdomyosarcome n1=prospective (étude) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 recherche contre le cancer --- r_associated #0: 10 --> rhabdomyosarcome n1=recherche contre le cancer | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 recherche sur le cancer --- r_associated #0: 10 --> rhabdomyosarcome n1=recherche sur le cancer | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 sarcoïde de Spiegler-Fendt (sarcoïde de ) --- r_associated #0: 10 --> rhabdomyosarcome n1=sarcoïde de Spiegler-Fendt (sarcoïde de ) | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 schwannogliome --- r_associated #0: 10 --> rhabdomyosarcome n1=schwannogliome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 syringocystadénome papillaire --- r_associated #0: 10 --> rhabdomyosarcome n1=syringocystadénome papillaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 taxinomique --- r_associated #0: 10 --> rhabdomyosarcome n1=taxinomique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 thymome --- r_associated #0: 10 --> rhabdomyosarcome n1=thymome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 tricho-épithéliome --- r_associated #0: 10 --> rhabdomyosarcome n1=tricho-épithéliome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 trichoépithéliome --- r_associated #0: 10 --> rhabdomyosarcome n1=trichoépithéliome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 tumeur --- r_associated #0: 10 --> rhabdomyosarcome n1=tumeur | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 tumeur bénigne --- r_associated #0: 10 --> rhabdomyosarcome n1=tumeur bénigne | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 tumeur cancéreuse --- r_associated #0: 10 --> rhabdomyosarcome n1=tumeur cancéreuse | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 tumeur du pancréas --- r_associated #0: 10 --> rhabdomyosarcome n1=tumeur du pancréas | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 tumeur maligne d'un ovaire --- r_associated #0: 10 --> rhabdomyosarcome n1=tumeur maligne d'un ovaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 tumeur maligne de la peau --- r_associated #0: 10 --> rhabdomyosarcome n1=tumeur maligne de la peau | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 tumeur maligne du pancréas --- r_associated #0: 10 --> rhabdomyosarcome n1=tumeur maligne du pancréas | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 tumeur maligne oesophagienne --- r_associated #0: 10 --> rhabdomyosarcome n1=tumeur maligne oesophagienne | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 tumeur maligne ovarienne --- r_associated #0: 10 --> rhabdomyosarcome n1=tumeur maligne ovarienne | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 tumeur maligne utérine --- r_associated #0: 10 --> rhabdomyosarcome n1=tumeur maligne utérine | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 tumeur à cellules folliculaires thyroïdiennes --- r_associated #0: 10 --> rhabdomyosarcome n1=tumeur à cellules folliculaires thyroïdiennes | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 tumeur à cellules fusiformes de la glande thyroïde avec différenciation thymus-like --- r_associated #0: 10 --> rhabdomyosarcome n1=tumeur à cellules fusiformes de la glande thyroïde avec différenciation thymus-like | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 épithélioma spinocellulaire --- r_associated #0: 10 --> rhabdomyosarcome n1=épithélioma spinocellulaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=10 rhabdomyosarcome polymorphe de l'adulte --- r_associated #0: 6 --> rhabdomyosarcome n1=rhabdomyosarcome polymorphe de l'adulte | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=6 IgD --- r_associated #0: 5 --> rhabdomyosarcome n1=IgD | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 IgE --- r_associated #0: 5 --> rhabdomyosarcome n1=IgE | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 adénocarcinome du côlon --- r_associated #0: 5 --> rhabdomyosarcome n1=adénocarcinome du côlon | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 adénocarcinome endométrial --- r_associated #0: 5 --> rhabdomyosarcome n1=adénocarcinome endométrial | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 adénome oncocytaire --- r_associated #0: 5 --> rhabdomyosarcome n1=adénome oncocytaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 anémie aplastique --- r_associated #0: 5 --> rhabdomyosarcome n1=anémie aplastique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 anémie par aplasie médullaire --- r_associated #0: 5 --> rhabdomyosarcome n1=anémie par aplasie médullaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 anémie par atteinte isolée de la lignée rouge --- r_associated #0: 5 --> rhabdomyosarcome n1=anémie par atteinte isolée de la lignée rouge | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 aplasie de globules rouges purs --- r_associated #0: 5 --> rhabdomyosarcome n1=aplasie de globules rouges purs | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 aplasie des globules rouges purs --- r_associated #0: 5 --> rhabdomyosarcome n1=aplasie des globules rouges purs | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 aplasie isolée de la lignée rouge --- r_associated #0: 5 --> rhabdomyosarcome n1=aplasie isolée de la lignée rouge | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 aplasie primitive de la lignée rouge --- r_associated #0: 5 --> rhabdomyosarcome n1=aplasie primitive de la lignée rouge | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 astrocytome --- r_associated #0: 5 --> rhabdomyosarcome n1=astrocytome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 cancer cutané --- r_associated #0: 5 --> rhabdomyosarcome n1=cancer cutané | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 cancer de la peau --- r_associated #0: 5 --> rhabdomyosarcome n1=cancer de la peau | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 cancer médullaire de la thyroïde --- r_associated #0: 5 --> rhabdomyosarcome n1=cancer médullaire de la thyroïde | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 carcinoma --- r_associated #0: 5 --> rhabdomyosarcome n1=carcinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 carcinome adénosquameux --- r_associated #0: 5 --> rhabdomyosarcome n1=carcinome adénosquameux | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 carcinome de l'endomètre --- r_associated #0: 5 --> rhabdomyosarcome n1=carcinome de l'endomètre | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 carcinome intra-épithélial --- r_associated #0: 5 --> rhabdomyosarcome n1=carcinome intra-épithélial | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 carcinome épidermoïde --- r_associated #0: 5 --> rhabdomyosarcome n1=carcinome épidermoïde | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 cellule épithéliale --- r_associated #0: 5 --> rhabdomyosarcome n1=cellule épithéliale | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 craniopharyngiome classique --- r_associated #0: 5 --> rhabdomyosarcome n1=craniopharyngiome classique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 craniopharyngiome de l'adulte --- r_associated #0: 5 --> rhabdomyosarcome n1=craniopharyngiome de l'adulte | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 craniopharyngiome papillaire --- r_associated #0: 5 --> rhabdomyosarcome n1=craniopharyngiome papillaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 en:Nijmegen breakage syndrome --- r_associated #0: 5 --> rhabdomyosarcome n1=en:Nijmegen breakage syndrome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 en:malignant neoplasm of skin --- r_associated #0: 5 --> rhabdomyosarcome n1=en:malignant neoplasm of skin | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 hamartome --- r_associated #0: 5 --> rhabdomyosarcome n1=hamartome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 histiocytose langerhansienne --- r_associated #0: 5 --> rhabdomyosarcome n1=histiocytose langerhansienne | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 histiocytose à cellules de Langerhans --- r_associated #0: 5 --> rhabdomyosarcome n1=histiocytose à cellules de Langerhans | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 hystiocytose à cellules de langerhans --- r_associated #0: 5 --> rhabdomyosarcome n1=hystiocytose à cellules de langerhans | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 leucémie aiguë myéloblastique --- r_associated #0: 5 --> rhabdomyosarcome n1=leucémie aiguë myéloblastique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 leucémie myéloblastique aigüe --- r_associated #0: 5 --> rhabdomyosarcome n1=leucémie myéloblastique aigüe | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 leucémie myéloïde aigüe --- r_associated #0: 5 --> rhabdomyosarcome n1=leucémie myéloïde aigüe | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 lipome --- r_associated #0: 5 --> rhabdomyosarcome n1=lipome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 muscle tibial antérieur --- r_associated #0: 5 --> rhabdomyosarcome n1=muscle tibial antérieur | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 méningiome angiomateux --- r_associated #0: 5 --> rhabdomyosarcome n1=méningiome angiomateux | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 neurinome --- r_associated #0: 5 --> rhabdomyosarcome n1=neurinome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 sarcome a petites cellules --- r_associated #0: 5 --> rhabdomyosarcome n1=sarcome a petites cellules | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 sarcome granulocytaire --- r_associated #0: 5 --> rhabdomyosarcome n1=sarcome granulocytaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 sarcome à petites cellules --- r_associated #0: 5 --> rhabdomyosarcome n1=sarcome à petites cellules | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 schwannome --- r_associated #0: 5 --> rhabdomyosarcome n1=schwannome | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 syringocystadénome papillifère --- r_associated #0: 5 --> rhabdomyosarcome n1=syringocystadénome papillifère | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 tumeur bénigne de la peau --- r_associated #0: 5 --> rhabdomyosarcome n1=tumeur bénigne de la peau | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 tumeur dans la veine --- r_associated #0: 5 --> rhabdomyosarcome n1=tumeur dans la veine | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 tumeur de l'oeil --- r_associated #0: 5 --> rhabdomyosarcome n1=tumeur de l'oeil | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 tumeur maligne de l'ovaire --- r_associated #0: 5 --> rhabdomyosarcome n1=tumeur maligne de l'ovaire | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 tumeur maligne de l'utérus --- r_associated #0: 5 --> rhabdomyosarcome n1=tumeur maligne de l'utérus | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 tumeur maligne des os --- r_associated #0: 5 --> rhabdomyosarcome n1=tumeur maligne des os | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 tumeur maligne osseuse --- r_associated #0: 5 --> rhabdomyosarcome n1=tumeur maligne osseuse | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 tumeur neuro-ectodermique primitive --- r_associated #0: 5 --> rhabdomyosarcome n1=tumeur neuro-ectodermique primitive | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 tumeur non classée de bénignité ou de malignité incertaine --- r_associated #0: 5 --> rhabdomyosarcome n1=tumeur non classée de bénignité ou de malignité incertaine | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 tumeur pancréatique maligne --- r_associated #0: 5 --> rhabdomyosarcome n1=tumeur pancréatique maligne | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 tumeurs du pancreas --- r_associated #0: 5 --> rhabdomyosarcome n1=tumeurs du pancreas | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 tumeurs à plusieurs autres sites, y compris le système nerveux central --- r_associated #0: 5 --> rhabdomyosarcome n1=tumeurs à plusieurs autres sites, y compris le système nerveux central | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 épithélioma malin --- r_associated #0: 5 --> rhabdomyosarcome n1=épithélioma malin | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=5 en:orbit rhabdomyosarcoma --- r_associated #0: 1 --> rhabdomyosarcome n1=en:orbit rhabdomyosarcoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome alvéolaire, de nature primitive ou secondaire non assurée --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome alvéolaire, de nature primitive ou secondaire non assurée | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome alvéolaire, métastatique --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome alvéolaire, métastatique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome avec différenciation ganglionnaire, de nature primitive ou secondaire non assurée --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome avec différenciation ganglionnaire, de nature primitive ou secondaire non assurée | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome avec différenciation ganglionnaire, métastatique --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome avec différenciation ganglionnaire, métastatique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome embryonnaire pléomorphe, de nature primitive ou secondaire non assurée --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome embryonnaire pléomorphe, de nature primitive ou secondaire non assurée | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome embryonnaire pléomorphe, métastatique --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome embryonnaire pléomorphe, métastatique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome embryonnaire, de nature primitive ou secondaire non assurée --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome embryonnaire, de nature primitive ou secondaire non assurée | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome embryonnaire, métastatique --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome embryonnaire, métastatique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome mixte embryonnaire et alvéolaire, de nature primitive ou secondaire non assurée --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome mixte embryonnaire et alvéolaire, de nature primitive ou secondaire non assurée | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome mixte embryonnaire et alvéolaire, métastatique --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome mixte embryonnaire et alvéolaire, métastatique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome non traité antérieurement --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome non traité antérieurement | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome pléomorphe --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome pléomorphe | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome pléomorphe, de nature primitive ou secondaire non assurée --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome pléomorphe, de nature primitive ou secondaire non assurée | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome pléomorphe, métastatique --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome pléomorphe, métastatique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome pléomorphe, sai --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome pléomorphe, sai | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome polymorphe de l'adulte, de nature primitive ou secondaire non assurée --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome polymorphe de l'adulte, de nature primitive ou secondaire non assurée | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome polymorphe de l'adulte, métastatique --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome polymorphe de l'adulte, métastatique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome récidivant --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome récidivant | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome traité antérieurement --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome traité antérieurement | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome à cellularité mixte, de nature primitive ou secondaire non assurée --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome à cellularité mixte, de nature primitive ou secondaire non assurée | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome à cellularité mixte, métastatique --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome à cellularité mixte, métastatique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome à cellules fusiformes, de nature primitive ou secondaire non assurée --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome à cellules fusiformes, de nature primitive ou secondaire non assurée | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome à cellules fusiformes, métastatique --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome à cellules fusiformes, métastatique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome, de nature primitive ou secondaire non assurée --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome, de nature primitive ou secondaire non assurée | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome, métastatique --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome, métastatique | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1 rhabdomyosarcome, sai --- r_associated #0: 1 --> rhabdomyosarcome n1=rhabdomyosarcome, sai | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=1